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FRONTISPIECE
DEFINITION AND CONVENTION
Absorption of a constituent of diet is the process in which it is taken up by the 
intestine and transferred to the body.
Bioavailability is the efficiency with which a nutrient is absorbed from a diet and 
utilised by the body.
The net luminal disappearance of constituent of diet is the difference between input 
and output, and it is determined by the use of isotopic tracers and is synonymous 
with luminal disappearance throughout this study.
Stable isotopes are indicated with the mass number as a preceding superscript e.g. 
58Fe
Radioactive isotopes are indicated with the mass number as a following script e.g. 
Fe-59
Subject identities: In the measurement of net luminal disappearance with rare earth 
markers, three investigations are described: Recovery of markers determined by 
INAA, recovery of markers by CNAA, and an investigation of the net luminal 
disappearance of Fe and Zn with account of marker recovery. In compilation of 
results, subjects in three studies are identified with prefixes A, B, and C.
ABBREVIATIONS
57La: Lanthanum 
62Sm: Samarium 
66Dy: Dysprosium
70Yb: Ytterbium
ZRE: Rare earth (elements)
Ce: Cerium 59Pr Praseodymium 60Nd: Neodymium
Eu: Europium 64Gd: Gadolinium 65Tb:Terbium
58
63
67
71
Ho: Holmium 
Lu: Lutetium
68Er Erbium 69Tm: Thulium
61Pm: Promethium (Radioactive)
NAA: Nuclear activation analysis 
INAA: Instrumental NAA
CNAA: NAA with chemical separation before or after irradiation 
HPGe: High purity germanium
ICP-MS: Inductively coupled plasma mass spectrometry 
AAS: Atomic absorption spectrophotometry
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SUMMARY
Previous studies for determination of intestinal uptake of trace elements by 
faecal monitoring using enriched stable isotopic tracers have required 
extended collection of faecal output to ensure quantitative recovery of 
excreted tracer. This requirement can lead to underestimation of 'absorption1 
since the contribution of 're-excreted' isotopic tracer initially taken up can not 
be identified. The use of non-absorbable dietary markers can enable account 
to be taken of faecal recoveries achieved in a reduced period of collection, 
removing the inconvenience of long-term collection of faeces and extending 
the potential applications of such investigations.
Faecal recoveries of rare earths and their excretion kinetics have been 
investigated to confirm that they meet the required criteria for nutritional 
markers. Particular attention is given to the extent to which markers duplicate 
the behaviour of tracers. Determination of intestinal uptake of iron and zinc 
by combined use of enriched stable isotopic tracers and rare earths as 
markers is then considered.
La, Sm, Eu, Tb, and Yb were administered to two healthy subjects with their 
lunch. Faecal samples were collected for 1 day before (baseline) and their 
concentrations in faecal output were determined by instrumental neutron 
activation analysis. The recovery investigation was then extended to six 
subjects with the rare earth contents of samples being separated by ion- 
exchange before irradiation, to minimize radiation exposure during analysis. 
This reduced the time required for analysis and improved limits of detection. 
Faecal recoveries of rare earths are interpreted in terms of profiles of 
excretion as a function of time and kinetic parameters.
Having established that recoveries of rare earths in faeces for a week after 
consumption were nearly quantitative, their application to determine intestinal 
uptake of iron and zinc is considered. Procedures for determination of
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intestinal uptake from a standard drink containing ferrous sulphate labelled 
with 57Fe tracer and Sm marker, and from a wheat flour based meal 
containing ferric chloride and zinc labelled with “ Fe and 70Zn tracers and Yb 
marker were established.
Seven healthy subjects consumed the standard solution and meal at a 3 day 
interval. Faecal samples were collected for 10 days starting from day before 
the first administration. Urine samples were collected for 24 h before the first 
and for 24 h after each administrations. Blood samples also were taken at 
the end of collection period to establish if there is any relation between 
intestinal uptake of iron and ferritin concentrations in blood serum.
Following ion exchange column separation, concentrations of Sm and Yb 
markers, and “ Fe and 70Zn tracers were determined by neutron activation 
analysis. 57Fe and natural background levels of rare earths in faeces and 
urine were determined by inductively coupled plasma mass spectrometry. 
Total iron and zinc contents of faecal samples were determined by atomic 
absorption spectrophotometry, to enable account to be taken of the isotopic 
contribution of iron and zinc of natural composition to enrichment in the 
faecal pool.
Faecal recoveries are interpreted in terms of the intestinal kinetic behaviour 
of markers and tracers and Intestinal uptake of tracers are derived from 
recoveries of markers and tracers for individual samples and for composites 
of sequential faecal outputs.
Recovery profiles of the rare earths show that they appear within 24 hours 
after consumption, and reach a maximum in 48 hours. The major fraction of 
recovery is with the first two samples, and recoveries with the three samples 
are not significantly different from recoveries with the first four or five 
samples.
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For iron consumed with a standard solution, intestinal uptakes obtained for 
composites of the first two and three samples are significantly different from 
those for composites of the first four samples and total collection. Correlation 
between serum ferritin levels and intestinal uptakes obtained for composites 
of the first two samples, and total collection suggest that iron is bioavailable 
in the ferrous state, taken up by the intestine and transferred into circulating 
blood at a slow rate, whilst a significant fraction is excreted with exfoliated 
epithelial cells.
Intestinal uptakes of iron consumed with the farina meal are more consistent 
and there is no significant differences between composites of the first two, 
three, and four samples, but not for composites of the following samples. 
This can be explained by the contribution of retarded excretion of iron intially 
taken up becoming significant in the later collections.
Intestinal uptakes of zinc, obtained from composites of the first to five 
samples are not significantly different. Excretion of endogenous zinc is 
approximately equivalent to its daily absorption.
For determination of intestinal uptake of essential trace elements with 
reduced faecal collection by the combined use of enriched stable isotopic 
tracers and rare earths as markers has been established for iron and zinc for 
specified conditions. It has been shown that rare earths enable such 
investigations with multi-isotopes/elements. It is anticipated that the method 
developed should be widely applicable to unconfined situations and 
vulnerable groups of subjects such as children and pregnant women.
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I. INTRODUCTION
Investigations to evaluate the adequacy of dietary intake are of increasing 
concern because of the effects of nutrition on health. The increased incidence 
of obesity, cardiovascular diseases, and some cancers etc is related to over 
nutrition with immense social and health care costs. In countries where some 
2 000 million suffer from anaemia, growth failure, delayed motor and mental 
development, impaired immunocompetence, and high risks of complications 
and death from infectious disease, 40 000 children under the age of five die 
every day from conditions related to under nutrition or inadequate food quality 
or variety (leading to deficiencies of vitamins and essential minerals (Parr and 
Fjeld, 1994).
Iron and zinc are recognized as essential trace elements for life competency. 
Although much is known about the functions and required amounts of these 
elements, further investigation is required to reveal their interactions with the 
constituents of dietary intake, and to optimize dietary bioavailabiiity, so 
enabling efficient use of resources. Investigations are also required for 
development of methodology to extend the knowledge of the absorption 
mechanism of essential trace elements and their utilization.
Trace element absorption is frequently measured by the difference between 
the element content of intake and output (balance), but this is not precise 
enough to measure low absorption, does not take account of the contribution 
of endogenously excreted elements to faecal losses, and requires reliable 
cooperation of subjects, usually involving confinement in a metabolic unit for 
an extended period of at least a week. Furthermore this technique does not 
measure 'absorption', it measures luminal disappearance and one can not 
presume that the difference between oral intake and faecal loss represents 
the amount transfered to the body, particularly when applied to trace 
elements. Isotopic tracer techniques, using either radioactive or enriched 
stable isotopes are highly suitable for trace element research. Investigations
1
involving radioactive tracers are prohibited for vulnerable population groups 
such as pregnant women and young children. Current opinion is opposed to 
any use unless clinically necessary. In applications with stable isotopic tracers, 
the major limitation is that enriched isotopes are expensive, so the number of 
subjects in an investigation may be limited.
Methods of determining absorption from a dietary source labelled with isotopic 
tracer involve measurement of the incorporated enrichment in systemic tissues 
(appearance method) or the difference between the amounts of isotopic tracer 
in input and in faecal output (disappearance method) or a combination of both 
methods. The disappearance method is non-invasive and potentially 
applicable to investigations with unconfined subjects provided that faecal 
collections are quantitative or account taken of incomplete recoveries.
Measurement of luminal disappearance with stable isotopic tracers requires 
an appropriate period of collection to ensure recovery of all excreted tracer. 
Extended periods of collection result in the inclusion of excreted endogenous 
isotope. The use of dietary non-absorbable markers would enable 
measurements from limited sample collection and also to take account of 
losses during sample collection.
2
1.1 ELEMENTAL COMPOSITION OF THE HUMAN BODY AND ESSENTIAL 
TRACE ELEMENTS
In recent decades, increasing attention has been paid to the biochemical 
behaviour of the elements, particularly at trace levels. The role of essential 
elements in nutrition and in biochemical processes in the body of man, both 
in health and disease is receiving continued attention.
Hamilton (1981) provides following useful guidelines in considering 
relationships between man and the elements ;
1. All the elements of the Periodic Table are available to enter man at some 
level of exposure and bioavailibility.
2. Above a defined level, in which the balance of elements is correct in terms 
of body requirements, all the elements are toxic.
3. When some essential elements are below a defined level, there results a 
state of primary deficiency per se, or secondary disease.
4. Substitution of one element for another sometimes occurs naturally, often 
related to their mutual relationships in the periodic table, without jeopardising 
health.
5. An abnormal concentration of an element at a disease site is not always an 
indication that the element is the primary cause of the disease.
1.1.1 CLASSIFICATION OF ELEMENTS IN THE HUMAN BODY
Chemical elements present in the body can be basically grouped into three 
categories:
1. Major elements: These elements consist of carbon, hydrogen, nitrogen, and 
oxygen which comprise 99% of body weight.
2. Minor elements: These elements maintain the electrolyte balance and 
include e.g. sodium, potassium, calcium, magnesium, chlorine.
3. Trace elements: The term 'trace elements' evolved when the elements 
could not be precisely quantified using classical methods. Although this usage 
continues, improvements in analytical sensitivity have led to the current 
definition as elements which constitutes less then one per cent of the wet 
weight of biological material, and whose concentration levels fall below a few 
part per million (Bowen, 1988 and Iyengar, 1989). A classification of the 
elements derived from Iyengar (1989), Parr (1987) and Heydom (1984) is 
provided in Table-1.
Trace elements may also be classified two groups; essential and toxic (Table- 
2). The definition and functions of the former will be discussed in the following 
section. Others are detected in human systems but no specific functions for 
them has yet been established. Elements such as Cd, Hg, Pb, and Tl are 
known to be inherently toxic, and are therefore classified as major 
environmental contaminants. There is occasional overlap in classification for 
elements such as As, F, and Se which are beneficial to health but which are 
toxic in excessive amounts.
1.1.2 ESSENTIAL TRACE ELEMENTS
An element is considered essential if an animal species deprived of it 
develops reproducible features which can be reversed or prevented by its 
intake. The nine trace elements, Fe, Zn, Cu, Mn, Se, Mo, Cr, I and Co are 
accepted as essential for optimum human health. Their biological functions, 
deficiency signs and occurrence of imbalance are summarized in Table-3, 
from Aggett (1985) and Parr (1987).
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Table-1: Classification of elements found in human tissues, and their total body 
content (Iyengar, 1989 and Parr, 1987)
MAJOR ELEMENTS (Structural) TRACE ELEMENTS
Element Amount, a % of bodv Element Amount, a % of bodv
Oxygen 43000 61 Silicon 18 0.026
Carbon 16000 23 Iron 4.2 0.006
Hydrogen 7000 10 Fluorine 2.6 0.0037
Nitrogen 1800 2.6 Zinc 2.3 0.0033
Calcium 1000 1.4 Rubidium 0.32 0.00046
Phosphorus 780 1.1 Strontium 0.32 0.00046
Sulphur 140 0.2 Bromine 0.2 0.00029
Lead 0.12 0.00017
Copper 0.072 0.0001
MINOR ELEMENTS (Electrolyte) Aluminium 0.061 0.00009
Element Amount, a % of bodv Cadmium 0.05 0.00007
Calcium 1000 1.4 Boron 0.048 0.00007
Potassium 140 0.2 Barium 0.022 0.00003
Sodium 100 0.14 Tin 0.017 0.00002
Chlorine 95 0.12 Manganese 0.012 0.00002
Magnesium 19 0.027 Iodine 0.013 0.00002
Nickel 0.01 0.00001
Gold 0.01 0.00001
Molybdenum 0.0093 0.00001
Chromium 0.0018 0.000003
Caesium 0.0015 0.000002
Cobalt 0.0015 0.000002
Uranium 0.00009 1.00e-07
Beryllium 0.000036
Radium 3.10e-11
Table-2 : Classification of trace elements found in human tissues (Heydom, 1984)
Biologically important_________  Potentially Toxic
Essential Possiblv essential
Cobalt Arsenic Arsenic
Chromium Fluorine Beryllium
Copper Nickel Cadmium
Iron Silicon Mercury
Iodine Tin Lead
Manganese Vanadium Selenium
Molybdenum Thallium
Selenium
Zinc
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Dietary deficiencies for essential elements have been reported in general 
populations for Fe, Zn, Se, I, and Ca but not for Cu, Mn, Mo, Cr, and Mg. 
Deficiencies of the latter minerals may also occur but only under special 
circumstances such as during total parenteral nutrition or the feeding of low 
birth weight infants (Hurrell et al., 1992).
Iron and zinc are the main concern of this investigation. Although their 
biochemical importance is well known, their bioavailibility from different foods, 
factors influencing their absorption and metabolism, and their homeostasis in 
health and disease requires further investigation. Optimized dietary intakes will 
enable avoidance of worldwide essential element deficiencies. Fe deficiency 
for example affects about one billion people. The incidence of Fe deficiency 
is higher in developing countries than in developed countries but overall the 
risk of Fe deficiency is greatest in populations with rapid growth, such as 
infants, young children, and in women (Tumlund et al., 1990). On the other 
hand there might be an increased risk of cancer with high levels of tissue iron 
(Knekt et al., 1994 and Stevens et al., 1994).
Zinc supplementation increases weight gain and linear growth in children who 
are zinc deficient and adolescents. Severe diseases have been known to be 
predisposing factors for Zn deficiency and such deficiency is common in 
middle east countries where high phytic acid levels in cereals and legumes 
constitute significant portion of diets consumed (Prasad, 1984). Zinc plays a 
fundamental role in expression of genetic potential; the synthesis, repair and 
structural integrity of nucleic acids require Zn (Fairweather-Tait, 1988).
Since methodological development is the subject of this investigation, a brief 
description of the absorption mechanism of Fe and Zn is provided below.
Iron absorption
Heme iron is absorbed from food more efficiently than inorganic iron. Heme 
iron enters the intestinal absorptive cell as an intact metalloporphyrin.
Subsequently, the iron is released from porphyrin in the intestinal mucosa by 
heme oxygenase and it then enters the same absorptive pathway as for 
inorganic iron.
Unlike inorganic iron, heme is soluble in alkaline solutions and is precipitated 
in an acidic medium, making chelation less important in facilitating solubility. 
Many substances that either enhance or inhibit absorption of inorganic iron 
have no effect on the absorption of heme iron because they do not chelate in 
this chemical form (Conrad and Umbreit, 1993).
"Dietary inorganic iron is solubilized at the acid pH of the stomach. It then 
combines with mucin which make the iron soluble and available for absorption 
with increasing pH in the small bowel. Integrins on the surface of the 
absorptive cell facilitate transfer of iron through the cell membrane for binding 
mobilferrin. Mobilferrin serves as the shuttle protein within the absorptive cell. 
If there is excess iron in the cell, apofemtin synthesis is stimulated and iron 
is deposited in ferritin to prevent oxidative damage to the cell from ionic iron. 
Transferrin receptors located on the basoletaral membranes of the absorptive 
cell probably act to permit iron to enter the cell from plasma similar to cells in 
other organs. In the gut, this keeps absorptive ceils attuned to the state of iron 
repletion in the body and aids in regulation of mucosal uptake of iron by 
binding or lack of binding of the proteins." (Conrad and Umbreit, 1993) Further 
discussion of iron absorption are provided by Charlton and Bothwell (1983), 
and Cook et al. (1993).
Zinc absorption
The process of zinc absorption can be divided into two processes; uptake of 
zinc from the lumen into the cell and zinc transport from the cell into 
circulatory system. Uptake or cellular entry of Zn is carrier mediated. A small 
portion of Zn uptake may also occur through simple diffusion. Subsequently, 
the receptor releases Zn intracellularly.
8
The capacity of the small intestine for Zn transport depends on the body's zinc 
requirement. Affinity for Zn is not affected by previous dietary Zn intakes. 
Thus, the increase in transport rate at low dietary Zn intakes is due only to 
increase in number of enterocyte receptors for free Zn or Zn bound to a low 
molecular weight ligand. Further discussion of the biochemistry and 
metabolism of zinc is provided by Fairweather-Tait (1988) and (Swinkels et al., 
1994).
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1.2 METHODS FOR MEASUREMENT OF TRACE ELEMENT ABSORPTION
In this section the concepts and approaches to investigating determination of 
absorption are described. Applications of isotopic tracers techniques in those 
approaches are considered with particular reference to iron and zinc.
1.2.1 TRACE ELEMENT ABSORPTION AND BIOAVAIUBIUTY
There is a need for mineral absorption and bioavailibility studies to investigate 
the dietary and physiological factors influencing mineral absorption and to 
understand the homeostatic mechanisms for adaptation to high and low 
intakes. In this way requirements for health and disease can be better defined 
and strategies can be developed so that requirements are met (Hurrell et al., 
1994).
The process of mineral metabolism can be considered as follows; "When a 
mineral is consumed as a constituent of food, a fraction is absorbed and 
passes into the blood stream, while the non-absorbed fraction passes to the 
stools. From the blood stream, some of the absorbed mineral will pass into 
body tissues and some will be excreted in urine. A second excretory pathway 
is from the body tissues back into the gut via the bile or gut secretions. This 
could include a small fraction of the dietary mineral recently absorbed, but is 
mostly mineral already present in the body. Although some of this 
endogenous mineral can be re-absorbed, the larger fraction passes into the 
stools" (Hurrell et al., 1994) (Figure-1).
DIETARY INTAKE
EXCHANGABLE BODY POOL
LU
ABSORPTION tsi
| MUCOSAL 
1 UPTAKE Z00
LU
00 SECRETION
Z
FAECAL OUTPUT
Figure-1: Schematic diagram of mineral metabolism
Bioavailibility is the fraction of any dietary nutrient consumed which is 
ultimately utilized in the body. Although bioavailibility is an important 
consideration for all nutrients, it is particularly pertinent for trace elements 
because so many factors affect their intestinal absorption and systematic use 
(Table-4).
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Table-4: Factors influencing the intestinal uptake and transfer of trace elements
(Aggett and Whitley, 1994)
SYSTEMATIC FACTORS
Anabolic demands
Growth in infancy and childhood 
Pregnancy and lactation 
Post-catabolic states 
Endocrine effects 
Infection and stress 
Specific systematic reserves of metal 
Genetic influence, inborn errors of metabolism 
Nutritional status for other nutrients
LUMINAL AND DIETARY FACTORS
Chemical form and oxidation state of element in the diet 
Presence of:
Antagonistic ligands (phosphate, carbonate, tannates, polyphenols, oxalate) 
Faciiitatory ligands (ascorbate for iron-, carboxylic acids, some sugars, amino 
acids, fatty acids)
Competing metals 
Intestinal redox state 
Luminal redox state
In practice bioavailibility is taken to be as the proportion of intake that is 
absorbed or retained in the body. Measurement of true bioavailibility requires 
determination of the appearance of minerals in specific body pools, which is 
not always practical or ethical, or is restricted usually to plasma and blood 
cells and the excretion of the nutrient in urine, so that experimental 
measurements frequently measure uptake to a specified stage (e.g. luminal 
disappearance or erythrocyte incorporation).
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Approaches to investigate trace element absorption can be classified as follows;
I. Chemical balance methods
Measurement of disappearance from the dietary pool by faecal monitoring
II. Isotopic tracer methods
Measurement of disappearance from the dietary pool by faecal monitoring 
Measurement of retention in the body by monitoring plasma appearance or tissue 
incorporation.
Simultaneous oral and intravenous isotope administration 
Compartmental modelling and kinetic analysis 
\l\. In-vitro procedures
1.2.2 CHEMICAL BALANCE METHODS
Mineral absorption by faecal monitoring has been frequently investigated by chemical 
balance. The difference between intake and faecal output of nutrient provides "net 
apparent absorption" (Same definition is also given for net luminal disappearance, 
when ’absorption' is measured by using isotopic tracers, see section 1.2.3.3) given 
. If urinary excretion is subtracted from the intake "maximum apparent retention" is 
determined, since no allowance is made for additional losses through skin, sweat, 
hair etc.
The major disadvantage in the chemical balance approach is that true absorption can 
not be determined as it is not possible to distinguish between faecal output of non­
absorbed elements of dietary origin and the same elements of endogenous origin. 
(Sandstrom et. al., 1994, Aggett and Whitley, 1994). Measurement of absorption by 
chemical balance is only applicable to studies of total diet. Measurements for 
elements which are not well absorbed can lead to large errors (Fairweather-Tait, 
1992).
In spite of its various drawbacks, the chemical balance technique offers one 
of the most definitive estimates of bioavailibility in adult man if performed 
carefully and with intakes near or below the minimal requirement (O'Dell, 1984). 
The following recent investigations demonstrate the importance of the
13
chemical balance techniques in studies which require monitoring of the effects 
of a diet for a long period of time.
Mason et. at, 1990 investigated the effect of moderately increased intakes of 
complex carbohydrates on iron and zinc balance in a study lasting 12 weeks. 
By monitoring faecal, urine and blood samples they found that there were no 
significant changes in Fe or Zn balance.
Such investigations as performed by Milne et at (1983) and Srikumar et al. 
(1992) are probably only possible with chemical balance methods. Milne et al. 
investigated the effect of dietary zinc on whole body surface loss of zinc on 
8 volunteers who lived for 6 months in a research environment under close 
supervision. The losses with whole body sweat were in a range of 0.24-0.62 
mg d'1, depending on the levels of input, suggesting that these losses reduced 
apparent balances by 12-84%, and need to be considered when evaluating 
zinc retention. Srikumar et al. (1992) measured trace element levels in faecal, 
urine, blood and hair samples from 26 subjects, switching from a mixed to a 
lactovegeterian diet for 48 months. The changes in trace element status was 
less optimal than a mixed diet with regard to Zn, Se and Cu but not for Mg. 
The investigation also revealed that drastic decrease in consumption of fish 
products (source of Hg) and alcoholic beverages (a major source of Pb) 
caused significant reduction in concentration of Hg and Pb in hair, while 
decreasing Cd concentration in hair was attributed to the higher intake of Ca 
from lactovegeterian diet depressing Cd absorption.
As an alternative to a long period of faecal monitoring for the chemical 
balance approach, a whole lavage technique has been proposed by Zheng et 
al. (1993). It was demonstrated that zinc absorption can be measured in 
humans from single foods containing a physiological dose of zinc by using a 
whole-gut lavage and that zinc bioavailibility from beef is about fourfold 
greater than from a single high-fibre breakfast cereal.
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1.2.3 ISOTOPIC TRACER METHODS
The metabolic fate of minerals can be followed by the use isotopic tracers. 
The absorbed fraction of a tracer dose can be. determined either by monitoring 
the amount appearing in the body (body, plasma or tissue monitoring) or that 
disappearing from the input (faecal monitoring). For enriched stable isotopic 
tracers, enrichment over natural abundance can be determined in serum, 
tissue, or faecal sample as required. For radioactive tracers, radioactivity can 
be measured in the same samples or by whole body counting. The 
advantages and disadvantages of these techniques are summarized in Table- 
5.
I.2.3.1 THE RADIOACTIVE TRACER TECHNIQUE
Approaches for determination of absorption were established with radioactive 
tracers until stable isotopic tracers became available. Moore etal. (1944) and 
Hahn et al. (1945) determined absorption of iron by measurement of tissue 
incorporation. This approach is still valid and enables determination of less 
than 1 % absorption of iron from foods from which it is poorly available (Cook 
et al., 1995). The metabolic fate of iron absorbed from a dose administered 
intravenously was investigated extensively with determination of losses 
through skin, urine, and luminal excretion by Dubach et al. (1955) and 
Bothwell et al. (1955). The determination of iron absorption by use of 
simultaneous oral and intravenous administration of two radioactive iron 
isotopes was established by Saylor and Finch (1953). The rate of entry of the 
isotope from the intestine into the plasma, and of the rate of disappearance 
from the plasma pool of the isotope caused by its uptake into the body tissue 
were measured. The same approach was also applied for plasma appearance 
and disappearance deconvoluation for Zn-69m by Molokhia et al. (1980).
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Table-5: Advantages and disadvantages of the stable and radioisotopic tracers
STABLE ISOTOPIC TRACERS 
Advantages
1 .They are not radioactive;
-No internal or external radiation 
-Especially useful for studies in vulnerable 
subjects (infants and women in 
reproductive years),
-Natural constituents of foods,
-Samples can be processed when 
convenient.
2.They permit multiple-labelling studies; 
-Mineral-mineral interaction studies are 
possible,
- Multiple isotopic studies are possible, 
-Longitudinal studies in the same individual 
are possible.
3.They permit studies related to group or 
field comparison studies
4.They can be measured (quantitative or 
isotopic ratio) with good sensitivity and 
precision by mainly TIMS and ICP-MS
Disadvantages
1 .Application to a substantial number of 
subjects is limited because of the high 
cost
2.Analysis techniques are expensive 
usually MS and NAA. In MS chemical 
separation is often required to eliminate 
isobaric interferences
3.The amount of stable isotope to be 
added may not represent usual dietary 
levels or the chemical form may differ from 
that found in food
RADIOISOTOPIC TRACERS
Advantages
1 .External monitoring by whole body 
counting is a reference method for 
measurement of mineral retention
2.Muttiple-labelling studies are possible 
-Mineral-mineral interaction studies are 
possible,
- Multiple isotopic studies are possible,
3.lsotope can be added as a true tracer 
without changing the total element content 
of the diet
4.They can be measured by relatively 
simple methods with easy detection in 
blood, urine or faeces
5.Relatively cheap so that a greater 
number of subjects can be studied
Disadvantages
1.They are a potential hazard of ionizing 
radiation, so are not applicable to 
vulnerable subjects
2.Muiti-labelling studies are limited with 
radiation dose accumulation
3.They require expensive measurement 
equipment
4.The time required for such studies is 
limited by the half-life of radioisotope(s)
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Whole body counting enables determination of trace element absorption by 
external monitoring and is accepted as a reference method. The fraction of a 
single dose retained can be measured in a whole body or a specific part of 
it. Examples of investigations concerned with iron and zinc metabolism are 
provided by Bothwell et al. (1955) and Will and Boddy (1967) for iron and 
Graig and Siegel (1960) and Spencer et al. (1965) for zinc.
Lunn et al. (1967) compared absorption of iron obtained from whole body 
counting with that obtained from faecal monitoring and found poor agreement 
The discrepancy was attributed to incomplete stool collection, suggesting the 
requirement for faecal marker as a yield indicator. Measurement of absorption 
with reduced faecal collection by the use of radioactive markers was 
confirmed by comparing results for absorption derived from whole body and 
faecal monitoring. Examples of investigations which compare the 2 
approaches are provided by Jasani etal. (1971) and Jasani & Fletcher (1972) 
using Fe-59 tracer and Ba-131 marker, and Payton etal. (1982) and Flanagan 
et al. (1985) using Zn-65 tracer and Cr-51 marker.
The main disadvantage of using radioactive tracers is the hazard associated 
with radiation exposure. This has partly been overcome with developments in 
radiation detection systems. Lykken (1983) used Zn-65 and Fe-59 
radioisotopes to monitor absorption and metabolism by whole body counting 
for 418 days. The radiation dose received was less than that received from 
naturally occurring radionuclides present in the body over the period of the 
study.
Although the applications of radioactive tracers in measurement of absorption 
are limited on subjects in reproductive age and vulnerable groups, 
investigations with radioactive tracers and their determination by whole body 
counting has been shown to be a reliable standard. An investigation for 
determination of zinc absorption by whole body counting with the use of 
radioactive Zn-65 tracer performed by Hunt et al. (1995) on post menopausal
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women is an example of a recent application. For monoisotopic elements, 
absorption investigations with the isotopic tracer approach are only possible 
with the use of their radioactive isotopes. The study for measurement of 
manganese (55Mn with 100% abundance) absorption (by whole body counting) 
by using Mn-54 involving men and women subjects aged 22-30 years 
(Davidsson et al., 1995) is a typical example for such elements.
I.2.3.2 THE ENRICHED STABLE ISOTOPIC TRACER TECHNIQUE
The basic principle of the enriched stable isotope approach is that an enriched 
stable isotope of an element is contained in an intake as a tracer and 
absorption is derived from enrichment determined in blood, urine, or faecal 
samples. An element must possess more than a single stable isotope to be 
amenable to the stable isotope approach. Of the 9 essential trace elements 
Mn, Co, and I are monoisotopic and thus are not amenable to the stable 
isotope approach (Table-6).
Table-6 : Stable isotope constitution of the 9 essential trace elements
Element 'Isotopes and natural abundance, %
Cr “ Cr (4.34), “ Cr (83.79), “ Cr (9.50), “ Cr (2.37)
Mn “ Mn (100)
Fe “ Fe (5.8), “ Fe (91.72), 57Fe (2.2), “ Fe (0.28)
Co “ Co (100)
Cu “ Cu (69.17), “ Cu (30.83)
Zn “ Zn (48.6), “ Zn (27.9), 87Zn (4.1), “ Zn (18.8), 70Zn (0.6)
Se 74Se (0.89), 76Se (9.36), ^Se (7.63), 78Se (23.78), “ Se (49.61), “ Se (8.73)
Mo
I
^ o  (14.84), “ Mo (9.25), “ Mo (15.92), “ Mo (16.68), 97Mo (9.55), 
“ Mo (24.13), 100Mo (9.63)
127l (1 0 0 )
* Commission of atomic weights and isotopic abundances (1991)
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The application of stable isotopic tracers in studies of human mineral 
absorption and metabolism was first described by Lowman and Krivit (1963). 
The study involved a comparison of plasma clearance rates of intravenously 
injected radioactive Fe-59 and stable 58Fe tracers. A stable isotope tracer was 
used to measure iron absorption by its incorporation in red blood cell by Dyer 
and Brill (1972). The authors measured the percentage transfer from the 
maternal plasma to infant's circulating blood at birth. Simultaneously injected 
50Cr, to measure blood volume, and 58Fe as a tracer were determined by NAA. 
Effects of oral contraceptives on mineral absorption from a daily intake 
labelled with “ Fe, 70Zn, and “ Cu with faecal monitoring and analysis by NAA 
has been described by King et al. (1978).
Extrinsic and intrinsic labelling
An isotopic tracer can be inserted into the diet in an extrinsic or intrinsic form. 
For extrinsic labelling the tracer is added to the diet as a chemical element. 
For intrinsic labelling isotopic tracer is biologically incorporated in the diet. For 
intrinsic labelling the most desirable method since the tracer incorporated with 
a nutrient represents natural food constituents.
Production of intrinsic tracers can be achieved by hydroponic cultivation, by 
direct injection to leaves of plants, by oral feeding, or by direct injection to 
animals. Labelling with these methods give low yields (Janghorbani and 
Young 1982, and Fox et al. 1991) so that it is expensive. Comparative 
absorption studies for foodstuffs intrinsically and extrinsically labelled with 
radioactive tracers (Fe-55 and Fe-59) have shown that absorption results 
obtained from both types of labelling do not differ significantly (Layrisse et al., 
1969 and Cook et al., 1972). A comparison with stable isotopic tracers has not 
been made for iron. However they would be expected to behave similarly to 
radioactive iron tags (Hurrell et al., 1994). In this context, it is worth 
mentioning that Barrett et al. (1994) found similar iron absorption from a meat 
meal labelled with 2.8 mg “ Fe and 10 ng of radioactive Fe-59.
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Janghorbani et al. (1982) compared the two labelling methods in an 
investigation of zinc absorption and found no difference between intrinsic and 
extrinsic labelling. Serfass et al. (1989) showed the applicability of extrinsic 
tagging for formula based infants diet. However Fairweather-Tait et al. (1991) 
emphasized the need for caution when using extrinsic labels for studies of Zn 
bioavailibility. Insignificant differences in absorption from intrinsically and 
extrinsically labelled nutrients have been reported for magnesium, by 
Schwartz et al. (1980) and for copper, by Johnson et al. (1988).
When an investigation is planned to determine absorption from a nutrient by 
extrinsic labelling, care should be taken that the level of element added to the 
diet should not perturb the physiological requirements and the mineral status 
of subjects. The chemical form and solubility of an element in natural 
constituents and the form added should also be taken into account. This is 
particularly important for iron in view of its solubility (Forbes et al., 1989) and 
for selenium regarding its chemical form (Janghorbani and Young, 1982).
1.2.3.3 APPROACHES TO INVESTIGATING 'ABSORPTION' BY USE OF THE STABLE 
ISOTOPIC TRACER TECHNIQUE
Measurement of disappearance from the dietary pool by faecal monitoring
When enriched isotopic tracers are used In determination of absorption by 
faecal monitoring, the difference between tracer recovered with faecal 
samples and that added to the diet provides the "net luminal disappearance" 
(NLD). NLD includes mucosal uptake and transfer of the mineral (i.e. 
absorption), and mucosal surface adsorption. It makes no assumption that all 
or any of the amount which has disappeared has been transfered to the body. 
The amount excreted includes the fraction initially absorbed and then re­
excreted into the gut lumen.
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Determination of luminal disappearance by faecal monitoring is particularly 
applicable to the elements Zn, Ca, Se, Mg, and Cu for which excretion from 
the intestinal system is significant. Measurement of absorption by this 
approach has been widely used for human subjects since it is not invasive. 
Examples of applications to infants are provided by Gordon et al. (1982) for 
Zn and Se, Ehrenkranz et al. (1984) and Ehrenkranz et al. (1989) for Zn and 
Cu, and Whitley and Aggett (1986) for Fe. Recent examples of applications 
to adults include Couzy et al. (1993), Johnson et al. (1988), and Tumlund 
(1990) for Cu, Mason et al. (1990) and Tumlund et al. (1990) for Fe, and 
Fairweather-Tait et al. (1992) and Couzy et al. (1993) for Zn.
A disadvantage of determination of luminal disappearance by faecal 
monitoring is that the contribution to output of isotopic tracer which was 
initially taken up and then re-excreted can not be identified. This can be 
significant for Ca, Cu, Se, and Zn and underestimate the fraction taken up. 
This effect was considered by Tumlund (1990) for Cu and Fairweather-Tait et 
al. (1992) for Zn and can be minimized by reducing the period of faecal 
collection after dose administration. With the use of markers, to account for 
recoveries in limited faecal collections, the effects of re-excretion may be 
significantly reduced.
Measurement of retention in the body by tissue incorporation or monitoring 
plasma appearance
Absorption can also be determined by measuring the extent of tissue 
incorporation of the element of interest. This approach has been frequently 
used in studies of absorption of iron. Usually an oral dose is given to subjects 
and the quantity incorporated in blood determined 2 weeks after 
administration. Iron incorporation into erythrocytes has been determined by 
the use of both stable and radioisotopic measurements (Skikne and Cook, 
1992, Barrett et al., 1992).
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Determination of iron absorption by this approach, with the application of a 
double isotopic technique, eliminates variation of absorption amongst subjects 
depending on their iron status. Practically, a reference meal or a reference 
solution, and a test meal, labelled with different isotopes are administered to 
subjects on consecutive days and absorption from the test meal adjusted with 
reference to the reference meal or standard solution (Forbes et al. 1989). 
Application of this approach to adult subjects with the use of stable isotopic 
tracers is limited since the provision of a determinable enrichment 14 days 
after administration requires a high isotopic input. The approach has been 
shown to be practical for studies on infants. Kastenmayer et al. (1994) 
determined absorption from an infant formula which was administered twice 
in a day, each labelled with different tracers with the amounts of 2.5 mg of 
S7Fe and 0.6 mg of 58Fe compared with the required dose (for adults) of 10 mg 
of 57Fe (in orange juice) for provision of a measurable enrichment when 10% 
of the dose was absorbed (Barrett et al., 1992).
Monitoring the appearance of nutrients in plasma after an oral dose is a semi- 
quantitative approach to assessing the absorption since the orally given 
nutrient myy be taken up by the liver before entering the systematic 
circulation. The method is not applicable to most food sources of trace 
elements without giving pharmacological doses. Principally a sufficient oral 
dose is administered to enable observation of plasma appearance kinetics 
(Fairweather-Tait, 1992).
Monitoring plasma disappearance following intravenous administration of a 
tracer is an alternative approach which can provide information on the 
magnitude of endogenous losses via intestinal lumen, size of exchangeable 
pool, body turnover time, and biological half-life and has been used for Zn 
(Jackson et al., 1984 and Jackson et al., 1988).
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Simultaneous oral and intravenous isotope administration
Following simultaneous oral and intravenous administration of two isotopic 
tracers, isotopic enrichments are measured with reference to a third isotope 
in urine or plasma samples as a function of time. Absorption the administered 
isotope is calculated with reference to the time-integrals of enrichment ratios.
Measurement of the absorption of iron by monitoring enrichments in plasma 
samples by this approach has been described by Whittaker et al. (1991) and 
Barrett et al. (1994) for Fe, and by Friel et al. (1992) for Zn. By measurement 
of enrichment in urine, Hillman et al. (1988) and Yergey et al. (1990) 
determined the absorption of Ca.
In determination of absorption by simultaneous oral and intravenous 
administration, both of the isotopes are assumed to be similarly metabolised. 
This may not be the case, because orally administered elements may be 
bound to different carriers in the plasma than those with which the intravenous 
isotope binds, and because orally given isotopes are more likely to be 
processed or taken up by the liver before entering the systematic circulation 
(Aggett and Whitley, 1994).
Compartmental modelling and kinetic analysis
With administration of more than one stable and/or radioactive isotopic tracers 
and their determination in the appropriate samples, it is possible to monitor 
the fate of absorbed trace elements. With this approach, compartmental and 
kinetic models have been developed and investigated.
Investigations by compartmental modelling and kinetic analysis have been 
carried out for zinc metabolism and kinetics by Foster et al. (1979), using 
radioactive Zn-69m, Wastney etal. (1986) with radioactive Zn-65, Wastney et 
al. (1991) with radioactive Zn-65 and stable 70Zn isotopes by simultaneous
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oral administration, and by Fairweather-Tait etal. (1993) to measure the size 
of exchangeable pools for zinc with 70Zn. Selenite metabolism has also been 
examined with the same approach, with the use of stable 74Se tracer 
(Patterson et a l , 1989). Theoretical modelling for these approaches is 
provided in Cobelli et al (1987).
In-vitro procedures
The composite effects of minerals in different diet or foods on bioavailibility 
and specific steps in absorption or metabolism processes have also been 
investigated by in-vitro procedures which simulate release of elements from 
foodstuffs and related processes. Such approaches have been applied to 
animal and human investigations.
The following investigations are examples of in-vitro studies; estimation of 
available dietary iron (Monsen et al., 1978), review of the use of laboratory 
animals in zinc bioavailibility studies with references for in-vitro applications 
(Forbes, 1984), the effect of picolinic acid on metal translocation across lipid 
bilayers (Aggett e ta l, 1989), soluble and ionizable iron determination in foods 
(Tumlund etal, 1990), absorption and subsequent metabolism of metal amino 
acid chelates and inorganic salts (Ashmead, 1991), selective extraction of iron 
species present in diet and rat gastrointestinal tract contents (Simpson et al, 
1992), investigations related to bioavailibility of different form of ferric 
phosphates (Willis and Montgomery, 1994).
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1.3 THE USE OF MARKERS IN MEASUREMENT OF TRACE ELEMENT 
ABSORPTION
The use of stable or radioactive tracers to measure faecal output enables the 
determination of net luminal disappearance (net intestinal uptake). 
Measurements based on faecal analysis requires reliable faecal collection 
over several days, until all unabsorbed tracer is excreted. Faecal collection for 
a longer period than required can cause low estimation of luminal 
disappearance, due to re-excretion of tracer initially absorbed. Re-excretion 
can be significant for elements for which homeostasis is maintained by 
intestinal excretion, depending on the amount of intake and state of health, 
e.g. Zn, Cu. Incomplete collection of faecal samples (accidental rejection, lack 
of care due to illness, or with toilet paper) can result in overestimation of 
luminal disappearance. By the use of markers completeness of faecal 
collection can be measured and the endogenous contribution can be 
minimized by determination of luminal disappearance with reduced sample 
collection.
1.3.1 CLASSIFICATION OF NUTRITIONAL MARKERS
The marker must be neither adsorbed nor absorbed, and must be either 
soluble or completely dispersed in water.The desirable properties of nutritional 
markers are summarized in Table-7 from Morgan (1986), Kotb and Luckey 
(1972), and Fordtran (1966).
Lack of digestibility, complete recovery, and ease of measurement have been 
the characteristics of major concern in the search for ideal nutritional markers 
(Kotb and Luckey, 1972). A marker which successfully meets the 
requirements of one application might not be useful in other applications. In 
most balance studies (particularly short-term studies) two type of faecal 
markers have been used: intermittent markers such as charcoal or carmine 
administered at the beginning and end of an experimental period to distinguish
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faeces related to the period of feeding, and continuous markers such as PEG 
or BaS04l which define the quantity of food, assuming that the marker and 
nutrient studied have similar transit times through the alimentary tract (Sharpe 
and Robinson, 1970, Bacon, 1980).
Table-7: Criteria for effective nutritional markers
An ideal marker
A. Should
1. Mix intimately with the usual food and remain uniformly distributed in the digesta, and pass 
through gastro-intestinal tract,
2. Enable an estimate of faecal irregularities in excretion and losses,
3. Be soluble and have diffusion space similar to test substance,
4. Be well defined chemically,
5. Be accurately determined at low concentrations.
B. Should not
1. Have toxic physiological affects,
2. Strictly be absorbable (slowly absorbed markers slightly underestimate absorption rate),
3. Be trapped by mucus or other intestinal content,
4. Influence digestion of the test substance,
5. Influence gut flora activity, or influence intestinal motility,
6 . Be degraded.
In applications of chemical balance techniques, markers have been used to 
indicate whether or not a steady state was obtained. After a period of 
continuous administration of intake tagged with a marker, absorption was 
determined by the difference between daily intake and output when a steady 
state was reached (Rose, 1964 and Davignon et al., 1968).
Radioactive and stable isotopic tracers enable determination of absorption 
from a single input. Radioactive tracers were used by Najean and Ardaillou 
(1962), Boender and Verfoop (1969), and Payton etal. (1982), and stable 
isotopic tracers by King et al. (1978). In the latter case, subjects were fed a
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controlled diet containing a constant amount of trace elements of interest on 
daily basis, and the isotopic tracers of Fe, Cu, and Zn were administered with 
2 g of polyethylene glycol (PEG) to measure completeness of faecal 
collection. Classification of the markers used in absorption investigations is 
provided in Table-8 derived from Kotb and Luckey (1972) and Morgan (1986).
Table-8 : Classification of markers [derived from Kotb and Luckey (1972) and Morgan 
(1986)]
A. Compounds
1. Organic; natural (carmine, chromogen) and synthetic dyes (methylene blue, anthraquinone 
violet, etc.), Polyethylene glycol (PEG)
2. Inorganic
a. Metal oxides (Cr203, TiO^
b. Mineral salts (BaS04, CuSCN, CrCy
c. Rare earths
3. Other (cellulose, plant sterols)
B. Natural, or artificial radioactive isotopes (^K , 51 Cr, 131Ba, 140La, ..)
C. Particulates
1. Radio-opaque pellets
2. Polymers (glass beads, rubber)
3. Cells, yeast, bacteria
Considerations and applicability in terms of toxicity and practicality are 
provided below for markers which are commonly used in investigations of 
trace element absorption. Although metabolic balance studies are not the 
concern for this investigation, some of the important characteristics of markers 
for such investigations are also considered, since recent investigations have 
involved the combined use of continuous input of a trace element with a 
dietary input (until a steady state is maintained) and a single input of the 
nutrient labelled with tracer isotope.
27
1.3.1.1 COMMONLY USED MARKERS
Dyes
Intermittent faecal dye markers are best used in conjunction with continuous 
markers as the advantages of two types will then combine. Continuous 
markers assess the extent of excretion of dietary substances, while 
intermittent markers indicate transit time and identify separate study periods, 
especially where new dietary or therapeutic regimes are introduced. This 
combination gives better accuracy than a marker alone and increases the 
reliability of the metabolic balance study, particularly where time is limited. 
Dye markers are observed by faecal colour (Bacon, 1980).
A noticeable effect of giving any dye is the tendency for it to spread out in the 
intestinal contents over several days. It has been shown that in a standard 
meal containing phenol red, dissociation occurs in the stomach to a solid 
phase rich in fat and poor in phenol marker, and a liquid phase poor in fat and 
rich in phenol red marker, which was preferentially emptied from the stomach. 
This and variation in transit time show that these are unsatisfactory markers 
for balance studies (Rose, 1964, Morgan, 1986).
Typical applications of intermittent dye markers have been described by 
Jackson et al. (1984), Mason et ai. (1990), Fairweather-Tait et al. (1992) for 
carmine; Couzy et al. (1993) for brilliant blue together with a marker (radio­
opaque pellets, CuSCN etc.) to measure completeness of stool collection on 
adult subjects. Dye markers have been widely used in studies of absorption 
on premature infants to mark the time interval for faecal collection, as 
described in studies performed by Ehrenkranz et al. (1984), Whitley and 
Aggett (1986), Ehrenkranz et al. (1989), Ziegler et al. (1989) using carmine 
red. The doses used are usually 500 mg for adults and 100 mg for infants.
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Metal oxides and mineral salts
Chromium compounds
Chromium is one of the least toxic of the essential trace metals on the basis 
of the ratio of essential to toxic dose. The mammalian body tolerates about 
100-200 times its total body content of chromium without showing effect. Rose 
(1964) suggested that Cr20 3 capsules were tolerated well by patients, whether 
adults or children, and no side effects were observed when 500 mg per day 
of Cr20 3 was administered to patients in a balance study. The required dose 
of Cr20 3 was proposed to be 300 mg per day by Davignon et al. (1968). For 
these high amounts of marker input, toxic effects have been occasionally 
reported, one development of pelvic appendicitis occuring in an investigation 
carried out by Whitby and Lang (1960).
In a study comparing the applicability of PEG and Cr20 3, it was found that 
Cr20 3 was excreted slightly more slowly than PEG. PEG was recovered 
quantitatively in 5 days after marker administration while Cr20 3 was still being 
excreted on day 7. Cr20 3 was recovered even 42 days after feeding ceased. 
The absence of Cr20 3 in some of the intervening samples during this time was 
explained by sedimentation of the relatively dense Cr20 3 (Allen etal., 1979). 
Late excretion could be significant when intestinal mobility was abnormal, as 
in steatorrhoea (Bacon, 1980).
Hinton etal. (1969) showed that chromium chromate (labelled with Cr-51) was 
not an ideal marker since significant losses occurred due to absorption. In 
attempts to determine trace element absorption with single input by the use 
of radioactive Cr salts as marker, CrCI3 (labelled with Cr-51) has been used 
in several investigations e.g. Powell etal. (1970) and Marx (1979). Gibson et 
al. (1988) found that the absorption of CrCI3 was 23-33% in pigs, compared 
with levels of up to 4% in humans.
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Barium sulphate
Figueroa et al. (1968) recommended that barium sulphate could be a more 
ideal marker on the basis of its specific gravity of being 1.5 in comparison with 
chromic oxide being 5.2.
In studies of iron absorption, Najean and Ardalillou (1962), Boender and 
Verloop (1969), Jasani et al. (1971), and Jasani and Fletcher (1972) used 
radioactive tracer (Fe-59) and BaS04 (labelled with Ba-131) as marker. 
Recoveries were shown to be nearly quantitative, and the level in samples 
provided a week after administration were below detection.
Copper thiocvanate
Copper thiocyanate has limited use due to the absorption of SCN radicals 
(Morgan, 1986). Daily adult doses of less than 500 mg over a limited period 
appear to be harmless (Kotb and Luckey, 1972 and Bacon, 1980). Jackson 
etal. (1984) used copper thiocyanate in the investigation of Zn absorption with 
stable isotopic tracer, but no details were provided.
Particulates
Radio-opaque pellet (ROP)
It has been shown that the rate of passage of various substances (e.g. cotton 
seeds, glass beads, rubber, cells etc.) along the gastro intestinal tract relate 
to their specific gravity and particle size. Morgan (1986) considered that ROP 
to be a satisfactory inert marker.
From an investigation of fat absorption by the use three markers (ROP, PEG, 
and Cr20 3), recoveries were found to be 98.1 % for ROP, 93.8% for PEG, and 
100.2% for Cr20 3 (Simpson et al., 1979). The authors concluded that ROPs 
are suitable as non-absorbable markers for faecal fat studies, and offer 
several distinct advantages over other markers. Transit time of the ROP was 
faster than that of Cr20 3, and the tailing effect of ROP shorter than that of
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Cr20 3. They are limited in use for infants and patients with gastro-intestinal 
obstructions (Morgan, 1986). The recovery of ROP's is determined by 
counting them in x-rays of stools. A recent application of ROP in absorption 
studies with stable isotopic tracers is provided by Taylor et aL (1991).
Polyethylene glycol (PEG)
Polyethylene glycol has become the most popular marker in absorption 
investigations following investigations carried out by Wilkinson (1971) on 
human subjects. Allen etal. (1979) reported an average cumulative recovery 
of 93.1 ±8.6% for 6 subjects. Low cumulative recovery was explained by 
losses due to absorption of small amounts of PEG by the intestine, or 
destruction of small amounts of PEG by bacterial or intestinal enzymes.
Lentner et al. (1975) showed that 99% recovery was obtainable with three 
markers, which were PEG, Cr20 3 determined chemically and by radioactive 
marker. Results from single and pooled stool specimens were identical. The 
results suggested that for practical reasons Cr20 3 was preferable to PEG. 
When intestinal mobility is abnormal, PEG, being water soluble and less liable 
to sediment than insoluble Cr20 3 or BaS04 provides advantage in its choice 
(Wilkinson, 1971).
PEG has been used as marker in investigations of trace element absorption 
with stable isotopic tracers by King etal. (1978), Swanson etal. (1983), and 
Tumlund et al. (1991).
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1.3.2 RARE EARTHS AS MARKERS
I.3.2.1 CHEMICAL PROPERTIES OF THE RARE EARTHS
The rare earths are the elements; La, Ce, Pr, Nd, Pm (artificial), Sm, Eu, Gd, 
Tb, Dy, Ho, Er, Tm, Yb, and Lu and these are all in Group III of the Periodic 
Table. Their chemical properties, involvement in biochemical systems, and 
metabolism are similar.
La is the most basic and Lu is the least basic. Within the group, the aqueous 
solubility of metal salts decreases with increase in atomic number. The toxicity 
of rare earth salts increases with their aqueous solubility. The solubility 
products of rare earth hydroxides range from 10"15 to 10'24. Poor solubility 
confers adsorptive capacity since adsorption to other materials is inversely 
related to the solubility product (Venugopal and Luckey, 1974).
The most characteristic properties of rare earths in aqueous solution are the 
high stability of the +3 oxidation state and the ionic nature of bonding 
complexing groups. The +4 oxidation state for Ce is stable. As the result of 
electronic configuration being a half-filled f-subshell with 7 electrons, the +2 
state is an exception for Eu. Europium in the +2 oxidation state may replace 
Ca+2 in view of the similarity of their coordination geometry. These specific 
characteristics of Ce and Eu reflect anomalies in natural occurrence (Gijbels, 
1987). The comparable properties of (RE)+3 and Ca+2 are of biochemical 
relevance, with their similarities in their sizes, bonding, coordination geometry, 
and donor atom preference (Evans, 1990).
The solubility of rare earths in natural waters is very low. The concentrations 
have been reported to be below pg mL’1 (Goldstein and Jacobsen, 1988, Laul 
et al. 1988, and Esser et al., 1994). In view of the low solubility of the rare 
earths, fractional transfer from soil to plant is expected to be low. However 
investigations of rare earth uptake by plants grown on a natural soil showed
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that the depletion factor (plant to soil concentration ratio) was 1CT4 (Laul and 
Gosselin, 1989), lO'MO'3 (Miekeley et al. 1994), and 10"1 (Ichihashi et al. 
1992). Concentrations for La and Yb reported by Sun etal. (1994) being 379 
and 13.1 ng g'1 in leaves, and 3.19 and 0.21 ng g'1 in grains of wheat from 
plants grown in soils where the corresponding concentrations were 47800 and 
2500 ng g'1. These levels provide depletion factors of ~1 O'2 for leaves and ~10s 
for grains.
With considering the concentration range for La in geological formations in 
Scotland being 10-50 pg g‘1 (British Geological Survey, 1991), and a depletion 
factor ranging 10‘1 -10"5, the levels of La enter to people via drinking water and 
food should be very low.
I.3.2.2 TOXICOLOGY AND INTESTINAL ABSORBABILITY OF THE RARE EARTHS
Investigations of the pharmacology, toxicology, and clinical applications of rare 
earths indicate that they have a low to moderate acute toxicity and cause very 
little change in animals when fed for several months (Venugopal and Luckey, 
1975). Single or repeated injections of chlorides of La, Ce, Pr, and Nd into 
rabbits caused considerable change in haemoglobin, leucocyte count, 
erythrocyte count whereas oral administration was without effect. Rare earths 
caused no internal organ damage when fed at levels of 0.01, 0.1 and 1 % of 
diet for 90 days. None of rare earths had an effect on growth or on the 
haematological data (Haley, 1965).
In summarising previous investigations, Kyker (1961) concluded that there is 
essentially no absorption of rare earths from the gastrointestinal tract. 
Absorption of orally administered rare earths is typically less than 0.05% for 
mammals. Toxicity studies comparing oral and intraperitonial routes in rats 
have shown that oral doses exceeding 2 g RE kg'1 are tolerated without 
adverse effects.
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In preparation for administration of rare earth markers to humans, Hutcheson 
et al. (1975) investigated the effect of rare earth oxides on three generation 
of mice. It was found that, there were no apparent effects as measured by 
growth, reproduction, haematology, and gross necropsy observations. Feeding 
monkeys with a diet containing rare earth oxides for 63 days Hutcheson et al. 
(1974) observed no effect and found no rare earths in tissues. Table-9 
provides the LD50 doses of rare earths (chloride and nitrate where available) 
and those of essential element compounds for comparison.
Table-9: Acute lethal dose for rare earth compounds (LD50) for oral administration in 
rat and mouse (Bruce et al., 1963 and Venugopal and Luckey, 1974)
Dose (LDgo), mg kg' 1
Rare earths/ComDOunds-* Chloride Nitrate Oxide
La 2370 4500 8500
Ce 1 2 0 0 1355
Pr 1700 800
Nd 2125 905
Sm 840 960
Eu 2075 1740
Tb 2175 1750
Dy 3290 1 1 0 0
Ho 3140 1078
Er 2700 NA
Tm 2635 NA
Yb 2995 1195
Lu 4400 NA
Iron chloride 186 (lethal)
Zinc sulphate 500
Copper chloride 6 6
Sodium selenate 4
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Whilst primarily interested in histological, morphological, and biochemical 
effects of LaCI3 as an agent, Kramsch et al. (1980) included absorption 
measurements were also included. 40 mg kg'1 d'1 LaCl3 was administered to 
rabbits for a period of 8 weeks and the same amounts were provided to 
monkeys for 10 months. After 8 weeks of treatment about 33 pg La+3 were 
found in the whole liver of rabbits, which was 0.0006% of the total intake and 
no La was detected in bone. The results for monkeys showed that small 
amounts (average 64.5 pg) were contained in urine collected for 24 h. An 
average of 17.1 pg (100 mL)'1 were found in circulating whole blood, but none 
was detected after 12 h. It was concluded that even the largest dosage of La 
administered orally did not impair general well being, and the normal growth 
and the development of growing animals. No physiological changes were 
observed in heart, haemopoietic, and nervous systems, which appeared to 
have retained their normal function. Structural Ca and P were unchanged.
Robinowitz etal. (1988) investigated the distribution of orally administered La 
in rat tissues. Radioactive La-140 tracer with additional LaCI3 solution in 
drinking water was administered for 3 days at 120 mg kg'1 d'1 (37.5 mg d'1) 
and the La content of the tissues was measured radiometrically by liquid 
scintillation counting. Absorption of La was found to be less than 1% of the 
total dose, with no toxic effect.
In an extensive review of biochemistry of rare earths, it is emphasized that 
nearly all authors agree that almost no absorption occurs through the 
gastrointestinal tracts of adult vertebrates and that there is nearly no transfer 
of rare earths from mother to fetus (Evans, 1990).
In the context absorbability, it is worth mentioning the levels of rare earths 
determined in human tissues by different authors (Table-10).
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Table-10: La and Yb concentrations in various human tissues
Tissue
Concentrations,
La
ng g' 1 or ng mL' 1 
Yb Author
Plasma 4.49 2.04 Esposito et al. (1986)
Plasma 6 4 Collechi et al. (1987)
Plasma and urine <0.3 <0.3 Allain etal. (1990)
Plasma 3.4 1.9 Esposito etal. (1993)
Whole blood 5.8-16.8 - Mosulishvili etal. (1985)
Human liver 3.5-190 <0.02-0.71 Tijoe et al. (1983)
Human heart 0.25-8.71 <0.03-<0.15 H
Human cortex 0.44-2.39 <0.03-0.13 IV
Human lung 1.5-75 0.25-6.00 Pietra etal. (1985)
Kidney stones 17-79 6.4-219 Koeberl and Bayer (1992)
Brain tissue 46 24 M
Cataracts 45-2266 - Stverak et al. (1988)
As can be seen from the table, concentrations of La and Yb in various tissues 
are very low, which indicate low accumulation in the body. Using a liver weight 
of 1.8 kg for standard man results in total contents of 6.3-342 |JQ La and 
<0.04-1.28 pg Yb.
I.3.2.3 THE USE OF RARE EARTHS AS MARKERS
Applications of rare earth markers to animal studies have been concerned 
with investigations of transit in ruminants, where the rare earths have been 
adsorbed on forage (Miller et a/., 1966, Ellis and Huston, 1967, Ellis, 1968, 
Huston and Ellis 1968, Olbrich etal., 1971, Hartnell and Satter, 1979, Crooker 
et al., 1982, Turnbull and Thomas, 1987) and with the studies of digesta 
kinetic modelling (Ellis etal., 1979, Poore etal., 1991 and Moore etal., 1992).
In preparation for the application of rare earth markers to studies of nutrient
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uptake by humans, Luckey etal. (1975) investigated the use such markers in 
rats, using nitrate salts. To investigate recovery after a single dose, inputs of 
27 pg of Tb, Yb, and Lu were added to diet, and virtually complete recovery 
(99%) was achieved after 3 days. For stabilisation of continuous input and 
determination of apparent absorption, daily inputs of the markers were 5 pg 
Yb, 7 pg Tb, and 4 pg Ce. A steady state excretion rate was achieved in 2 
days. Apparent absorptions of kcal, Ca, K, and Fe determined directly 
(balance) and indirectly (marker correction) showed some variability, but 
generally agreed within ±5%. Anomalies are possibly explained by counting 
statistics associated with the nuclear characteristics and the levels at which 
some markers were used. It was concluded that some heavy metal salts could 
be used for a variety of purposes in studies of nutrient absorption.
In a study of monkeys, primarily concerned with safety aspects of the use of 
rare earth markers, Hutcheson et aL (1974) added oxides to diet to provide 
daily inputs of approximately 1.3 mg of Sm, Dy, and Tb, 0.7 mg for La, 0.1 mg 
for Yb, and 0.04 mg for Eu. In two balance periods with constant input, 
recoveries were 101.6±6%, excluding Tb, where low yields were attributed to 
procedural problems. It was concluded that oxides of the metals used could 
be safely used as nutritional markers.
The first multiple marker application to humans was described by Luckey et 
al. (1977). Rare earth oxides were administered in a capsule, with addition of 
methyl cellose, at 100 times the levels intended for daily marker use, thereby 
allowing quantitative determination of 0.1% of the total marker input several 
days after administration. For a single input, the amounts of rare earths 
ranged from 0.06 mg (for Dy) to 60 mg (for La). Recoveries were 91.5±10% 
for La, 84.7±10% for Sm, 95.7±11 % for Eu, 88.5±8% for Tb,and 96.9±12% for 
Yb. There were no differences in faecal excretion patterns despite the fact that 
metals differed in atomic weight and specific gravity. In four subjects, 
differences were found in the rate of excretion. 95% of the marker appeared 
in 2 days for two subjects, and 3 and 4 days for the others. Recoveries also
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apparently correlated with rate of throughput, 2 day excretion providing a yield 
of 96±10%, with 3-4 day 87±6%.
Hutcheson et al. (1979) applied rare earth markers to determine absorption 
of 4 nutrients (energy, fat, protein, and calcium), each nutrient being 
associated with a different marker For 7 days, the daily marker inputs were 
120 pg for Sm (for energy), 0.5 mg for Eu (for protein), 850 pg Yb (for Ca), 
and 1.3 mg Sc (for fat). The total doses received were therefore 0.84 mg of 
Sm, 3.5 mg of Eu, 6 mg of Yb, and 9.1 mg of Sc. Metal oxides were added 
to food before cooking. Tb was used as a marker of total intake with a daily 
input of 1.2 mg. Apparent absorption by balance and marker correction 
showed good agreement, as can be seen in Table-11.
Table-11: Comparison of absorption determined by balance and marker correction 
(Hutcheson et al., 1979)
Nutrient (marker)
Absorotion. % 
Balance method Marker method
Energy (Sm) 94.1±1.2 94.8±2.5
Protein (Eu) 93.4±0.9 94.7±1.4
Ca (Yb) 34.7±5.0 34.5±7.4
Fat (Sc) 96.0±1.4 95.9±0.6
With trace element uptake being determined by measurement of output after 
a single dose, the use of rare earth markers may enable account to be taken 
of recoveries in limited sample collection, this being less demanding of 
subjects, and potentially applicable in unconfined situations.
1.4 CALCULATION OF ABSORPTION
Calculation of absorption in faecal monitoring
Some of the approaches used in calculation of absorption by faecal 
monitoring, using marker correction for quantitative, limited, and/or single 
sample collections are provided below. For ease of comparison, a standard 
notation has been applied, with fractional "absorption" being indicated by F 
and the fractions of nutrient and marker in faeces and diet by lf and ld , and 
Mf and Md respectively..
Irwin and Crampton (1951) investigated the apparent absorption of dietary dry 
matter in man, using Cr20 3 as an inert marker for yield correction, where total 
faecal collection was considered.
Seife (1962) considered that the combined use of a radioactive inert-indicator 
and a radioactively labelled nutrient could eliminate the need for quantitative 
feeding and stool collection. The absorption by dogs from a single input of 
fat labelled with 1-131 was measured with the use of BaS04 (labelled with Ba- 
131) as an inert marker. The formula used in the calculations for fractional 
absorption, F is given by,
w
Boender and Verloop (1969), and Jasani and Fletcher (1972) applied the 
same approach using the radioactive marker technique associated with 
radioactive tracer for limited and/or single sample collection. They used BaS04 
(labelled with Ba-131) as marker and Fe-59 as tracer for measurement of iron 
absorption, and measured the fractional "absorption" for limited sample 
collection by using marker yield correction. The same approach was also 
applied by Luckey et al. (1975) and Hutcheson et al. (1979) using the rare 
earths as marker for determination of macronutrient "absorption" (by chemical
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balance method) with limited and/or single faecal sampling when steady state 
had been reached for animals and human subjects respectively.
Payton et al. (1982) measured the fractional absorption of zinc, using 
radioactive tracer and marker, Zn-65 and CrCl3 (labelled with Cr-51). They 
postulated that fractional absorption can be determined by retention 
measurement by whole body counting or recovery measurement with limited 
faecal collection. Fractional absorption, F was determined from:
M,
The formula was also applied to whole body counting, since the retention of 
tracer and marker within the body could be determined after defeacation.
Calculation of luminal disappearance
When mineral absorption is determined with stable isotopic tracers, net 
luminal disappearance is provided by the difference between input and faecal 
output. In such calculations account must be taken of elemental output 
containing the natural abundance of the enriching isotope (endogenous 
contribution). The time dependent appearance in faeces of marker, isotopic 
tracer, and the endogenous contribution of the isotope are provided in Figure-
2 .
LdO
TIME POST DOSING, d
Figure-2: Profiles of recoveries of marker, isotopic tracer, and endogenous 
contribution of the isotope in faeces, after a single dose
Notation,
Ef : Amount of element in faeces, including unabsorbed enriched isotopic tracer,
E „: Amount of element in faeces which consists of the fraction of total element of 
natural composition,
lf : Total isotopic content of faeces, including endogenous excretion and unabsorbed 
isotopic tracer,
lu : Amount of unabsorbed isotopic tracer in faeces,
I . : Endogenous contribution of the enriching isotope to the total isotopic contents of 
faeces,
Re : Natural abundance of the enriching isotope,
M : Fractional recovery of marker
ld : Amount of enriched isotopic tracer provided with the dose 
F: Fractional net luminal disappearance
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a. The total amount of the element of natural composition in a faecal sample,
E  =E,-/ 1-an  *" / u
b. The amount of unabsorbed isotopic tracer in a faecal sample,
lu=l,le 1 ' b
c. The endogenous isotopic contribution of a faecal sample in natural 
composition,
1-c
d. For a recovery M (as indicated by marker), at a fractional luminal 
disappearance of F, lu is given by
/„=/U(1 -F)/tf 2-a
so F can be calculated from:
F - M!d~!u 2-b
M!d
e. Combining equations 1-a and 2-a gives
£„=£,-M(1 -/=)/„ 3-a
f. From equations 3-a and 1-c, I. is given by
/#=flJ£r M(1 -F)/J 3-b
g. Substituting I, from equation 3-b in equation 1-b gives
/u=/r /?j£r M(1 -£)/J 3-c
h. Substituting lu from equation 3-c in equation 2-b gives
Af/,-[/r ffJ£r M(1 -F)/J] 4
M l,
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a. The total amount of the element of natural composition in a faecal sample,
E  =£ ,-/ 1-an ’ u
b. The amount of unabsorbed isotopic tracer in a faecal sample,
i -b
c. The endogenous isotopic contribution of a faecal sample in natural 
composition,
'e=R£ n 1-c
d. For a recovery M (as indicated by marker), at a fractional luminal 
disappearance of F, lu is given by
so F can be calculated from:
/„=M( 1 F)ld
p_ Mld fy 
M L
2-a
2-b
e. Combining equations 1-a and 2-a gives
En=Ef-M (  1 -F ) id
f. From equations 3-a and 1-c, le is given by
le=RJiEr M ( i - F ) Q
g. Substituting le from equation 3-b in equation 1-b gives
llr l r R lE r M Q -F M
h. Substituting lu from equation 3-c in equation 2-b gives
M ld- [ / r RJiEf-M (  1 -F)/J]
M l.
3-a
3-b
3-c
42
1.5 METHODS OF ANALYSIS
The required dose of a stable isotopic tracer depends on the limit of detection 
and precision of the analytical method employed to determine isotopic 
enrichment in the analytical medium, and the naturally occurring levels of the 
isotope.
Determination of isotopic tracers by NAA is only possible if the irradiation 
product of an isotope has suitable decay characteristics for its determination. 
Enrichment by a factor of 5-10 over natural level for a specified isotope in a 
diet has been reported to be satisfactory for studies of mineral absorption, 
based on a single input of the enriched source (Janghorbani and Young, 
1982). Enrichment in faecal samples caused by the unabsorbed fraction of 1 
mg orally administered 70Zn (0.6% natural abundance) could be determined 
with 1-5% precision by neutron activation analysis (NAA), Janghorbani et al. 
(1980). The precision for determination of the enrichment of the same isotope 
in plasma following an oral administration of 3.2 mg of 70Zn was 5-8% 
(Janghorbani et al., 1981-a). Precision for determination of 46Ca in faecal, 
plasma, and urine samples has been reported in a range of 1-5% by 
Janghorbani et al. (1981-b), whilst the precision for 58Fe is typically 1%. 
Examples of applications of NAA in absorption investigations with stable 
isotopic tracers are provided by King et al. (1978), Solomons et al. (1982), 
Gordon ef al. (1982), Whitley and Aggett (1986), Gokmen et al. (1989), and 
Bang-Fa Ni et al. (1991).
In principal all isotopes of an element can be measured by mass 
spectrometric (MS) methods. Although NAA and MS have comparable limits 
of detection, MS provides better precision in a range of 0.1-1%. ICP-MS can 
achieve better than 1 % precision when applied to quantification of an isotope 
or isotopic ratio measurements. Applications of ICP-MS in measurements of 
absorption studies have been described by Ting and Janghorbani (1986) for 
Fe, Ting and Janghorbani (1987) for Cu, Zn, and Fe, and Schuette et al.
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(1988) for Mg isotopes. Janghorbani and Ting (1989) have surveyed the use 
of ICP-MS in investigations of absorption.
In the current investigation, NAA was employed for determination of the rare 
earths used as markers and also to determine the enrichment of 58Fe and 70Zn 
tracers. For determination 57Fe tracer, which is not amenable to NAA, and rare 
earth baseline levels, ICP-MS was used. The total element content of 
samples, required to take into account the natural isotopic abundance of the 
element were determined by AAS. The principles of analytical methods 
employed are summarized below. Further details are available in De Soete et 
at., 1972 (for NAA), Jarvis etal., 1992 (for ICP-MS), and Haswell, 1991 (for 
AAS).
1.5.1 NEUTRON ACTIVATION ANALYSIS
In activation analysis elements are determined by measurement of the 
radioactivity induced when they are irradiated with nuclear particles. Nuclear 
activation with neutrons is called 'neutron activation analysis' (NAA). Thermal 
neutrons are the most widely used of alt irradiating particles in view of:
a.The availability of large fluxes of thermal neutrons in nuclear reactors.
b.The large volumes of uniform neutron flux intensity.
d.The large cross sections existing for radiative capture of thermal neutrons.
e.The avoidance of many radionuclides produced through endoergic reactions
The absolute activity at the end of irradiation A0 of a radionuclide Y generated 
in a mass m of an element X by activation in a flux of $  thermal neutrons per 
cm2 s*1 is given by:
A0=nz2C?eA '1® o ( l - e ‘At) ( e * ^ )
where
N= Avogadro’s number,
Re= The fractional abundance of parent nuclide AX in element X,
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a= The cross section for the reaction (AX + n -► Y) in cm2 per nucleus,
A= The atomic weight of element X,
A= The decay constant of radionuclide Y,
t= The period of exposure to activating neutrons,
td= The period of decay between activation and counting, and
1 -e_xt is the saturation factor for the length of irradiation.
The activity produced tends asymptotically to a maximum as the period of 
activation increases, and little is to be gained by increasing the time of 
irradiation beyond ten half-lives.
The equation provides the absolute activity at the end of irradiation for a 
specified stable isotope, but requires input of parameters which are not always 
accurately known (e.g. neutron flux, reaction cross-section). This equation can 
be applied for absolute analysis, but analyses are usually carried out by 
comparing the activities produced in samples with those produced in known 
amounts of the elements of interest (assuming natural isotopic composition). 
However, since measured activation products arise from specific stable 
isotopes, NAA can also be applied to determine isotopic enrichment. The 
mass of the required isotope is provided by
Ittl=m2~^
where
m1 and A1 are mass and activity of a standard, and m2, A2 are mass and 
activity of the sample respectively.
The measured count rate for a sample or a standard, C is given by
C=keA0e Xtd
where A0 is the absolute activity at the end of irradiation, e is the efficiency of 
detection, and k is a factor accounting for chemical processing yield, and flux 
correction. High detection efficiency is desirable for minimum limits of
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detection.
Selection of a suitable procedure for an NAA application requires 
consideration of the following:
1.The choice of target isotope,
2. The irradiation facility,
3. Requirements for chemical processing,
4.Time of irradiation and the conditions,
5. Activity measurement,
6. Data processing,
7. Limit of detection, desired precision and accuracy.
1.The choice of target isotope: Most elements consist of several stable 
isotopes, which on irradiation yield different activation products. In selecting 
an appropriate target isotope (stable), it is necessary to take account of 
isotopic abundance, reaction probability (cross-section), and half life and 
decay scheme of the activation product.
2. The irradiation facility: The study was performed at the Scottish Universities 
Research and Reactor Centre (S.U.R.R.C.). The nuclear reactor at the centre 
operates at up to a maximum power of 300 kW, providing thermal neutron 
fluxes in excess of 1012 n cm'2 s'1. The capacities of irradiation facilities and 
available neutron fluxes are summarized in Table-12.
3.Requirement for chemical processing: When compared with other methods 
of analysis, additional considerations for NAA are radiation exposure (which 
can be controlled), and time factors related to the half-life(s) of the isotopes(s) 
measured, i.e. activation and decay time, time of chemical separation (where 
required), and counting time
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Table-12: Irradiation positions and the thermal neutron fluxes available in the UTR- 
300, at 300 kW
MAXIMUM SAMPLE SIZE MAXIMUM THERMAL NEUTRON FLUX
irra d ia tio n  position Diameter x Length (cm x cm) (n cm'2 s'1)
a. Fast transfer facilitv
Large rabbit 3x 10 2.3 x 1012
Small rabbit 2 x 5 2.5 x 1012
b. Central vertical strinaer 6 x 15 4.2 x 1012
c. Thermal column 10 x 150 2.7 x 1012
The principle activation products of biological samples for a few days after 
irradiation are Na-24 (t1/2=15h) and Br-82 (t1/2=35h). Where the required 
isotopes have sufficiently long half-lives, they can be measured after an 
appropriate decay time, 5-10 days for Na-24 and 20-30 days for Br-82, which 
also reduces radiation exposure. For other isotopes, interfering activities must 
be chemically removed. Such separations have usually been carried out post 
irradiation, but with increasing concern for radiation exposure the current 
application principally used pre-irradiation separations which require account 
to be taken of recoveries.
4. Time of irradiation and the conditions: The maximum amount of radioactivity 
of a given radionuclide obtained on irradiation (the saturation activity) is 
almost achieved by an irradiation time of five half-lives of the product. This 
level is useful when the trace elements sought are at the limit of detection. 
Where sufficient activity is produced for determination of the required 
element(s), irradiation time are often comparable to the half-life of the product, 
or less.
5. Activity measurement For measurement of radioactivity the limit of 
detection (minimum detectable count) depends on the background at the 
specified energy and the net number of counts required to obtain acceptable
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statistics. Therefore counter efficiency and background must be considered 
when selecting a detection system.
Whilst Nal(Tl) detectors provide good efficiency, their energy resolution is 
determined by statistical fluctuations in the production of photo electrons, and 
is typically 6% with 10-12% scintillation efficiency for 7-rays of 661 keV. 
Resolution can be improved by using detectors which produce more carriers 
per incident radiation event. This can be achieved by solid state detectors, 
where detection is based on electron-hole pair collection from semiconductors 
such as Ge and Si (Knoll, 1989, pp 337).
Until the availability of high purity germanium (HPGe) detectors, impurities in 
germanium were neutralized by drifting in lithium, to produce Ge(Li) detectors. 
Both types require operation at low temperature, HPGe may be allowed to 
warm up when not in use, but Ge(Li) detectors required permanent cooling to 
avoid Li mobility. Energy resolution and detection efficiency are nearly 
identical for HPGe and Ge(Li) detectors of the same size (0.2-0.3% resolution 
with 1-2% efficiency).
Recording of output pulses from a detector is performed by a multichannel 
analyzer (MCA) which comprises of two basic components: an analog-to- 
digital converter (ADC) and a memory. An analog signal is converted to an 
equivalent digital number. The output of the ADC is stored in a computer-type 
memory, which has as many addressable locations as the maximum number 
of channels into which the recorded spectrum is required to be subdivided 
(Knoll, 1989, pp 660). Modem radioactivity measurement systems are usually 
combined with a computer to control the system, which can also be used for 
calculation of results. A schematic diagram of the detection system used is 
provided in Figure-3.
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6 . Data processing: The MCA program enables a spectra! Hie to be saved but 
the file does not contain any readable information. Software designed to 
analyze the spectra generated by the MCA converts the file to a standard 
(spectral) format, containing the number of counts in each channel. The 
program then performs a "semi quantitative" analysis of the data, to provide 
net photo-peak areas with energy and channel number. The output at this 
stage contains photo-peak energies and count rates, with additional 
background and statistical information, but peaks to be further processed 
require specific identification. Subsequent processing of the data is carried out 
by. an NAA program which ultimately provides quantitative results from inputs 
of samples and standards, with error propagation and systematic corrections 
as required.
7. Limit of detection, precision and accuracy: Limit of detection and precision 
of the measurement of radioactivity depend on the following parameters:
a. Induced activity: The induced activity is the principle parameter affecting the 
limit of detection and precision, and is a function of the nuclear characteristics 
of the irradiated isotope.
b. Conditions of radiation measurement: Counting parameters which affect 
limit of detection and precision are energy resolution and efficiency of the 
detector for the measured 7-ray, detector background, and minimum 
resolveable counting rate above background.
c. Sample constituents: The characteristics of other constituents in samples 
can affect limit of detection where the result in an increased background 
(continuum) under the photopeaks of interest.
d. Chemical procedure: Since irradiation of the sample can activate other 
constituents in it, purification of the required elements by chemical treatment 
(pre- or post-irradiation) improves the limit of detection. The chemical yield of 
the procedure applied, and decay during the time from the end of irradiation 
to counting also affect the detection limit and precision of the measurement.
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1.5.2 INDUCTIVELY COUPLED PLASMA SOURCE MASS SPECTROMETRY (ICP- 
MS)
ICP-MS was developed by adaptation of two pre-existing technologies; 
inductively coupled plasma sources as used in atomic emission spectrometry 
and mass spectrometry, with an effective interface. This development meets 
the major requirements for elemental analysis by mass spectrometry: The 
source used should dissociate the sample as completely as possible, produce 
a high yield of singly charged ions but the minimum output of polyatomic 
fragments and multiply charged ions (Denoyer, 1991, Jarvis et at., 1992 pp 
2).
The basic principles of ICP-MS are
1. Samples are introduced into the central channel of an argon plasma at 
5000-8000 °K as a finely dispersed mist which is rapidly desolvated and 
vaporised.
2. During transit through the plasma core dissociation and ionisation occurs.
3. Ions are extracted from the central channel of the plasma through a 
vacuum pumped interface containing a cooled metal sampler cone, and 
separated from the bulk of the argon.
4. Extracted ions are transmitted into the mass spectrometer through a cooled 
metal skimmer cone.
5. In the mass spectrometer, the ions are separated on the basis of their 
mass to charge ratio.
6 . The separated ions are subsequently detected by an electron multiplier 
(Sargent & Webb, 1993). A diagram of the PlasmaQuad ICP-MS (Fisons 
Instruments), which was used in this investigation used is provided in Figure-
4.
7. The instrument is calibrated with standards of known concentrations, and 
account of variations in operating condition taken by including an internal 
standard in samples.
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Figure-4: Schematic diagram of the PlasmaQuad ICP-MS
The principle advantages of ICP-MS technique are its capability of providing 
both elemental and isotopic measurements with high sensitivity. Detection 
limits in aqueous solution are generally below 0.1 ng mL‘1. Instruments 
provide a wide dynamic range with a resolution of more than 300 , which 
enables separation of most interferences. Multielemental analysis is possible 
with a high throughput.
ICP-MS is widely regarded as relatively interference free but as with all 
analytical techniques there are several significant sources of error. Isobaric 
interferences (overlapping peaks) can mask the isotope of interest. These 
interferences may arise from isotopes of other elements within the sample 
matrix, elemental combination with plasma gas, formation of polyatomic oxides 
or hydroxides (mostly M/Z<81) and, doubly charged ions. Mass discrimination 
and variation of sensitivity across the mass scale can cause error in 
measurement of isotope ratios.
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Matrix effects may be overcome by matrix matching, standard addition, 
chemical separation, or the use of isotopic dilution analysis. Physical affects 
such as viscosity and surface tension affect the uptake rate and aerosol 
production, as does high salt content which also results in drift and damaging 
deposits on the nebuliser, torch, and interface. Dissolved solids give rise the 
to deposition on the interface cones leading to drift in response and eventually 
causing blockage. For this reason the sensitivity of ICP-MS is limited, with a 
maximum concentration of dissolved solids recommended (Ross et al., 1993).
ICP-MS was principally used for measurement of isotopic concentration of 
57Fe, since the neutron activation product is also stable (58Fe). For 
determination of “ Fe and 70Zn, NAA was preferred because of the overlap of 
S8Ni+ with 58Fe+ (Ni is material of metal cones) and, ^Cl^Cf with 70Zn+ in ICP- 
MS.
NAA and ICP-MS are compared in Table-13, from Dybczynski (1980), 
Janghorbani et al. (1985), Turnlund (1989), Ward et al. (1990), Savory and 
Wills (1991), Ross et al (1993), Sargent and Webb (1993), and Filby and 
Olsen (1994).
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1.5.3 ATOMIC ABSORPTION SPECTROPHOTOMETRY (AAS)
NAA and ICP-MS enable determination of the total amount of tracer isotopes 
in diet and faeces, but measurement of absorption requires account to be 
taken of the endogenous contribution to the output. This can be obtained by 
determination of the element by AAS and taking account of the natural 
isotopic abundance.
The characteristic emission from atoms of an element can be absorbed by 
other atoms of that element. The basic principle of AAS is the use of an 
element as light a source and measurement of the absorbed fraction of the 
emission by the element existing in an atomic vapour of a sample.
Analysis by AAS requires the element to be determined to be present in an 
atomic vapour. This can be generated by a flame or electrically heated 
furnace (usually graphite). The spectrophotometer used in the current 
investigation was based on flame atomization (FAAS). The atomization 
process consists of two basic steps: generation of a fine aerosol of the sample 
solution with a nebulizer (e.g. pneumatic nebulizer) and, dissociation of the 
analyte into gaseous ground state atoms by a flame, based on the 
combination of a fuel gas (e.g. acetylene) with an oxidant (e.g. nitrous oxide) 
providing 2000-3000 °C.
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1.6 OBJECTIVES
Determination of net tuminai disappearance from an input containing isotopic 
tracer by faecal monitoring requires quantitative faecal recovery of the 
excreted fraction of the tracer Collection of faeces may be incomplete 
because of losses on toilet paper, in general manipulation, and through 
accidental rejection. Account of incomplete faecal collection can be made by 
the use of an inert, non-absorbable, marker as a yield indicator
One of the crucial issues to establish when using faecal monitoring is the time 
required for faecal collection, to minimise addition of endogenously excreted 
isotopes for elements with a high intestinal endogenous excretion. By using 
an inert marker, the difficult task of complete stool collection can be simplified, 
with optimization of faecal collection period for limited or more desirably single 
sample collection. This approach is only valid if no absorption of markers 
occurs during passage through the intestinal tract, and the rates of excretion 
of marker and isotopic tracer are similar.
Hutcheson et al. (1979) have described the use of rare earths as markers in 
determination of the utilization of macronutrients. The investigation was based 
on the chemical balance approach. Subjects were provided with a continuous 
input, with energy, protein, fat, and calcium marked with different rare earths. 
After a steady state was reached, the absorption of the macronutrients in 
faecal samples was determined by single sampling. The authors postulated 
that the method described would allow the use of multiple nutrient markers for 
monitoring any of several nutrients, and enable determination of the 
absorption of nutrients without direct monitoring of food intake or extended 
faecal collection.
The current investigation is concerned with the applicability of rare earth 
markers in determination of the net luminal disappearance of essential trace
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elements by the use of enriched stable isotopic tracers with the following 
objectives:
Clinical objectives
1. To confirm non absorbability or high faecal recovery of orally administered 
rare earths.
To accomplish this, a preliminary recovery investigation involving 2 subjects 
is performed by oral administration of 5 selected rare earths in a range of 
doses and recoveries of the rare earths are determined by INAA. Having 
experienced on design and possible procedural difficulties, the investigation 
for the same rare earths is than extended to a greater number of subjects with 
an improved study design and chemical separation procedure. Particular 
attention is also given to background levels of the rare earths in faecal 
samples provided before administration.
2. To evaluate the faecal recovery pattern of rare earths and their excretion 
kinetics to establish the time required for recoveries of major fraction of an 
administered dose.
The recoveries obtained from above investigations are evaluated to obtain 
recovery profiles of the rare earths for the fractions recovered with individual 
and consecutively accumulated faecal samples. Attention is also given to 
parameters related with the intestinal kinetics of rare earths.
3. To demonstrate the validity of the combined use of stable isotopic tracers 
and rare earth markers for determination of the net luminal disappearance of 
iron and zinc.
Having confirmed the ability to use rare earths as markers, it is intended to 
establish a method for measurement of luminal disappearance by limited 
faecal collection for multi-element and/or multi-isotope studies where the mode
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of intakes can be different. For this investigation, attention has been given to 
ail faecal samples obtained during the study period (to provide a maximum 
collection yield), and changes of the levels of rare earths in urine samples (for 
further confirmation of non-absorbability). Particular attention is given to the 
comparability of the faecal excretion kinetics of rare earths and the excreted 
fraction of isotopic tracers. The possibility of determination of luminal 
disappearance from limited (specified) samples is investigated.
Cook et al. (1979 and 1991) have suggested the use of absorption from a 
reference solution containing ferrous iron and ascorbic acid to account for 
inter- and intra-subject variation of absorption from a meal. The use of a 
worldwide-consumed wheat based Farina meal containing ferric iron has also 
been proposed as a reference standard to investigate if subject to subject 
variations in absorption relate to differences in iron status of subjects or to the 
meal (Forbes et al., 1989). For current investigation, the luminal 
disappearance of iron from the two standard intakes is determined with the 
use of a rare earth marker and a stable isotopic tracer for each. Measurement 
of the luminal disappearance of zinc from the meal is also included in 
anticipation of wider applicability of the marker recovery approach.
2. Analytical objectives
1. To select 5 rare earths, which have the lowest limits of detection for the 
rare earths by NAA, and to establish the required doses for specified 
conditions for investigation to confirm of the absorbability of rare earths. 
Having determined faecal recoveries of the rare earths by INAA, a procedure 
for pre-irradiation column separation of rare earths will be established, to 
reduce radiation exposure, to enable early counting, and to improve limits of 
detection.
2. To select isotopic tracers and to establish the required doses for 
investigation of determination of luminal disappearance of iron and zinc with 
combined use of rare earths as markers. The least abundant isotopes require
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addition of the smallest amount of enriched isotopic tracer. Isotopic tracers 
and rare earths are principally determined by NAA.
A possible approach providing above concerns is to provide iron labelled with 
57Fe with the standard drink, and iron and zinc labelled with “ Fe and 70Zn with 
the meal. For determination of faecal recoveries, a different rare earth for 
each mode of intakes is used. Rare earths and 58Fe, 70Zn, and 57Fe tracers 
contents of faecal samples are determined by NAA and ICP-MS (the 
introduction of a second analytical method arises since 57Fe produces a stable 
activation product). Total iron and zinc contents of faecal samples are 
determined by AAS, to account for the isotopic contribution of iron and zinc 
of natural composition to enrichment in faecal pool. ICP-MS is also employed 
to determine baseline levels of the rare earths in faecal samples, and in urine 
samples provided before and after the administrations.
3. To establish a pre-irradiation ion exchange separation of iron and zinc, to 
achieve the lowest limits of detection by NAA and to avoid isobaric 
interferences in ICP-MS. By using pre-irradiation separation for determination 
of saFe, time required for decay and radiation exposure are also minimised. 
For determination of 70Zn, a post-irradiation separation procedure is also 
considered, to minimise interference caused by the activation product of Mn 
which has a half-life comparable to that of 71mZn.
4. Luminal disappearance will be established from results obtained from single 
samples, and the data considered in terms of cumulative outputs, to identify 
the minimal collection required for acceptable measurement.
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II RARE EARTH RECOVERY INVESTIGATIONS
In this chapter, investigations carried to confirm non-absorbability of rare 
earths are described. The first part includes theoretical criteria for the choice 
of rare earths and their required doses for a faecal recovery investigation, a 
practical assessment of measurement of the selected rare earths by INAA, 
and a preliminary recovery investigation performed for two subjects.
Rare earth recovery studies with a chemical separation procedure, and a 
faecal recovery investigation on 6 subjects are described, background levels 
attained in the recovery investigations are compared with natural levels of rare 
earths, and the faecal appearance profiles are evaluated in the second part.
11.1 FEASIBILITY STUDIES FOR THE USE OF RARE EARTHS AS 
MARKERS
11.1.1 CHOICE OF RARE EARTHS AND DETERMINATION OF OPTIMUM DOSE
1. Choice of rare earths as markers
Theoretical limits of determination of rare earths were calculated for the 
isotopes selected with reference to their cross section, natural abundance, 
and the intensities of emitted 7-energies of their activation product providing 
lowest limits of determination. Nuclear characteristics of the selected isotopes 
are provided in Table-14.
For calculation of limits of determination of the isotopes of rare earths, It was 
considered that the elements were irradiated for 6 h in the CVS (at the flux of 
4.2x1012 n cm"2 s"1). Count rates were calculated for counting at 10 cm above 
a 130 cc Ge detector, taking account of the absolute intensity of the 7-rays 
measured and detector efficiency at the specified energy. Limits of
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Table-14: Nuclear characteristics and their activation products of stable rare earth 
isotopes which provide the lowest limit of detection
NUCLIDE ACTIVATION PRODUCT
El A1 Abund,% *n(b) 2 A Half life 7 -energy, keV Intensity
La 139 99.9 9.2 140 40.3 h 1596 95
Ce 142 1 1 .1 0.95 143 33 h 293 42
Pr 141 1 0 0 8 142 19.2 h 1576 3.7
Nd 146 17.2 1.3 147 10.9 d 91 28
Sm 152 26.6 204 153 46.8 h 103 28
Eu 151 47.9 5800 152 13 y 1408 2 1
Gd 158 24.8 2.5 159 18.6 h 363 1 0
Tb 159 1 0 0 23 160 72.1d 879 30
Dy 164 28.2 1 0 0 0 165 2.3 h 95 3.6
Ho 165 1 0 0 63 165 26.8 h 81 6 . 2
Er 170 14.9 5.7 171 7.5 h 308 64
Tm 169 1 0 0 103 170 128.6 d 84 3.2
Yb 174 31.6 19 175 4.19 d 396 6.5
Lu 175 31.8 16.4 176m 3.7 h 8 8 8.7
1. Atomic mass of the selected isotopes of rare earths 2. Thermal neutron cross sections for 
the isotopes, barn (b=ornx 1 0 24 cm'2)
determination were taken as the amount which could be determined with 1 % 
precision (10,000 counts) in a 1 hour count. The calculated determination limits of 
rare earths are provided in Table-15.
As can be seen from Table-15, the calculated limits of determination for all rare 
earths for counting immediately after irradiation show that the lowest limit of 
determination is for Dy whilst Nd is the highest. The use of Dy, Er, and Lu is not 
practical when compared other rare earths of longer half-life where analysis by INAA 
is required, because of their short half-life. Since a period of decay is required to 
reduce radiation exposure and allow for decay of interfering activities, the 
determination limits of the remaining rare earths were considered in selection of 
markers. From comparison of the limits of determination, and bearing in mind 
interference effects, particularly at low energy it is obvious that Sm, La, Yb, Tb, and
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Eu are the best available, since the characteristic 7 -energies for Ho and Tm occur 
in the low energy region of the spectra which are influenced by Compton continua 
and X-rays.
Table-15: Determination limits of rare earths determined immediately after a 6  h, and 
after 2 and 4 days decay
Limits of determination, ua
Rare Earth Immediate 2  d decay 4 day decay
La 0.16 0.36 0.82
Ce 5.46 15.0 50.0
Pr 1.82 10.4 59.7
Nd 26.3 29.8 82.2
Sm 0 .0 1 0 .0 2 0.05
Eu 4.74 4.74 4.74
Gd 2.56 15.3 j
Tb 2 . 6 6 2 .6 6 2.76
Dy 0 .0 0 2 - -
Ho 0 .0 2 0.09 0.29
Er 0.14 - -
Tm 3.07 2.33 2.35
Yb 0.76 1.06 1.47
Lu 0 .0 2 - _
1 .Activity not detectable in view of short half-life
2.Determination of optimum dose
To determine a small fraction of input dose in faeces, a low limit of determination is 
required. Limits of determination for the proposed procedure, and the consequent 
amounts of the rare earths required for inputs were calculated on the following 
theoretical basis:
a.Samples are irradiated for 6  h in the CVS (4.2x1012 n cm' 2 s'1),
b.A precision of ±1% is required for 1 h count (which is equivalent to 3 cps),
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rc.An average detection efficiency of 1 % was assumed (which can be obtained 
by placing the samples in close proximity to the detector),
d.The minimum detectable amount was required to be 0.1% of the total input 
in 10% of a faecal sample.
Further assumptions made for dose calculations of Sm and Tb were;
a.Since the 103 keV 7-radiation of Sm-153 is in a lower energy region of the 
spectrum, where the photo-peak is associated with high background counts, 
five times the calculated dose was considered sufficient to compensate for this 
increased background. The ratio of the background counts for Sm-153 at 103 
keV to La-140 at 1596 keV was practically found to be 30.
b.For the initially specified precision requirements, a relatively high input was 
required for Tb. By acceptance of ±2% precision, a dose of 7.5 mg was 
considered to be adequate.
Calculated limits of determination and the doses of rare earths required to 
meet these conditions are provided in Table-16. The doses used by Luckey 
et al. (1977) are also provided for comparison.
Table-16: Determination limits and proposed doses of the rare earths
Determination limit Dose, mg
ELEMENT M9 Proposed Luckey <
La 0 .1 2 1 60
Sm 0 .0 2 1 39
Eu 0.9 1 0 15.5
Tb 3.6 7.5 50
Yb 0.5 5 30
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11.1.2 DETERMINATION OF RARE EARTHS BY INAA
The use of INAA for determination of the rare earths in studies of nutrition 
has been described by Gray and Vogt (1974) with detection limits for specific 
analytical conditions. The objective of this investigation is to consider the 
suitability of facilities available at SURRC (lower neutron flux, but more 
efficient detectors) for such studies. Determination of the selected rare earths 
(La, Sm, Eu, Tb, and Yb) was investigated by analysis of faecal samples to 
which known amounts of the rare earths had been added.
1. Procedure
Sample preparation: Approximately 20 g samples of freeze-dried faeces were 
ashed at 400-500 °C for 24 h. Five fractions of 0.2 g were weighed and 
transferred into labelled aluminium sachets. Two of the fractions were 
processed for determination of background levels above which output would 
have to be measured. Three samples were spiked with solutions of the rare 
earth prepared from 1000 pg mL"1 spec pure AAS standards (Johnson 
Matthey, Materials Technology/U.K.). Three reference standards for the same 
elements were also prepared by pipetting the solution onto 0.2 g of cellulose 
in aluminium sachets.
Irradiation and counting: The samples and standards were irradiated for 6 
hours in the CVS, and allowed to decay for 3 days. Samples and standards 
were then transferred to polythene ampoules for counting on a 25 cc Ge(Li) 
detector for 1 hour each, 10 cm above the detector, to measure La-140 
(t-i/2=40.3 h) and Sm-153 (t1/2=46.8 h) activities. Samples were counted again 
a week after irradiation for measurement of Yb-175 (t1/2=4.2 d), Tb-160 
(t,,2=72.1 d), and Eu-152 (t1/2=13 y) for 5000 s each at 5 cm above the 
detector. One sample and standard together with the baseline samples were 
counted for 15 h each on contact with the detector after decay of a month for 
detection of Eu-152. The concentrations of the samples and standards were 
calculated with reference to one of the standards.
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b. Results and conclusion:
The amounts of the rare earths determined in standards and samples are 
provided in Table-17.
Table-17: Amounts of the rare earths in standards and in faecal samples, 
pg±SD (error of single measurement)
Reproducibility of rare earth standards Natural levels of rare earths
RE Added Found Added Found DudI. 1 DudI. II
La 8 .0 8 .6 ±0 .1 2 . 0 2.410.02 0.710.2 0.910.1
Sm 2 0 17.6±0.1 5.0 4.910.02 ND1 ND
Eu 0.4 ND 0 .1 ND 0.0210.003 0.0210.04
Tb 2 0 19.3±0.2 5.0 5.210.2 0.0510.06 0 .0 6 1 0 .0 1
Yb 1 0 9.910.02 2.5 2 .8 1 0 .1 0.210.04 0.210.04
Amounts determined in rare earth added faecal samples
RE Added Found Added Found Added Found G&V:
La 8 .0 8.610.3 4.0 5.010.1 2.0 2.910.3 19.6
Sm 2 0 16.910.05 1 0 10.610.05 5.0 4.210.04 40.2
Eu 0.4 ND 0 .2 ND 0.1 0.110.005 1.1
Tb 2 0 17.010.6 1 0 11.610.4 5.0 4.110.1 43.0
Yb 1 0 9.910.3 5.0 5.510.3 2.5 2.910.1 4.7
1. Not detected
2. Amounts measured in faeces by INAA (Gray and Vogt, 1974)
1. Reasonable agreement between the results expected and the amounts 
found for standards is evidence that the specific activities are reproducible. 
Low results for some of the samples can be explained by difficulties of 
quantitative transfer of the samples from the aluminium irradiation sachets to 
polythene counting vials.
2. Rare earths were determined in faecal samples to which no rare earths 
were added, to provide an indication of background levels. The precision 
obtained for the measurement of baseline samples could be improved by 
increased irradiation time and chemical isolation of the rare earths from other
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interfering elements.
3. The quantities of rare earths added were generally 1/2,1/4 and 1/8 of those 
determined by Gray and Vogt (1974). The irradiation and counting facilities 
used [6 h irradiation in a flux of 4.2x1012 n cm’2 s’1 and counting on a 25 cc 
Ge(Li)] were approximatly equivalent to the conditions used by Gray and Vogt 
[20 min irradiation in a flux of 5x1013 n cm’2 s'1 and counting on a 45 cc 
Ge(Li)]. However, lower amounts of the elements were determined in 0.2 g 
of ashed samples (equivalent to approximately 2g of dry weight), than for 
those determined in 1 g of dry samples by Gray and Vogt.
The lowest quantities determined were 2 pg for La and 0.1 pg for Eu. These 
are comparable to 2% or 0 .1% recoveries of a 1 mg dose in a 0.2 g fraction 
of ashed faecal sample, with the precision indicated. The poor precision 
obtained for Eu, and the requirement of a long decay period before counting 
indicates that when using instrumental NAA a higher amount of Eu is 
required for reasonable precision and to enable earlier counting.
This preliminary study demonstrates that the concentrations chosen for the 
rare earths can be determined nondestructive^. The use of a pure Ge 
detector with high resolution and greater efficiency (proportional with the 
volume of detector) would enable measurement of lower concentrations with 
improved precision.
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11.1.3 RECOVERY OF ADMINISTERED RARE EARTHS BY INAA
A practical assessment of recoveries of the rare earths following consumption 
by two subjects was undertaken to confirm that they could be quantitatively 
recovered, with analysis by INAA.
11.1.3.1 PROCEDURE FOR DOSE PREPARATION, ADMINISTRATION, AND SAMPLE 
COLLECTION
1. Ethical approval and protocol:
Ethical approval was obtained from the Joint Ethical Committee of the 
Grampian Health Board and The University of Aberdeen (since this study was 
carried out in collaboration with the Department of Medicine, University of 
Aberdeen), and the participants gave their informed consent. A copy of the 
information and consent form is provided in Appendix-1.
2. Preparation of dose solution:
Specpure oxides (Johnson Matthey, Material Technology/U. K.) containing 4.89 
mg of La, 4.83 mg of Sm, 50.0 mg of Eu, 36.9 mg of Tb and 24.9 mg of Yb 
were weighed and transferred to a 50 mL beaker. The oxides were then 
converted to chlorides by dropwise addition of analytical grade 6 M HCI and 
dried by slight heating. The residue was transferred to a 50 mL flask with -20  
mL distilled water. A few drops of 10 M HCI were also added to ensure total 
dissolution. The volume was then made up. 10 mL fractions of the final 
solution (containing 0.98 mg of La, 0.97 mg of Sm, 10.00 mg of Eu, 7.38 mg 
of Tb and 4.98 mg of Yb) were transferred to universal tubes as dosing 
quantities. The solutions were then further diluted with 20 mL of water to 
minimize the acidity and possible unpleasant taste.
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3. Administration and sample collection:
The subjects consumed the dose solution with their lunch since future 
application was to be the determination of luminal disappearance from dietary 
inputs. Two water rinses of the container were also taken to ensure total 
consumption, and the time of administration was recorded as a reference time 
for following records of bowel movements. All stool samples, including toilet 
papers were collected for 6 days by using a toilet ring and biohazardous 
polythene bags shown in Figure-5 (as proposed by Hinton e t  al., 1969). 
Individually collected samples were weighed and stored in a deep-freeze at 
-20 °C for further processing.
Figure-5: Faecal sample collection system used in preliminary rare earth recovery 
investigation
3.Sample preparation:
Stool samples were autoclaved, transferred to aluminium trays, and freeze- 
dried (at The Rowett Research Institute, Aberdeen). The samples were ashed
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in a furnace at gradually increasing temperatures of 200-450 °C for 16-24 h. 
Losses from such ashing have been shown to be .insignificant (Pietra et al., 
1982, Heydom, 1984, pp 60-61). On completion of ashing (when sample 
colour became light green), their ashed weights were recorded. The samples 
were ground to provide homogeneity, which was confirmed by analysis of 
duplicate sub-samples. Duplicate fractions of samples were weighed into 1.5 
mL polypropylene irradiation containers (0.05-0.2 g as appropriate for the 
expected rare earths contents) and stored in polythene containers for further 
use.
11.1.3.2 ANALYTICAL PROCEDURE, RESULTS AND DISCUSSION
1.Irradiation and counting:
Standards of rare earths were prepared from specpure AAS standard 
solutions (1000 pg mL'1 rare earths), by pipetting 10 pg of Sm, and 20 pg of 
La, Eu, Tb and Yb on to cellulose powder contained in irradiation vials. A 
fraction of 100 pL of the supplement dose was also prepared in a vial 
containing cellulose powder. The standards were then dried under an infra-red 
lamp. The irradiation vials containing samples and standards were heat- 
sealed, flux monitors (iron wire) were attached, and then wrapped in 
aluminium foil. Batches of the samples and standards were then irradiated for 
3-6 h in the CVS as appropriate for the expected rare earth contents.
Samples were allowed to decay for 4-7 days after irradiation' to reduce 
radiation exposure and to enable reasonable counting geometry. The samples 
and standards were then unwrapped and counted at 15 cm geometry for 
1000-3000 s to obtain counts with good precision (generally <±1%). Flux 
monitors were also counted at contact geometry for 600 s. The rare earth 
contents of the samples and the dose solution were then found by matching 
their specific activities with those for standards. A schematic diagram of 
overall procedure and a sample spectrum are provided in Figure-6 and 7.
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DECAY FOR 4-7 d
STERILISATION BY AUTOCLAVE
SAMPLE STORAGE IN DEEP-FREEZE
SAMPLE ASHING
SAMPLE GRINDING FOR HOMOGENEITY
FREEZE DRYING OF SAMPLES
TRANSFER TO ALUMINIUM TRAYS
COUNTING & DATA ANALYSIS
IRRADIATION OF SUBSAMPLES
DOSE ADMINISTRATION & 
SAMPLE COLLECTION
Figure-6 : Procedure for rare earth recovery determination by INAA
71
a >
E
•oa.
m Xin a
.. o
•4 -4 ■C ro
J Zo»n m0 .. XI
* ca h.0 -4-4 o
Q. a >*■+*u
Ea
■a
S
uoa
0
-4 -4
0tn a Q
os
z rz i) vz- on
(Am sn t) ovi-m-
(Am cnO »-*
(Am aoci) w —oh '
(Am son) zsi-"3-
(Am s i.ii) obi—‘u - 
</m ZIU) W l—"3 ■
(am 8801) ZDL-n3
(Am *88) Z5l-ng
(Am 6/8} 081-<11 
(m its) zsi-na
(Am s ia ) on-«n
Am lie
(Am isy) on-m
ooo
(Am 88Z) 8ZI-8A — —
(Am « *) 151-03-----------------
^ aa) on-m '
(Am 882) 081
(Am ebz) szi-<u' 
(Am 9YZ) 281—03
(Amcoi) EBl—***S
( 6uu sdo) A}ISUS}UI >jD9d
o
d
oo
d
Fi
gu
re
-7
: 
y- 
ray
 
sp
ec
tru
m 
of 
as
he
d 
fa
ec
al 
sa
mp
le 
pr
ov
ide
d 
18 
h 
aft
er
 c
on
su
m
pt
ion
 
of 
rar
e 
ea
rth
s
2. Results and quality control:
Weights of faecal samples and the mean concentrations determined in ashed 
samples are provided in Appendix-2. Sm concentrations determined in 
duplicate samples (for subject A2) are provided in Table-18. Agreement 
between the results for duplicates show that sample homogenization was 
satisfactory.
The results for the rare earth contents of the dosing solution for six irradiation 
batches were calculated by comparing their specific activities with those for 
the AAS standards irradiated in the same batches. The difference between 
the results was found to be insignificant (paired t-test, p>0.05). The mean of 
six results and the expected concentrations are also provided in Table-18.
Table-18: Concentrations of Sm found in duplicate ashed faecal samples and 
rare earth concentrations in dosing solution
Sm conc. in ashed samples Mean RE conc. in dosing solution
Sample
No DudI. I
pg g^iSD1 
DudI. II Mean RE
pg mL’lSDM 
Found ExDected
1 47.6±0.7 48.3±0.7 47.9±0.5 La 95.8±7 97.8
2 63.5±0.9 62.7±0.8 63.1 ±0.6 Sm 98.5±6 96.6
3 29.2±0.8 30.0±0.8 29.6±0.6 Eu 1029±92 1 0 0 0
4 4.9±0.2 4.7±0.2 4.8±0.2 Tb 790.5±77 738
5 0.68±0.04 0.64±0.06 0.66±0.03 Yb 498.3±36 498
6 0 .1 1  ±0 .0 2 0.14±0.05 0.13±0.02
1 .Error of measurement
Quantitative recovery for all rare earths was obtained for subject A2 
(99.0±4.9%, mean and 1SD for 5 rare earths, range of 95.1-107.4%) but the 
mean recovery for subject A1 was 91.8±3.3%, with a range of 88.4-95.6%. 
This difference is attributed to losses when preparing samples for freeze- 
drying, and expected to be overcome by oven drying. Recoveries of the rare 
earths determined in 6 day collection of faeces are provided in Table-19.
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Table-19: Recoveries of the rare earths in 6 day collection of faeces
RE
RE recoveries for subjects, %±3SD 
Subject A1 Subject A2
La 93.6±4.7 107.4±7.5
Sm 95.6±1.9 95.1 ±3.6
Eu 88.4±7.6 99.2±7.8
Tb 93.0±5.8 96.9±6.3
Yb 88.3±3.2 96.2±4.7
MearttSDM 91.8±3.3 99.014.9
1 .Measurement error at 99% confidence limit
La recovery for subject A2 was found to be higher than those of the 4 other 
rare earths. This could indicate that the contribution of the natural level of La 
in faecal samples to the recovery result is significant. Details of the recoveries 
are discussed in sections II.2.4-II.2.6 with particular attention to natural levels 
of La in faecal samples provided before administration.
In conclusion, no problems were encountered in procedures followed for 
preparation of the dosing solution or dose administration. Samples were 
stored in a deep-freeze at -20 °C until collection period was complete, and 
sterilized by autoclave. Sample transfer to aluminium trays after sterilization 
for freeze drying, was found to be cumbersome, and could cause losses (for 
subsequent studies, oven-drying was applied to avoid this). The requirement 
for homogenization before taking a fraction of an individual sample could 
possibly cause inter sample contamination and requires care.
The results of this preliminary investigation demonstrated that losses during 
sample preparation could be significant. Recoveries of 4 of rare earths agreed 
closely, but a variation for La suggests a possible contribution from natural 
output, which would require further investigation.
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11.2 INVESTIGATION OF OUTPUT PROFILE AND RECOVERY OF 
ADMINISTERED RARE EARTHS, BY PRE-IRRADIATION SEPARATION 
NAA
11.2.1 ESTABLISHMENT OF P RE -IRRADIATION SEPARATION FOR 
DETERMINATION OF RARE EARTHS AND ITS APPUCATION TO DETERMINE 
FAECAL RECOVERIES
Determination of the rare earths by INAA showed that a period of decay after 
irradiation was required to reduce radiation exposure. This increases the time 
required for analysis and also effects limits of determination since half-lives 
of some rare earths activation products (La-140, t1/2=40.3 h, Sm-153, t1/2=46.8 
h, Pr-142, t1/2=19.2 h) are comparable with those of major interfering 
radionuclides (Na-24, tl/2=15 h, K-42, t1/2=12 h).
Such interferences can be removed before or after irradiation, but the latter 
does not reduce radiation exposure. A pre-irradiation separation method was 
established, with the addition of Pr as a yield tracer to take account of 
recoveries. Elimination of the major interfering elements (alkali and alkaline 
earths group) in the procedure was demonstrated with Na-24 tracer. The 
following investigations were carried out to optimise conditions for the pre- 
irradiation separation of selected rare earths from faeces, based on ion- 
exchange procedures previously applied to geological samples (Crock & 
Lichte, 1982, Crock et al, 1984 and Terekado, 1989).
11.2.1.1 CONDITIONS FOR Na-24 REMOVAL 
Procedure
Duplicates of 200 mg of ashed faecal samples were labelled with 1 mL of Na- 
24 tracer, and digested in aqua-regia by heating. The solutions were heated 
to near dryness and diluted to 50 mL with 1M HN03. They were then passed 
through cation exchange columns (100-200 mesh Bio-Rad AG 50W-X8 resin
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in $=1cm, H=10 cm bed volume, previously equilibrated with 1M HN03) at a 
rate of 1-2 mL min*1. The columns were eluted with 5x25 mL fractions of 2M 
HN03. All effluent and the resin contents of columns were collected in 
counting bottles and made up 50 mL. The solutions and 50 mL standards 
were counted for 1000-2000s on contact geometry and recoveries were 
calculated with reference to the activity of 0.1 mL standard.
Results
The counts of eluent showed that most of the Na is eluted with the initial 1M 
HNO3 and 50 mL of 2M HN03. The amount of Na-24 detected in the fourth 
and subsequent fraction of 2M HN03 was found to be insignificant. The 
activity retained on columns were <0.01% of added activity. The fractions of 
Na-24 eluted are indicated in Table-20, where it can be seen that the total 
recoveries were nearly quantitative, 99.7 and 97.1% for the two columns.
Table-20: Na-24 recovery from doped faecal sample by column separation
Na-24 recovery, %±1SD 
Eluent Column I Column II
1M HNO3 (sample loading solution)
50 mL 80.7±0.5 77.0±0.5
2M HNO3
I. 25 mL 17.5±0.1 18.2±0.3
II. 25 mL 1.4±0.01 1.7±0.01
III.25 mL 0.1 ±0.002 0.2±0.003
IV. 25 mL 0.01 ±0.001 0.02±0.001
V. 25 mL <0.01 ±0.003 <0.01±0.003
Total recovery %±SD 99.7±0.5 9 7 .1 ±0 . 6
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11.2.1.2 RECOVERY OF RARE EARTHS IN ION EXCHANGE SEPARATION
Having demonstrated effective elimination of Na, the recovery of rare earths 
from a cation exchange resin was investigated with radioactive rare earth 
tracers.
Procedure
Fractions of 50 |jL of spec-pure AAS standards for La, Sm, Eu, Tb and Yb 
(1000 pg mL'1) were pipetted into counting vials and dried under an IR-lamp. 
They were then irradiated for 6 h in the CVS system. The standards were 
allowed to decay for 4 days to reduce radiation exposure, then transferred into 
a 50 mL graduated flask and made up with 1M HN03. 10 mL fractions of 
standard solution were loaded onto three columns containing cation exchange 
resin, previously equilibrated with 1M HN03. The Na elimination procedure 
was then performed as described above.
The rare earth contents of the 3 columns were eluted by 50 mL of 6 M and 50 
mL of 8M HN03 gradually (3x10 and 1x20 mL of 6 M, and 1x20 and 1x30 mL 
of 8M HN03 for 2 columns and 50 mL of 6 M and 50 mL of 8M HN03 for 1 
column). The contents of all eluents, resin contents of the columns and the 
standard (10 mL of stock solution) were counted after appropriate dilution. 
Recoveries were calculated with reference to standard activities.
Results
Recoveries of the rare earths with the eluents are represented by results for 
La in Table-21 for the 3 columns. It can be seen from Table-22, providing total 
recoveries of the rare earths that they are not removed from the columns by 
1M and 2 M HN03 and that they are completely removed by 6M and 8M 
HN03. The residue on the columns were below the limit of determination.
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Table-21: Sequential recovery of La from cation exchange columns
Recovery of La, %±SD
Eluent Column I Column II Eluent Column III
6  N HN03 6  N HN03
1.10 mL 6 .2 ±0 .1 1 0 .2 ±0 .2 50 mL 84.610.8
11.10 mL 31.1±0.6 31.2±0.7
111.10 mL 28.4±0.6 25.0±0.5
IV.20 mL 24.1 ±0.3 25.7±0.4
8  N HN03 8  N HN03
1.20 mL 6 .8 ±0 .1 7.610.3 50 mL 1 2 .1 1 0 .1
II.30 mL 2 .6 ±0 . 2 2 .Q1 0 .2
TOTAL, %±SD 99.2±1.0 101.710.8 96.710.8
Table-22: Recovery of rare earths by ion exchange separation (summation of all 
eluents)
RE 1M HN03 2M HNO
Recovery, %±SD 
3 Column I Column II Column III Resin
La <0.04 <0.04 99.211.0 101.710.8 96.710.8 <3.4
Sm <0 .0 2 <0 .0 2 98.110.4 100.410.4 96.110.3 <0 . 8
Eu <1.63 <1.58 103.112.5 106.712.6 102.011.7 <1.7
Tb <1.15 <1 .1 1 1 0 2 .6 1 2 .1 94.912.2 103.911.1 <1 .1
Yb <0.35 <0.34 100.411.0 1 0 8 .8 1 1 . 2 95.810.5 <2 .1
MeaniSD 100.712.1 102.515.5 98.913.8
11.2.1.3 RECOVERY OF RARE EARTHS FROM SPIKED FAECAL SAMPLES
In order to demonstrate that efficient separation can be attained with faecal 
samples, where other constituents could effect the separation, the procedure 
was applied to faecal samples to which radioactive rare earth tracers were 
added.
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Procedure
After preparation of a 50 mL of rare earth tracer solution, as described above, 
10 mL fractions of the solution were added to 200 mg duplicates of ashed 
faecal samples. The samples were dissolved in aqua-regia with addition of 5 
mL of 30% H20 2 (if necessary) and evaporated to near dryness. The residues 
were then re-dissolved in 50 mL of 1M HN03. The solutions were passed 
through columns, prepared as described above, and major interfering 
elements eluted with 125 mL of 2M HN03. The rare earth contents of the 
columns were recovered with 50 mL of 6 M and 50 mL of 8M HN03 . All 
eluents, loading solution and the rare earths standard (10 mL of stock 
solution) were collected in counting bottles and counted on a 130 cc pure Ge 
detector after appropriate dilution. The recoveries were calculated with 
reference to standard activities.
Results
The results are provided in Table-23 showing that the losses with the initial 
dilute eluent acid can be significant, where cation contents of sample is 
exceed ion-exchange capacity of column. The recoveries obtained for Column 
I, lower than 100%, indicates that there is a need for a tracer to determine the 
yield of separation. Obtainable quantitative recoveries from a solution, 
containing the rare earths (as described in the previous procedure) and from 
ashed faecal sample, spiked with the rare earths suggests that there is no 
matrice effect to the separation procedure.
Table-23 :Rare earth recovery from spiked ashed faecal samples (sum of 6 M and 
8 M HN03 elution)
Recovery, %±SD
RE Column I Column II
La 96.9±0.9 101.5±0.7
Sm 95.3±0.2 101.4±0.2
Eu 99.1 ±2.4 105.6±2.5
Tb 96.1±1.5 101.3±1.3
Yb 96.8±0.9 100.4±0.8
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11.2.1.4 RECOVERY MEASUREMENTS WITH Pr AS YIELD TRACER
The results of the column separation procedure for 5 rare earths, as 
described above demonstrates that good recoveries can be obtained for a 
representative set of rare earths. Because 141 Pr is 100% abundant and its 
neutron activation product (Pr-142) has a relatively short half-life (19.1 h) and 
an interference-free characteristic 7-ray at 1576 keV (4% intensity), Pr was 
used as a yield tracer for the pre-irradiation separation described above. To 
demonstrate the applicability of the use of Pr yield tracer, recoveries derived 
from separation were compared with those derived from nondestructive 
analysis.
Procedure
100pL of spec-pure Pr solution (1000 pg mL'1 AAS standard) was pipetted into 
duplicates of an ashed faecal sample (obtined from the preliminary faecal 
recovery investigation containing -40% of the supplement dose) and processed 
by following the acid digestion and separation procedure (Figure-8 ). The rare 
earth standards (prepared from 1000 pg mL'1 spec-pure AAS standards as 20 
pL of Eu and Tb, 10 pL of La, Sm and Yb, and 100 pL of Pr) and 100 pL of 
dosing solution (fraction of supplement dose) were pipetted into polypropylene 
vials and heat-dried under an IR-lamp.
Fe-wires were then attached to the irradiation vials and they were irradiated 
for 6h in the CVS. After 2 days decay, the samples and standards were 
counted on a 130 cc Ge detector at the same geometry for 2000 s each. The 
flux monitors were also counted on contact geometry for 600 s. The yield of 
the procedure was found by comparison of the Pr activities produced in 
samples and standard. The rare earth contents of the samples and the dosing 
solution were determined with reference to the standards used, and the 
recoveries were calculated by comparison of the contents of samples and 
dosing solution.
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EVAPORATE SOLUTION
NAAOFRE
REDUCE VOLUME BY 
EVAPORATION
DISSOLVE RESIDUE 
50 mL of 1 M HNO,
ELUTION OF THE ALKAUNES 
125 mL of 2MHNO-
TAKE SUBSAMPLE 
Spike with yiekf tacer(Pr)
TRANSFER SAMPLE TO 
IRRADIATION VIALS & DRY UNDER 
AN IR-LIGHT
RE ELUTION 
50 mL 6M 
50 mL 8M HNO,
DISSOLVE SAMPLE 
1Q-20 mL of aqua-regia 
5 mL H202 (30%)
LOAD TO CATION EXCHANGE 
COLUMN
Pretreated with 1 M HNQ
Figure-8 : Schematic diagram of rare earths chemical separation procedure
Results
For validation of the separation procedure with a yield indicator, the recovery 
results of the rare earths with a faecal sample (from preliminary application on 
two subjects) obtained by INAA are compared with those obtained after 
chemical separation procedure (CNAA) by using Pras chemical yield indicator 
in Table-24.
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Table-24: Comparison of rare earth recoveries determined by chemical separation 
with Pr yield tracer and INAA
Recoveries,%±SD of ingested dose 
Column separation (CNAA) INAA
RE Column I Column II MeamSDM Dupl. I Dupl.ll MeentSCM
La 40.1±1.0 40.5±1.1 40.3±0.7 43.2±1.0 41.4±1.0 42.3±1.0
Sm 40.2±0.8 39.8±0.8 40.0±0.6 38.1 ±0.9 37.4±0.8 37.8±0.9
Eu 38.9±2.6 40.6±2.8 39.7±1.9 40.7±1.9 40.2±2.7 40.6±1.9
Tb 42.7±2.1 40.5±2.2 41,6±1.5 39.4±1.7 40.0±2.4 39.6±1.7
Yb 40.9±1.2 40.4±1.6 40.7±1.0 39.1±1.1 38.1±1.5 38.7±1.1
Column yield, %±SD
87.1 ±0.8 93.6±0.7
Good agreement between the results obtained from two different techniques 
(p>0.05 by paired t-test where mean of the recoveries of rare earths were 
40.5±0.7 and 39.8±1.7 for CNAA and INAA respectively) demonstrate that the 
use of Pr as a yield tracer is an applicable technique for the chemical 
separation procedure. Agreement between the recovery results by CNAA and 
INAA in 95% confidence limit is also illustrated in Figure-9.
Conclusion
1 .The acid digestion procedure followed for ashed faecal samples was found 
satisfactory. Samples were heated to dissolve after addition of 15 mL of aqua- 
regia for a 200 mg sample. For complete digestion, on some occasions 
addition of an extra 5 mL of aqua-regia and 5 mL of 30% H20 2 was required.
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Figure-9: Difference between recoveries (average of 5 rare earths) obtained by CNAA 
and INAA
2. Effective elimination of the alkali and alkaline earths (Na, K, Mg, Ca etc.) 
was demonstrated by separation of Na-24 tracer from the cation exchange 
columns. The elimination of major interfering elements can be seen in Figure- 
10. It can be seen that K-42 is eliminated from the processed sample and the 
reduction of Na-24 to a level comparable with that of K-40 in the natural 
background is attributed to trace quantities of Na in the sample containers.
The pre-irradiation separation procedure described provides less radiation 
exposure and/or permits counting at a shorter time after irradiation. The dose 
rates from unshielded samples after 2 days decay were 50 pSv h‘1 (at 20 cm) 
for column separated samples whilst the dose rates were more than 200 pSv 
h*1for unprocessed samples 4 days after irradiation. Practical exposure was 
significantly less than these levels, since irradiated samples were stored in 
shielded containers. No significant exposure was observed on finger monitors, 
which were worn in addition to a film badge and personal radiation monitor
3. Recovery results of rare earth separation procedure confirmed that recovery 
of rare earths with 50 mL of 6M HN03 was 90% and 50 mL of 8M HN03 was
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required to recover remaining 10%.
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Figure-10: Spectra for the same sample obtained before (upper spectrum) and after 
chemical separation
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11.2.2 RARE EARTH RECOVERY WITH PRE-IRRADIATION SEPARATION
The investigation for faecal recovery of the rare earths, with inclusion of the 
separation procedure, was extended to six subjects for further confirmation of 
their non-absorbability, with particular attention to their natural levels in faeces. 
The fractions of supplement dose recovered in individual faecal samples, and in 
faecal pools consisting of their consecutive accumulation were evaluated to obtain 
faecal recovery profiles for each subject. The principle aim was to identify the 
fraction of output required to obtain sufficient recovery for measurement of luminal 
disappearance from mineral nutrients labelled with stable isotopic tracers.
11.2.2.1 PROCEDURE FOR DOSE PREPARATION, ADMINISTRATION, AND SAMPLE 
COLLECTION
1. Ethical approval and protocol:
The investigation was approved by The Joint Ethical Committee of Grampian 
Health Board and The University of Aberdeen.
The subjects, 5 males and 1 female in good health, pursuing normal sedentary 
activities were provided with an explanatory form containing the theoretical 
background, requirements of the investigation, and instructions for the use of the 
sample collection system. The physical characteristics of 6 subjects who 
participated in two investigations [2 subjects (AS1-2) in the preliminary recovery 
investigation and 6 subjects (BS1-6) in the extended, including the same 
participants] are provided in Table-25. The sample collection system and 
instruction for its use was described to each of the subjects and they were 
requested to collect all stool samples and toilet papers used, starting from the day 
before administration (one sample as baseline) followed by a period of a week. 
Their informed consent was obtained before participation. A copy of the 
information and consent form is provided in Appendix-1.
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Table-25: Physical characteristics of the subjects participated in rare earth 
recovery investigations
Subject Sex Age, y Height, m Weight, kg
AS1 (BS1) M 56 1.74 79
AS2 (BS2) M 37 1 .6 8 65
BS3 M 54 1.85 95
BS4 M 42 1.83 78
BS5 F 28 1.57 55
BS6 M 32 1.77 60
Mean±SDM 42±11 1.74±0.1 72±15
2. Preparation of dose solution
Specpure oxides of the rare earths consisting of 9.75 mg of La, 9.79 mg of Sm, 
100.10 mg of Eu, 77.24 mg of Tb and 50.55 mg of Yb were converted to chloride 
form by HCI treatment and contained in 100 mL of solution as described 
previously. Six fractions of the final solution of 10 mL for each (containing 0.98 
mg of La, 0.98 mg of Sm, 10.00 mg of Eu, 7.72 mg of Tb and 5.05 mg of Yb) 
were transferred to universal tubes and diluted with additional 20 mL of water to 
reduce the acidity for consumption.
3. Administration and sample collection
Subjects drank the solution containing a dose of rare earths with their lunch and 
took two further water rinses of the container to ensure total consumption. They 
recorded the time of preceding and following bowel movements on record cards 
provided with the volunteer information sheet as requested. Each of the stool 
samples was collected in a "biohazard" (autoclave resistible) sample bag, 
contained in a plastic bowl. Samples were brought to laboratory, weights recorded 
and stored in a deep-freeze at -20 °C.
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11.2.2.2 ANALYTICAL PROCEDURE
The overall procedure including analytical processes is provided in Figure-11.
NEUTRON IRRADIATION
DOSE ADMINISTRATION AND SAMPLE COLLECTION
CHEMCAL SEPARATION OF RE FROM 2 SUBSAMPLES 
(0X5-Q.2g)
DECAY FOR 3-4 d
ASHING
STERILISATION BY AUTOCLAVE
GRINDING FOR HOMOGENITY
COUNTING AND DATA ANALYSIS
STORAGE AND DEEP FREEZE
Figure-11: Procedure for the investigation of rare earth recovery 
Sample and standard preparation
After completion of sample collection, the samples for each of the subjects 
were transferred to a "biohazard" bag and they were then autoclaved. The 
requirement of sample transfer to aluminium trays for freeze-drying (which 
caused sample losses in the preliminary application) was eliminated by oven- 
drying. The samples were dried in an oven at 50-70 °C and their weights
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recorded. They were then ashed at gradually increased temperatures of 200-450 °C 
for 16-24 h and their ashed weights also recorded. The samples were ground to 
ensure homogeneity and stored in polythene containers for further use.
Duplicate fractions of samples were weighed (0.05-0.2 g as appropriate for the 
expected rare earth contents) and spikes of 100 pg of Pr were added. Samples were 
dissolved, their rare earth contents were separated by cation exchange and 
transferred to irradiation vials as previously described. Standard vials were prepared 
to contain;
a) 20 pg of La and Tb, and 10 pg of Sm
b) 20 pg of Eu and 10 pg of Yb
c) 100 pg of Pr standard (for chemical yield measurement)
d) 1 0 0  pg of supplement dose as dosing standard.
All standards were then dried under an IR-light, iron flux monitors attached to each, 
and wrapped in aluminum foils for irradiation.
Irradiation and counting
Batches of samples (provided by the same subject) and standards were irradiated 
in the CVS system for 3-6 h as appropriate for the expected rare earth contents. After 
3 days decay, the samples and standards were counted at an optimum geometry for 
1000-2000 s. The standards and dose solution were also counted at a constant 
geometry (15 cm above the detector) for all irradiation batches for quality control. 
Flux monitors were counted at contact geometry for 600s.
The yields of the chemical procedure were found by comparing the specific activities 
of Pr for the samples with those of the standards. The rare earth contents of the 
samples (after chemical yield correction) and the supplement dose were found by 
comparing the specific activities of the rare earths for samples and for the dose with 
those for the standards. The recoveries of the administered dose were then 
calculated as the fraction of supplement dose, taking into account the ashed weights 
of the samples and the concentrations found (as means of duplicate measurements). 
Weight of faecal samples and the mean concentrations determined in ashed samples 
are provided in Appendix-3.
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11.2.2.3 COMMENTS ON PROCEDURE
Sample collection and preparation for analysis:
No problems were reported by any of the subjects relating to dose consumption 
and/or sample collection throughout the study. None of the subjects had any illness 
whilst participating in the study. All subjects completed the study period without 
overlooking any samples, but It was noted that some samples did not include toilet 
paper although subjects were specifically requested to include this.
Analytical procedure and quality control:
Yields of 80-100% were obtained for the separation procedure. The use of a pre­
irradiation separation reduced the dose rates from irradiated samples. For a 1000 s 
count for measurement of the Pr activity in samples and standards a standard error 
of <1 % was obtained, resulting in a negligible contribution to the precision of rare 
earth concentrations determined. Agreement between the concentrations for 
duplicates, with chemical yield correction, confirmed that sample homogenization was 
satisfactory and it justified yield measurements for chemical separation by Pr tracer. 
Table-26 provides a set of Sm concentrations found for duplicates samples after 
chemical yield correction for subject B2 as an example. As can be seen from the 
table that differences between concentrations, with reference to their means, before 
yield correction is significantly higher than that of after yield correction.
Table-26: Sm concentrations in ashed faeces for duplicate samples, determined by 
chemical separation with yield correction, for subject B2
Chemical yield,% Sm concentration in ash, pg g 1±SD1 Difference, %
Col. I Col. II Column I Column II MeaniSDM2 Before After
91 98 0.26±0.01 0.28±0.01 0.27±0.01 28 7
8 6 96 112.3±1.7 114.0±1.8 113.1±1.2 13 1
87 95 83.1±1.3 84.4±1.3 83.8±0.9 1 0 2
83 93 27.8±0.4 28.2±0.4 28.0±0.3 13 1
90 91 5.6±0.1 5.8±0.1 5.7±0.1 5 3
8 6 8 8 0.47±0.02 0.49±0.02 0.4810.01 6 4
84 85 0.23±0.01 0.25±0.01 0.2410.01 9 8
1)Error of measurement, 2) SD for mean
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The rare earth content of dosing solution was determined for 10 irradiation batches 
with reference to specific activities of the simultaneously irradiated AAS standards. 
The mean concentrations in the dosing solution obtained for all irradiation batches 
are compared with the expected values in Table-27. Insignificant difference between 
the specific activity or the rare earth concentrations determined for the dosing 
solution and expected values are evidence that the results of measurement are 
reliable (p>0.05, paired t-test).
Table-27: Comparison of the mean concentrations of rare earths determined and 
those expected of dosing solution
Mean concentrations (n=1 0 ), pg mL' 1
RE Found±SDM ExDected
La 8 8 .2 ± 1 1 97.5
Sm 94.8±10 97.9
Eu 1031.1 ±122 1 0 0 1
Tb 762.2±81 772.4
Yb 482.1±49 505.5
Conclusion
1. The procedure used for sample collection and preparation for analysis minimized 
sample losses during the process. However, sterilization by autoclave and sample 
drying in polythene bags remained inconvenient.
2. The pre-irradiation separation of the elements of interest provided better precision 
and reduced radiation exposure, so that the time required for radioactive decay was 
minimized.
3. Agreement between results obtained for duplicates subject to the chemical 
procedure demonstrated that the processes for homogenization and the 
measurement were satisfactory.
Discussion of the recovery results and their kinetic interpretations is provided in 
section II.2.4 and II.2.5. Investigation of the natural (background) levels of rare earths 
found in faeces and their effect on calculation of recoveries are described in the 
following section.
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11.2.3 NATURAL (BACKGROUND) LEVELS OF RARE EARTHS IN FAECAL 
SAMPLES
The natural levels of rare earths in faeces were determined in samples 
provided before administration of the dose solution, to confirm that this level 
was regained by the end of collections. Concentrations were determined 
principally by ICP-MS. The rare earths used in the recovery investigation 
were also determined by INAA to confirm results obtained by ICP-MS.
11.2.3.1 ANALYTICAL PROCEDURE
Procedure for INAA
Duplicates fractions of 0.2 g of ashed samples, blank (cellulose powder), and 
standard for the rare earths of interest (10 pg of each) were prepared and 
irradiated in the CVS for 6 hours, as described previously. The samples were 
allowed to decay for a week to reduce the contribution of major interfering 
nuclides to the rare earths counts.
The samples were counted for 4000 s for determination of La, Sm and Yb at 
10 cm geometry. After 4 weeks decay, counting was repeated for 5-1 Oh at 
contact geometry for determination of Tb and Eu. The contents of the samples 
were determined with reference to the specific activities of the standards 
which were counted under the same conditions.
Procedure for ICP-MS
0.1 g of ashed samples (equivalent to 5 g of wet weiight) were dissolved in 
10 mL of 16 M aristar HN03 by heating and solutions were evaporated to near 
dryness. The digestion procedure was then repeated with addition of 5 mL of 
the HN03, 5 mL of 30% H20 2 was also added dropwise for complete digestion 
of organic material and the solutions were evaporated to dryness. The 
residues were dissolved in 2% v/v HN03, transferred to 100 mL graduated 
flasks, and made up to provide a sample concentrations of 0.1%, w/v. A blank
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solution was also run through the sample digestion procedure.
Multi-element standards containing all rare earths in 0.2, 1 and 10 ng mL'1 
concentrations were prepared from specpure standards (1000 pg mL'1). The 
standards, samples and the blank solutions were spiked with 115ln as internal 
standards to monitor signal fluctuations. The detection system was then 
calibrated for each of rare earths by introduction of the standard, the 
regression coefficient for the calibration was found 0.9999 for the isotopes 
chosen for the rare earths analysis provided in Table-28.
Table-28: Stable isotopes used for determination of rare earths by ICP-MS
Isotope Natural abundance, % Isotope Natural abundance, %
139La 99.99 159Tb 100
140Ce 88.5 162Dy 25.5
141 Pr 100 185Ho 100
146Nd 17.2 ieeEr 33.4
147Sm 15.0 1KTm 100
151E u 47.8 174Yb 31.8
157Gd 15.7 175Lu 97.4
The rare earth contents of the blank and samples were determined by 
triplicate measurements. No significant internal standard drift was found in any 
of the measurements. The rare earth concentrations for the ashed samples 
were then calculated by application of the sample dilution factor, after 
subtraction of blank levels. The characteristics of the ICP-MS instrument used 
and the analysis parameters are provided in Table-29.
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Table-29: Operational parameters of the Plasma Quad PQ1
Plasma 
R.f. power
Gas controls
Nebulizer 
Spray chamber 
Ion Sampling 
Sampling cone 
Skimmer cone 
Sampling distance 
Optimization
Vacuum
Expansion stage
Intermediate
Analyzer
Data acquisition (Peak
Sweeps
Dwell time
Channels
Dead time
Forward 1.35 kW
Reflected <10 W
Auxiliary 0.55 L min' 1
Coolant 14 L min' 1
Nebulizer 0.73 L min' 1
Meinhart: concentric type
Scott-type double bypass, water cooled (ambient)
Nickel with 1.0 mm orifice 
Nickel with 0.75 mm orifice 
1 0  mm from load coil
The lenses were adjusted to maximize the 115ln signal
2.4 mbar 
<1x1 O'4 mbar 
4x10* mbar 
scanning)
1600 
80 ps 
512 
2 0  ns
II.2.3.2 RESULTS
The concentrations of rare earths in the blank solution (containing chemicals used 
in sample preparation for ICP-MS ) and irradiation vials (sample containers for 
irradiation) were found to be <0.01x10*3 pg mL'1 and <0.1x1 O'3 pg g'1 respectively, 
and were insignificant compared with concentrations detected in the ashed faecal 
samples. The concentrations of all rare earths determined by ICP-MS and of 
those obtained in the recovery investigation (determined by INAA) are provided 
in Table-30.
Conclusion
It can be seen from Table-30 that good agreement was found between the results 
obtained by ICP-MS and by INAA. Chondrite normalized (Evensen et a/., 1978) 
rare earth concentrations determined by ICP-MS, as a function of atomic 
numbers, are depicted for subject BS4 with the measurement precision and for 
the average of 4 subjects with the standard deviation of the mean in Figure-12.
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Figure-12: Chondrite normalised rare earth pattern in baseline faecal samples (O, 
results for subject B4 with measurement precision and # , average of 4 subjects with 
standard deviation of the mean)
The production of smooth trends can be taken as further indication of the 
reliability of the results. As can be seen from the figure, the normalised 
concentrations descends from 10 to 1 (from La to Lu). These values would be 
from 1 to 0.1 if the concentrations were given on the basis of dry weight of the 
faecal samples (the ratio of ashed/dry weight was always close to 0 .1) which 
agrees with the results of Laul and Gosselin (1989) for vegetable standards. 
This suggests that the amounts found in baseline faecal samples probably 
originate from vegetables.
95
11.2.4 EFFECT OF NATURAL RARE EARTH LEVELS ON RECOVERY RESULTS
Contribution of the natural levels of rare earths to recovery measurements
Rare earth concentrations obtained in the final collections for 5 subjects are 
compared with the pre-dose concentrations in Table-31. Recovery was 
incomplete for subject B6 when the investigation ended. In the final sample 
from this subject, the average recovery was 1 %.
Table-31: Concentrations of rare earths (pg g'1 in ashed sample) in samples provided 
at the end of the investigation
RE concentration, pg g 1±3SD
Subject (time, h) 1 La Sm Eu Tb Yb
B1 (143) 2.16±0.12 0.28±0.01 1.8810.24 2 .1 1 1 0 .1 0 1.3810.05
B2 (142) 2.30±0.21 0.24±0.02 2.4810.76 1.9110.90 1.1510.36
B3 (163) 1.30±0.06 0 .1 8 1 0 .0 1 0.5510.06 0.4210.04 0.3910.02
B4 (113) 0.76±0.05 0 .1 2 1 0 .0 0 1 0.3210.21 0.3210.21 0.2510.15
B5 (163) 1.25±0.08 0 .1 0 1 0 .0 2 0.3910.18 0.3010.15 0 .2 0 1 0 . 1 0
MeantSDM 1.56±0.65 0 .1 8 1 0 .0 8 1.1210.99 1.0010.93 0.6810.55
Natural levels in pre-dose samples
MearctSDM 1.43±0.51 0.1910.03 0.1410.08 0.0910.06 0.1410.03
1 Time post-dosing
It can be seen that when samples are provided 110-160 h (5-7 days) after 
consumption of the dose solution the concentrations of the elements of Eu, 
Tb and Yb were found to be higher than their pre-dose levels, but it should be 
emphasized that these represent less than 0.1 % of the input. The contribution 
from a recovery of 0.1% of an input 1 mg of La and Sm to background level 
in the final collection can not be discriminated because the background 
abundances of these elements are significant. For elements where a higher 
levels of input was used (10 mg for Eu, 7.5 mg of Tb and 5 mg for Yb), the 
contribution of the background concentrations to the levels determined in the 
samples provided at the end of the investigation were found to be not
96
significant.
The background level of La was subtracted from output levels in calculating 
La recoveries, assuming the level remained constant through the collection 
period. Sm recoveries were not similarly adjusted, since its background level 
was less than the error of measurement. The effect of taking account of the 
La background for each of individual collection can be seen in Table-32, 
where recoveries of La are compared with the mean of recoveries of other 4 
rare earths for subject B4, as an example. It is evident that the contribution 
of the low abundant (heavy) rare earths to recovery results is negligible but 
that for La recoveries account must be taken of the background level. The La 
background is more significant when correcting lower recoveries.
Table-32: Effect of the background contribution to La recovery (subject BS4)
Time Recovery. %±3SD
Sample no post-dosing, h La before correction La corrected Mean of 4 Rl
1 19 26.25±1.15 25.25±1.18 25.1610.3
2 43 61.15±3.47 59.3613.50 59.7910.7
3 67 9.04±0.54 7.9410.62 7.6810.3
4 90 2,36±0.16 1.3610.32 1.4010.07
5 116 0.70±0.03 - 0 .1 0 1 0 .0 1
6 141 0.72±0.05 - 0.0510.04
Total 100.22±3.70 93.9113.76 94.1910.82
Conclusion
The significant difference between the concentrations determined in pre-dose 
and in final samples (6-7 days after administration) for Eu, Tb and Yb can be 
explained by the fact that a longer period of collection is required to reach 
natural levels for the higher inputs of these elements. The recoveries of these 
elements in final samples were 0 .1% or less.
Intersubject variations in recoveries for the final samples may be due to
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individual idiosyncrasies and/or the composition of diets consumed, but the 
regular descending recovery with time post-dosing indicates that the remaining 
insignificant quantities would be excreted in the following samples. This 
regularity also indicates that absorption of the elements are unlikely, otherwise 
good agreement between the recoveries of La after background effect 
correction and the mean of the other 4 rare earths would not be found. No 
significant difference was found when corrected La recovery results were 
compared with the average of those for the other 4 rare earths in Table-33 
(p>0.05, paired t-test) for all investigations (INAA and CNAA). This 
insignificant difference indicates that natural levels of the rare earths were 
very low (except La) and remained constant through the study period, and 
might be evidence that the losses occurred during sample collection but not 
due to absorption where recoveries were found not to be quantitative.
Table-33: Effect of the background contribution on recoveries of La for 8  subjects
Subiect
Recovery, %±3SD 
La before correction La corrected Averaae of 4 RE±3SDM
A1 93.6±4.7 88.6±4.7 90.0±6.7
A2 107.5±8.0 102.7±8.0 96.9±5.0
B1 100.7±3.5 98.1 ±3.6 96.3±2.4
B2 103.8±4.2 99.9±4.4 100.3±3.4
B3 97.0±2.1 90.5±2.2 91.3±3.2
B4 100.2±3.7 93.9±3.8 94.2±2.0
B5 89.4±2.6 86.1 ±2.7 88.6±2.8
B6 100.9±2.0 97.6±2.7 93.9±3.9
MeantSDM 99.1 ±5.7 94.7±5.9 93.9±3.9
98
11.2.5 RESULTS OF RARE EARTH RECOVERY INVESTIGATIONS
Results
Faecal rare earth recoveries (% of ingested dose) obtained in the initial 
investigation, where samples from 2 subjects (A1-2) were analysed by INAA 
are provided in Table-34.a and bwith recovery profiles in Figure-13.a and b. 
Recoveries and recovery profiles for the second study, where subsamples 
from 6 subjects (B1-6) were analysed after a pre-irradiation separation are 
provided in Table-34.c-h and Figure-13.c-h respectively. Experimental data is 
provided in Appendix-2 and 3. All recoveries for La are given after background 
correction.
The tables contain the time elapsed after administration of the dose, 
recoveries for each of the rare earths in individual stools, means of recoveries 
for 5 rare earths for each sample, and cumulative recoveries obtained by 
addition of sequential outputs. Standard deviations for total recoveries take 
account of measurement errors for each element (99% confidence limit), 
whilst the deviation for total of the mean recoveries takes account of standard 
deviations for the mean of recoveries for each of the samples.
As can be seen from the tables, standard deviations at total recovery for 
individual collections vary between the elements of interest, since the 
detection sensitivity depends on the nuclear characteristics of the isotopes, 
and the efficiency of detector for the characteristic gamma emission 
measured. Precision of measurement of the elements was found to decrease 
in the order Sm:Yb:La:Tb:Eu, i.e. the best precision was obtained for Sm and 
Yb.
The recoveries of rare earths as function of time post-dosing for individual and 
cumulative collections with standard deviations are provided in the figures. As 
can be seen, the recoveries were extrapolated to the time when the dose was 
consumed, to make the recovery profiles more visible.
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Table-34.a: Faecal recoveries of rare earths for subject A1
SUBJECT A1
Faecal
sample
No
Time
post-
dosing
(h)
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean C U M U L A T IV E
1 18 23.45 24.19 23.41 24.78 23.67 23.90 23.90
2 41 48.28 51.22 47.94 50.88 49.76 49.62 73.52
3 48 13.66 15.32 15.15 13.80 1 2 .8 6 14.16 87.68
4 67 1 .2 1 1.23 1.28 1.46 1 .1 2 1.26 88.94
5 1 0 0 - 0.37 0.57 0.45 0.39 0.45 89.39
6 124 - 0.04 0.08 0.15 0 .1 1 0 .1 0 89.49
Total,% 
±3SD
86.60
±4.65
92.37
±1.81
88.43
±7.65
91.52
±5.68
87.91
±3.15
89.49
±1.91
89.49
±1.91
100
10090
80
80
60
70
40
60 20
20 40 60
TIME POST-DOSING, h
40
30
20
6040 BO 100 120 
time; POST-DOSING, h
20 140 160
Figure-13.a: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject A1
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Table-34.b: Faecal recoveries of rare earths for subject A2
SUBJECT A2
Faecal
sample
No
Time
post-
dosing
<W
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean C U M U L A T IV E
1 18 5.91 4.44 4.06 4.13 4.21 4.55 4.55
2 35 41.73 37.80 40.60 39.60 38.70 39.68 44.23
3 60 35.21 33.90 34.70 34.20 34.30 34.44 78.67
4 78 16.38 15.60 16.10 15.60 15.60 15.85 94.52
5 1 1 0 3.44 3.29 3.49 3.34 3.34 3.38 97.90
6 152 - 0 .1 2 0 .2 1 0.13 0.13 0.15 98.05
Total,% 
±3SD
102.7
±8 .0
95.15
±2 . 6
99.16
±8 .2
96.90
±6.4
96.38
±4.2
98.05
±1.83
98.05
±1.83
100
100
80
60
70
40
20
50 20 40
TIME POST-DOSING, h
40
30
18060 14020 40 80 100 120 
TIME POST-DOSING, h
Figure-13.b: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject A2
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Table-34.c: Faecal recoveries of rare earths for subject B1
SUBJECT B1
Faecal
sample
No
Time
post-
dosing
<h)
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean C U M U LA TIV E
1 2 0 43.50 44.12 43.76 43.14 43.14 43.53 43.53
2 44 49.66 50.43 49.88 51.20 50.09 50.25 93.78
3 67 3.58 1.74 1.38 2.26 2 .0 1 2.19 95.97
4 92 0.55 0.28 0 .2 2 0.29 0.29 0.31 96.28
5 1 2 0 0.33 0 .1 1 0.06 0.07 0 .1 0 0.13 96.41
6 143 0.44 0.17 0 .1 1 0.16 0.16 0 .2 1 96.62
Total,%
±3SD
98.06
±3.56
96.85
±3.23
95.41
±4.69
97.12
±3.86
95.79
±3.69
96.62
±1.13
96.62
±1.13
100
10090
80
80
60
70
40
60 20
TIME POST-DOSING, h
40
30
20
6020 40 80 100 120 
TIME POST-DOSING, h
140 160
Figure-13.c: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject B1
102
Table-34.d: Faecal recoveries of rare earths for subject B2
SUBJECT B2
Faecal
sample
No
Time
post-
dosing
(h)
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean C U M U L A T IV E
1 11 0 .2 1 0.04 0 .0 1 0 .0 1 0 .0 1 0.06 0.06
2 30 63.29 65.64 67.53 65.48 64.00 65.19 65.25
3 55 31.17 29.52 27.88 29.76 29.24 29.51 94.76
4 77 3.38 3.24 3.18 3.27 3.21 3.26 98.02
5 98 0.98 2.27 1.90 2.09 1.96 1.84 99.86
6 118 0.44 0 .1 0 0.07 0.07 0.09 0.15 1 0 0 .0
7 142 0.43 0 .1 2 0 .1 2 0 . 1 2 0 .1 1 0.18 1 0 0 .2
Total
%±3SD
99.90
±4.42
100.9
±2.44
1 0 1 .0
±3.06
1 0 1 .0
±3.73
98.62
±2.77
1 0 0 .2
±1.13
1 0 0 .2
±1.13
100
10090
80
80
70
40
60 20
SO 20 40 60 80 100 120 140 160
HUE POST-DOSING, h
40
30
60 80 100 120 
TIME POST-DOSING, h
140 16020 40
Figure-13.d: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject B2
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Table-34.e: Faecal recoveries of rare earths for subject B3
SUBJECT B3
Faecal
sample
No
Time
post-
dosing
(h)
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean C U M U L A T IV E
1 18 30.31 30.19 30.22 29.56 30.58 30.17 30.17
2 42 46.33 44.71 47.48 46.65 45.01 46.04 76.21
3 6 6 11.31 12.61 12.34 12.09 11.89 12.05 88.26
4 90 2.13 2.04 1.97 2.33 2.33 2.16 90.42
5 117 0.40 0.54 0.52 0.55 0.55 0.51 90.93
6 141 - 0.13 0 .1 1 0 .1 2 0 .1 0 0 .1 1 91.04
7 163 - 0.17 0.05 0.05 0.07 0.08 91.12
Total,% 
±3SD
90.48
±2.15
92.69
±0.64
92.69
±4.06
91.35
±2.41
90.53
±2 .2 1
91.12
±1.33
91.12
±1.33
100
10090
£  8080
60
70
60 2  20o
so
TIME POST—00SINC. h
40
30
20
20 6040 100 120
TIME POST-DOSING, h
140 160
Figure-13.e: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject B3
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Table-34.f: Faecal recoveries of rare earths for subject B4
SUBJECT B4
Faecal
sample
No
Time
post-
dosing
(h)
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean CUMULATIVE
1 19 25.25 25.37 25.25 24.73 25.29 25.18 25.18
2 42 59.36 58.79 60.21 60.47 59.69 59.70 84.88
3 67 7.94 7.41 7.52 7.87 7.94 7.74 92.62
4 90 1.36 1.38 1.32 1.44 1.47 1.39 94.01
5 116 - 0.09 0.09 0 .1 0 0 .1 0 0 .1 0 94.11
6 140 - 0 .1 1 0.03 0.03 0.05 0.05 94.16
Total, % 
±3SD
93.91
±3.76
93.15
±1.13
94.42
±4.93
94.64
±4.03
94.51
±3.03
94.16
±0.60
94.16
±0.60
100
100K
*  80
00
BO
BO
60 o 20
50 20 40 60
HUE POST-DOSING, h
6020 40 80 100
TIME POST-DOSING, h
120 140 160
Figure-13.f Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject~B4
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Table-34.g: Faecal recoveries of rare earths for subject B5
SUBJECT B5
Faecal
sample
No
Time
post-
dosing
(h )
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean CUMULATIVE
1 14 2.83 3.02 3.08 3.40 3.00 3.07 3.07
2 39 74.70 77.70 75.94 74.91 75.32 75.71 78.78
3 62 7.87 8.26 8.99 8.90 8 .6 8 8.56 87.34
4 8 6 0.45 0.51 0.57 0.48 0.50 0.50 87.84
5 98 0.26 0 .2 2 0.27 0.23 0.24 0.24 88.08
6 113 - 0 .0 2 0 .0 1 0 .0 1 0 .0 1 0 .0 1 88.09
7 135 - 0 .0 1 0.004 0.004 0.004 0.003 88.09
Total,% 
±3SD
8 6 .1 1
±2 . 6 6
89.74
±0.83
8 8 .8 6
±4.16
87.93
±3.04
87.75
±0.92
88.09
±1.31
88.09
±1.31
100
10090
80
70
>-
60
SO 20 40
TIME POST-DOSING, h
40
20
40 6020 80 100 120 
TIME POST-DOSING, h
140 160
Figure-13.g: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject B5
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Table- 34.h: Faecal recoveries of rare earths for subject B6
SUBJECT B6
Faecal
sample
No
Time
post-
dosing
(h )
% of INGESTED RE DOSE IN STOOL
La Sm Eu Tb Yb Mean CUMULATIVE
1 7 0 .1 0 0 .0 2 0 .0 1 0 .0 1 0 .0 1 0.03 0.03
2 28 41.73 39.53 40.93 41.16 41.16 40.91 40.94
3 54 29.49 27.81 28.47 28.77 27.96 28.50 69.44
4 73 19.95 20.39 20.67 19.77 2 0 .1 1 20.18 89.62
5 99 2.76 2.03 1.80 2.44 1.89 2.18 91.80
6 124 2.34 1.38 1.31 1.63 1.51 1.63 93.43
7 144 1 .2 0 0.85 0.78 1.08 1.25 1.03 94.46
Total,%
±3SD
97.59
±2.03
92.01
±0 .6 6
93.97
±3.67
94.86
±2.31
93.89
±2.19
94.46
±1.28
94.46
±1.28
100
10090
fe 80
80
70
40
80
50 20 40 60
TIME POST-DOS IN Q, h
40
20
60 80 100 120 
TIME POST-DOSING, h
140 16020 40
Figure-13.h: Faecal profile of recovery (mean of 5 rare earths) for individual samples
and composite of sequential outputs for subject B6
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11.2.6 DISCUSSION OF RARE EARTH RECOVERIES
In this investigation, the same 5 rare earths as used by Luckey et a\. (1977) 
were used, but in lower quantities and with a single input, to ascertain of 
quantitative recovery of the doses could be achieved following administration 
as chloride solution. These studies were carried out to confirm the feasibility 
of the use of single inputs of markers in studies of trace element absorption 
with stable isotopic tracers.
11.2.6.1 DOSE AND PROCEDURE
Luckey etal. (1977) investigated the faecal recovery kinetics of rare earths on 
3 subjects using single inputs of 5 rare earth oxides contained in capsules. 
This was repeated on the same subjects to check reproducibility and/or intra 
subject kinetic variations. Samples were collected the day before consumption 
and for the following week. Subsamples of a 0.7g of dried samples were 
analyzed by INAA as described by Gray and Vogt (1974).
Six subjects were involved in this study; 5 rare earth chloride solutions were 
used, and the amounts administered were calculated to be at a level which 
would enable detection of 0 .1% of the dose in a fraction of output by using 
a high resolution 133 cc HPGe detector. The precision of measurement, 
particularly significant at lower concentrations, was improved by pre­
concentration (ashing and pre-irradiation chemical separation). This 
improvement enabled investigation of rare earth recovery kinetics with 60, 5, 
1.5, 7 and 6 times lower than those of used by Luckey et al. (1977) for La, 
Sm, Eu, Tb and Yb respectively. The procedure also enabled use of larger 
amounts of sample, which also allowed detection of lower concentrations (less 
than 0.1% of recoveries were measured with ±5% precision with a 99% 
confidence limits where 0.2 g of ash sample were used equivalent to 2 g of 
dry sample).
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11.2.6.2 FAECAL RECOVERIES OF THE RARE EARTHS
Faecal recoveries obtained from this and those obtained by Luckey et al. 
(1977) are provided in Table-35. The recoveries of the rare earths consumed 
(mean of 8 applications, average of 5 rare earths for all subjects with 1SDM) 
were found to be 94.1 ±4.2% in a range of 88.1-100.2%. For 5 of the 8 
recovery studies the results were approximately quantitative, 96.7±2.5% 
(mean of 5 applications with 1SDM, average of 5 rare earths) in a range of 
94.2-100.2%, while the other three were 89.6±1.5% (mean with 1SDM, 
average of 5 rare earths) in a range of 88.1-91.1% because of losses with 
accidental rejection (reported by subject with 88 .1% recovery), and with toilet 
papers which were not included in the sample collection.
The variability of recoveries after correction for the La background effect 
(specified in 11.2.3) was found to be less than ±6%, and differences were 
found to be insignificant for all applications (p>0.05, paired t-test).
Luckey et al. (1977) obtained variations of inter-subject and inter-element 
recoveries, 5 of 7 applications and 3 of the 5 elements were significantly 
different from the mean of recoveries for the applications and for the 
elements. The results obtained from this study are more consistent 
(insignificant inter-subject and inter-element variation, p>0.05). It is apparent 
that the use of pre-concentration and chemical separation together with the 
improved detection limit provides more precise results. Comparison of the 
inter-element variations found in subjects A1-2 and B1-6 demonstrates the 
benefit of chemical separation.
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Reproducibility of recoveries was also examined for the investigation carried 
out by Luckey et at (1977) (applied to 3 subjects) and for this investigation 
(applied to 2 subjects). Good agreement is found for 2 of the 3 subjects 
investigated by Luckey (94.7±0.4% with 1SDM for subject BV and 86.0±2.0%, 
1 SDM for subject TL) whilst the reproducibility for subject DH significantly poor 
(95.6±18.2% with 1 SDM). The reproducibilities for this study were found to be
93.1 ±5.1% and 99.5±2.1% (with 1SDM) for Subject-1 and 2 respectively. The 
variation of intra-subject recoveries can be explained by losses during sample 
collection (due to losses beyond control) in both cases. However the 
reproducibility of nearly quantitative recovery results, particularly for Subject-2 
(99.5±2.1% with 1SDM) confirms the conclusion made for incomplete 
recoveries and indicates that the losses due to significant absorption is less 
probable.
11.2.6.3 FAECAL APPEARANCE PROFILE
Faecal recoveries of the rare earths for all 8 applications demonstrate that 
rare earth markers enable determination of the yield of sample collection. The 
profiles of faecal output as a function of time after consumption were 
considered, to identify the optimum time for limited sample collection when 
applied to determination of luminal disappearance with stable isotopic tracers. 
Parameters related to intestinal kinetics of the rare earths were also derived 
from the recoveries for possible applicability to measuring intestinal passage 
times of pharmaceuticals and to calculate exposure of dose where radioactive 
tracer(s) or marker(s) are used.
Recoveries of the rare earths with the first samples following consumption 
ranged between 0.03 and 43.5% (16.3±16.5% in 16±5 h with 1SDM). The 
major fraction of the doses were recovered in 2 consecutive samples 
(69.7±18.7% in 38±6 h with 1SDM). Recoveries were nearly quantitative with 
in summation of 3 faecal outputs (86.8±8.9% in 60±7 h with 1SDM) for all 
subjects, providing no significant difference (p>0.05; paired t-test) from the
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following consecutive accumulations (92.4±3.7% in a period of 82±9 h with 
1SDM). Recoveries obtained with 5 and 6 sample collection were nearly 
quantitative (93.6±4.2% in 115±16 h and 93.9±4.2 in 135±13 h respectively). 
Fractions of the total rare earth recoveries for 2-4 consecutive sample and 
time post-dosing are provided in Table-36. Cumulative recoveries (as % 
fraction of total recoveries) as a function of time post-dosing for 1-6 sample 
accumulation are depicted in Figure-14 with standard deviations for both 
recoveries and time post dosing.
Table-36: Faecal recoveries of rare earthsin composites of 2-4 sequential outputs
2 Samples  3 Samples_____  4 Samples
SUBJECT Time, h Recovery, %* Time, h Recovery,% Time, h Recovery,%
AS1 41 82.1 48 98.0 67 99.3
AS2 35 45.1 60 80.1 78 96.4
BS1 44 96.6 67 98.9 92 99.2
BS2 30 65.3 55 94.8 77 98.0
BS3 42 83.6 6 6 96.9 90 99.3
BS4 42 90.2 67 98.4 90 99.9
BS5 39 89.5 62 99.1 8 6 99.7
BS6 28 42.8 54 72.7 73 93.9
MEAN±SDM 38±6 74.4±20.9 6Q±7 92.3±10.1 82±9 . 98.2±2.1
* Recoveries for the composites represent percentage of the total recoveries provided in 
Tabie-34.a-h for each subject
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Figure-14: Cumulative faecal rare earth recoveries as a function of time post dosing 
(mean of 8  applications with ±1SDM)
Since the transit time of digesta can be estimated from fractional retention as 
a function of time (Kotb and Luckey, 1972, and Luckey, T.D., 1979), the 
retention patterns of the rare earths were assessed to provide further 
information on their intestinal kinetics. Retention patterns for each of the 
subjects were evaluated to determine the first appearance time (duration 
required for digesta to enter excretion compartment) by extrapolating to 100% 
retained, the gastro intestinal half life of the rare earths, and quantitative 
excretion time. The faecal excretion parameters derived from recoveries in 8 
applications are provided in Table-37 with standard deviations obtained in the 
linearity equation;
LogR% =(a±SDJt+(b±$D,)
and with regression coefficients. The retention pattern for subject B2 is 
provided in Figure-15.
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Table-37: Parameters for intestinal kinetics of the rare earths
Time of first Time for
Subject appearance.h G.l. half- life.h quantitative excretion ,h r2 (linearity)
AS1 16.4±4.2 23.3±6.0 61.9116.0 0.920
AS2 26.0±4.3 36.0±6.0 92.7115.5 0.947
BS1 11.2±2.5 18.5±4.1 60.0H3.3 0.968
BS2 10.8±0.9 22.4±2.0 87.817.7 0.990
BS3 12.1±0.5 23.2±0.9 86.113.5 0.998
BS4 15.5±1.0 23.711.6 70.014.7 0.996
BS5 11.7±1.5 20.112.7 67.319.6 0.976
BS6 11.1±1.5 28.113.6 122.5115.7 0.956
MeantSDM 14.3±5.2 24.415.5 81.0120.9
100
0 20 40 60 80 100 120
TIME POST-DOSING, h
Figure-15: Recovery kinetics for the mean of 5 rare earths for subject B2 (A:time of 
first appearance time, B:gastro intestinal half-life, and C: time for quantitative 
excretion)
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It can be seen from Table-37 that both the first appearance time and gastro­
intestinal half-life for subject A2 were found to be significantly difference from 
those found for the other subjects (p>0.05). This significance for subject A2 
can be explained by the subject have slowest digesta flow rate comparing with 
the others.
The recoveries obtained from this investigation were also interpreted in terms 
of the rate of flow of the rare earths through the alimentary tract, as suggested 
by Luckey et al. (1977) and Luckey (1979). Patterns of recovery rates 
obtained from recoveries of the rare earths for the same subjects (1 and 2 ) 
are provided in Figure-16.a and b. As can be seen from the figures, the 
patterns were reproducible for Subject1-1 (A1 and B1 in Figure-16.a) whilst 
those for Subject-2 (A2 and B2 in Figure-16.b) were different. These observed 
differences might be explained by individual idiosyncrasies or differences in 
composition of foods (e.g. fibre contents) consumed.
100
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Figure-16.a: Faecal excretion rates of administered rare earths for Subject-1
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Figure-16.b: Faecal excretion rates of administered rare earths for Subject-2
Luckey (1979) found that significant quantities of digesta enter the excretion 
compartment in about 10 h (first appearance time) and the half-life of digesta 
is about 25 h. Luckey et at (1977) and Luckey (1979) showed that digesta 
flow rate into the excretion compartment vary between subjects and that this 
could not be related to physical characteristics, diet, sex, age, or life style but 
could be related to intestinal physiology. The results of this investigation for 
the kinetics of rare earth markers agree with those obtained by Luckey et al. 
(1977).
11.2.6.4 CONCLUSION
The results of this investigation performed on 6 subjects with 8 applications 
show that the rare earths are nearly quantitatively recovered following 
consumption of a solution of rare earths chlorides with a meal. The 
determination of a significant effect of La baseline levels on recovery results
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and agreement between marker elements recovered with each sample, even 
for low recoveries, might be a further evidence that losses are due to 
incomplete collection (losses particularly with toilet papers) where recoveries 
are less than 100%.
The mean of total recoveries (as an average of 5 elements) was found to be
94.1 ±4.2% with SDM (in a range of 88.1-100.9%) with better reproducibility 
than those found by Luckey et al. (1977) for the same rare earths for 7 
applications (91.4±8.8% with SDM in a range of 82.7-108.5%). Good 
agreement is obtained when the results of this investigation are compared 
with those of Hayes et al. (1964) (96±4% with SDM in a range of 91-104% for 
22 applications) where the recoveries determined by the use radioactive La- 
140.
Patterns of recoveries of the rare earths with individual samples have a similar 
configuration for each of the applications. In all of the subjects, the first 
appearance was detected 24 h after consumption. The patterns showed a 
maximum recovery in 40 h and nearly quantitative excretion in 72 h. The 
amounts appearing by 120 h were approximately 0.1%. A major fraction of the 
dose, as percentage of total recoveries, was recovered with the first 2 
samples (74±21% with SDM in a range of 43-97% for 8 applications). The 
mean recovery with the first 3 samples was nearly quantitative (92±10% in a 
range of 73-99%) providing no significant difference from 100%.
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III. MEASUREMENT OF LUMINAL DISAPPEARANCE USING STABLE 
ISOTOPIC TRACERS AND RARE EARTH MARKERS
Having investigated the faecal recovery and recovery rates of potential rare 
earth markers, with establishment of suitable analytical procedures and 
demonstration of near quantitative recovery, their application in determination 
of the luminal disappearance (intestinal uptake) of trace elements by using 
enriched stable isotopic tracers was investigated. Faecal recovery profiles of 
rare earth marker and of the excreted fractions of isotopic tracers were 
compared to investigate the applicability of the rare earth marker approach in 
trace element absorption studies
To demonstrate the applicability of rare earths for determination of the luminal 
disappearance, the luminal disappearance of iron from 2 modes of 
sequentially administered intakes, a standard solution and a wheatflour based 
meal (Farina), each being labelled with a stable isotope of iron and a rare 
earth was measured. The inclusion of an isotopic tracer of zinc with the Farina 
meal enabled consideration of measurement of uptakes of two elements. 
Attention was given to faecal recovery profiles of the rare earths markers and 
the excreted fractions of the isotopic tracers.
111.1 STUDY DESIGN AND PRE- AND POST-IRRADIATION SEPARATION 
FOR DETERMINATION OF ISOTOPIC TRACERS
111.1.1 CHOICE OF ENRICHED STABLE ISOTOPES AND DETERMINATION OF 
REQUIRED INPUTS
For measurement of the luminal disappearance of iron and zinc, selection of 
appropriate stable isotopes and the required inputs are determined by the 
factors:
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1.Range of luminal disappearance
Luminal disappearance varies widely, depending on status of subjects, mode 
of intake, oxidation state of the elements, and constituents of diet The 
following examples illustrate these variations for iron and zinc.
Luminal disappearance of ferrous iron, from a solution containing 1 mg of Fe 
was found to be 37.6% (SD 16.8) with a range of 3.6-60.7% for 15 male 
subjects (Marx, 1979). In 96 normal men, Magnusson etal. (1981) found the 
mean absorption to be 21.6% (SD 11.3), with a significant negative correlation 
between absorption and serum ferritin leve). Uptake by 2 male 1 female 
subjects from a meal containing 3.2 mg of ferric iron was 14.5±9.4% (range 
of 5-23.9%), Jasani et al. (1971), whilst the uptakes by 8 female subjects from 
a cereal-based diet containing 14 mg d‘1 iron was 9.0% (Tumlund et al., 
1990).
The luminal disappearance of zinc however has shown less variability 
compared. Uptake by 2 male and 2 female subjects, from a solution 
containing 2 mg Zn was 61 ±3.0% in a range of 57-65% (Wastney etal. 1991), 
whilst the uptake by 9 male subjects, from a breakfast diet containing 2 mg 
of zinc was 38.9% (SD 9.8) in a range of 27.5-54.2%, Couzy et al. (1993).
2. Natural abundance of the enriching isotope
The natural abundance of the enriching isotope is a major factor influencing 
the choice of dose. The total dose of an element containing enriched isotopic 
tracer should be similar to the normal daily intake, and should not exceed the 
physiologically required dose, unless so required for specific investigation. By 
considering this, the amounts of iron and zinc for a single input administered 
with breakfast are considered to be approximately 3 mg since the average 
contents of food obtained for daily consumption in the U.K. are 10.9 mg for 
iron and 9-12 mg for zinc (Department of Health, 1991). The intake for 
measurement of iron absorption from a standard solution has been 
recommended to be 3 mg by WHO (Magnusson, et al., 1981).
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It is evident that enrichment of the least abundant isotope of the element of 
interest results in use of the lowest amount of isotopic tracer for labelling the 
dose. This choice should lead to better accuracy compared with that obtained 
from the same quantity of a more abundant isotopic tracer. A disadvantage 
of using enriched isotopic tracers of the lowest abundant isotope is the high 
cost.
3. Degree of isotopic enrichment
The degree of isotopic enrichment required to enable measurement of luminal 
disappearance from a dose depends on the precision of the analytical 
technique used.
The required doses of pure isotopes for iron and zinc can be calculated with 
the following assumptions, with regard to the above factors.
a.The luminal disappearance of the tracerfrom the dose is 60% for iron 
and 50% for zinc,
b.A week after administration, measurement of 1% of the excreted 
dose is achievable in a single stool sample,
c.The analytical technique used is capable of measuring 5% 
enrichment over natural levels of the isotopes,
d.For adult subjects, the natural levels of the elements in daily faecal 
output are about 16.8 mg for iron and 13.0 mg for zinc (Mason et al., 
1990).
The calculated inputs to meet these criteria and the cost and enrichment of 
commercially available enriched stable isotopes are provided in Table-38.
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Table-38: Input of stable isotopes required to enable measurement of 1% of excreted 
dose (when 60% of iron and 50% of zinc are absorbed)
Isotope 
(Mass no)
Natural abundance1 
(Atom %)
Available2 
Required dose enrichment 
(mg of isotope) (Atom %)
Cost2
(£mg1)
Fe
54 5.8 12.2 95-97 10-20
56 91.7 NA3 - -
57 2.2 4.6 ' 80-97 10-28
58 0.28 0.6 65-93 100-300
Zn
64 48.6 NA - -
66 27.9 NA - -
67 4.1 5.3 76-94 12-28
68 18.8 24.4 37-99 2-6
70 0.6 0.8 65-88 80-300
1. Commission atomic weights and isotopic abundances (1991)
2.Aggett and Whitley (1994)
3. Not applicable since the required input exceeds physiological requirements
It can be seen that the use of ^Fe or MZn is not practical for a single dose 
where the daily requirement and intended detection in a single stool sample 
obtained a week after administration are considered. For these isotopes, lower 
doses can be used if the enrichment is measured in a total faecal pool, where 
enrichment over natural levels of the isotopes can be much more than 5%. 
Such an approach has been followed by Tumlund et al. (1990) with inputs of
1 mg ^Fe, by Sian et al. (1993) with a range of 3-10 mg of 67Zn and 68Zn 
and by English et al. (1989) with 4 mg of 68Zn.
III.1.1.1 DETERMINATION OF REQUIRED DOSES
By the use of the least abundant isotopes (“ Fe, 57Fe and 70Zn) as tracers, the 
required doses to investigate luminal disappearance were determined by 
considering the analytical technique used to measure their enrichment. The
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following assumptions were made in calculating the required amount of 
enriched stable isotopes.
1) Fractional luminal disappearance is 10% for iron and 50% for zinc when 
they are administered with a meal, and 60% for iron sulphate (+2 oxidation 
state) when it is given with a solution containing ascorbic acid.
2 ) 1 % of a nonretained fraction of the isotopic doses is measurable in an 
ashed sample obtained 5 day after administration.
3) The tracer isotopes for the elements administered with meal, “ Fe and 70Zn, 
are determined by NAA. The isotope for iron given with the solution is 57Fe 
and is determined by ICP-MS.
4) The solution and meal are marked with Sm and Yb, which provide the 
lowest limit of determination by NAA, of the rare earths considered.
By taking account of nuclear parameters and detection efficiency, it can be 
calculated that;
a) When approximately 1 pg of S8Fe is irradiated for 6 h in a flux of 3.6x1012 
n cm'2 s'1 and counted on a 130 cc HPGe detector (~2% efficiency for 
characteristic 7-ray of Fe-59 at 1099 keV), it provides 10000 counts, 
producing 1% precision.
b) When approximately 0.5 pg 70Zn is irradiated 1 h in the pneumatic transfer 
system (in a flux of 2.4x1012 n cm'2 s'1) and counted on the detector (~3% 
efficiency for characteristic 7-ray of Zn-71 m at 386 keV) on contact, it can be 
determined with 2% precision.
c) 3% over the natural level of 57Fe can be determined by ICP-MS where the 
precision for measurement of the isotope is 1 %.
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With the above assumptions, the required doses are 1 mg for each of saFe 
and 70Zn, assuming 1 pg of “ Fe and 0.5 pg 70Zn are measured in 10% of 
the total ash weight of a single sample. The dose for 57Fe is 2 mg.
d) The required dose for Sm and Yb are 1 and 5 mg respectively where 0.1% 
of the dose in 10% of ashed faecal samples is determined with 1% precision 
by CNAA (Section 11.1.1). The use of 1 mg of Yb could be sufficient where the 
samples are counted for a longer period than 1 h on contact geometry with 
higher detection efficiency.
Nl.1.1.2 EFFECT OF THE TIME INTERVAL BETWEEN SEQUENTIAL ADMINISTRATIONS
The process used to enrich a specified isotope of low abundance can enrich 
other similar isotopes with low abundance (e.g. 95% S7Fe enriched iron could 
contain 2% “ Fe for which the natural abundance is 0.28%). Attention should 
therefore be given to time interval required between the two administrations 
to minimize the possible effects of isotopic overlap in the outputs.
The isotopic and elemental composition of each of sample collection following 
both administrations was calculated, with following assumptions;
1) The standard solution is administered first.
2) The recovery of excreted dose is completed within 5 days following 
consumption. The recovery kinetics of the isotopic tracer is the same as that 
of the rare earth marker. The fractional distribution of the marker in 5 
consecutive collections after dose consumption, based on results obtained for 
rare earth recoveries are 0.2, 0.6, 0.15, 0.03 and 0.02.
3) The elemental composition of a regular daily output, based on results 
provided by Mason et al. (1990) is constant and contains 16.8 mg of iron and 
13 mg of zinc.
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4) The elemental and isotopic composition of the mode of intakes are 
considered to be;
a) A standard drink containing 3 mg of iron, including 2 mg of S7Fe and 0.02 
mg of “ Fe (enrichment in 57Fe enriched Fe),
b) A standard meal containing 3 mg of iron, including 1 mg of 58Fe and 0.2 mg 
of 57Fe (enrichment in 58Fe enriched Fe). The meal also contains 3 mg of zinc 
including of 1 mg of 70Zn,
c) The drink and the meal contain 1 mg of Sm and 1 mg of Yb respectively.
The distribution of the isotopes and elements for each of the individual 
samples for 57Fe are provided in Tables-39 and 40, for “ Fe in Tables-41 and 
42 for intakes consumed at 1 and 3 day intervals, and in Table-43 for 70Zn 
for 3 days interval. The isotopic distribution in the samples are also provided 
with the figures illustrating the cases for 57Fe, as example (Figures-17 and 18). 
The abbreviations for the tables are as follows;
M is fractional marker recovery
Es and Em are elemental contribution from the standard drink and meal respectively 
Ef is total element (consisting of Es , Em and the natural level of the element in daily 
faecal output)
ls and lm are isotopic contribution from the standard drink and meal 
lb is isotopic baseline containing the natural level of the isotope in daily faecal output 
and the isotopic contribution from the doses in natural composition 
lt is total isotope in sample
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Table-39: Elemental iron and 57Fe composition of faecal samples when the standard
drink and meal are given at a time interval of 1 day (drink enriched in ^Fe)
Fe content, ua —Fe content ua
DAY M E. Em Et 1. L >b It
0 0 0 0 16800 0 0 369.6 369.6
1 0 . 2 240 0 17040 160 0 371.4 531.4
2 0 . 6 720 540 18060 480 36 374.9 890.9
3 0.15 180 1620 18600 1 2 0 108 370.9 598.9
4 0.03 36 405 17241 24 27 369.9 420.9
5 0 .0 2 24 81 16905 1 6 5.4 369.8 391.2
6 0 0 54 16854 0 3.6 369.6 373.2
1000
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drink900
□ Natural
800 •  Fa from maal
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100
TIME, d
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Figure-17: Calculated S7Fe isotopic distribution in faecal samples when the standard 
drink and meal are administered at a time interval of 1 day
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Table-40: Elemental and S7Fe composition of faecal samples when the standard drink
and meal are given at a time interval of 3 days (drink enriched in 57Fe)
Fe content, ua ^Fe content, ua
DAY M E, Em Et I. L lb 1,
0 0 0 0 16800 0 0 369.6 369.6
1 0 . 2 240 0 17040 160 0 371.4 531.4
2 0 . 6 720 0 17520 480 0 374.9 854.9
3 0.15 180 0 16980 1 2 0 0 370.9 490.9
4 0.03 36 540 17376 24 36 369.9 429.9
5 0 .0 2 24 1620 18444 16 108 369.8 493.8
6 0 0 405 17205 0 27 369.6 396.6
7 0 0 81 16881 0 5.4 369.6 375.0
8 0 0 54 16854 0 3.6 369.6 373.2
1000
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Figuie-18: Calculated 57Fe isotopic distribution in faecal samples when the standard 
drink and meal are administered at a time interval of 3 days
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Table-41: Elemental iron 58Fe composition of faecal samples when the standard drink
and meal are given at a time interval of 1 day (meal enriched in 58Fe)
Fe content, ua —Fe content, ua
DAY M E, Et L 1. K It
0 0 0 0 16800 0 0 47 47
1 0 0 240 17040 0 1 .6 47.0 48.6
2 0 . 2 540 720 18060 180 4.8 48.1 232.9
3 0 .6 1620 180 18600 540 1 .2 50.1 591.3
4 0.15 405 36 17241 135 0 . 2 47.8 183.0
5 0.03 81 24 16905 27 0 .2 47.2 74.4
6 0 . 0 2 54 0 16854 18 0 47.1 65.1
7 0 0 0 16800 0 0 47.0 47.0
Table-42: Elemental iron 58Fe composition of faecal samples when the standard drink
and meal are given at a time interval of 3 day (meal enriched in 58Fe)
Fe content, ua —Fe content. H9
DAY M Em E. Et L 1. lb It
0 0 0 0 16800 0 0 47.0 47.0
1 0 0 240 17040 0 1 .6 47.0 48.6
2 0 0 720 17520 0 4.8 47.0 51.8
3 0 0 180 16980 0 1 .2 47.0 48.2
4 0 . 2 540 36 17376 180 0 .2 48.1 228.3
5 0 . 6 1620 24 18444 540 0 . 2 50.1 590.2
6 0.15 405 0 17205 135 0 47.8 182.8
7 0.03 81 0 16881 27 0 47.2 74.2
8 0 .0 2 54 0 16854 18 0 47.1 65.1
9 0 0 0 16800 0 0 47.0 47.0
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Table-43: Elemental and 70Zn composition of faecal samples when the standard drink
and meal are given at a time interval of 3 days
DAY M
Zn content, ua
Em E,
2£n
1.
content, i
0 0 0 13000 0 78.0 78.0
1 0 0 13000 0 78.0 78.0
2 0 0 13000 0 78.0 78.0
3 0 0 13000 0 78.0 78.0
4 0 .2 300 13300 1 0 0 79.2 179.2
5 0 .6 900 13900 300 81.6 381.6
6 0.15 225 13225 75 78.9 153.9
7 0.03 45 13045 15 78.2 93.2
8 0 .0 2 30.0 13030 1 0 78.1 8 8 .1
9 0 0 13000 0 78.0 78.0
The luminal disappearance of tracers for the cases given in the above tables 
were calculated using Equation-5.b provided in section 1.5. The calculated 
fractional luminal disappearances for each of the single samples, and for 
summation of sequential collections are provided in Table-44.
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Table-44: Calculated fractional luminal disappearance of 57Fe (consumed with a 
standard solution) and of 58Fe and 70Zn (consumed with a meal) for single (FJ and 
cumulative (FJ faecal collections, for the drink and the meal given at times interval 
of 1 and 3 days
57Fe
1 d interval
Luminal disappearance of tracer, % of dose
“ Fe%
3 d interval 1 d interval 3 d interval
70Zn, %
3 d interval
Day F, Fc F. Fc F. Fc F. Fe F. Fc
0 NA NA NA NA NA NA NA NA NA NA
1 60.0 60.0 60.0 60.0 NA NA NA NA NA NA
2 57.9 58.5 60.0 60.0 8.6 8.1 NA NA NA NA
3 35.3 54.8 60:0 60.0 9.9 9.4 NA NA NA NA
4 29.2 54.0 18.9 58.7 9.9 9.5 9.9 9.9 50.0 50.0
5 50.7 54.0 -125 55.1 9.7 9.5 10.0 10.0 50.0 50.0
6 NA 53.8 NA 54.1 10.0 9.5 10.0 10.0 50.0 50.0
7 NA NA NA 54.1 NA 9.5 10.0 10.0 50.0 50.0
8 NA NA NA 54.0 NA NA 10.0 10.0 50.0 50.0
9 NA NA NA 53.8 NA NA NA 10.0 NA 50.0
Expected F, % 60.0 10.0 50.0
NA: Not applicable
As can be seen from the calculated luminal uptake of iron, overlap between 
the the isotopic contents of the two inputs significantly effects calculation of 
iron uptake, when the inputs are consumed at an interval of 1 day. This effect 
is approximately 25% when luminal disappearance of iron from the standard 
drink is measured in a single sample 3 days after consumption of the drink 
(15% recovery of marker). The luminal disappearance from the meal deviates 
by 14% from the expected value 1 day after consumption (marker recovery 
20%). Administration of intakes with a 3 day interval provides insignificant 
isotopic overlap between the two measurements for the first 3 samples from 
which 95% of marker is recovered. Possible deviations from the expected 
luminal disappearance, as found for 57Fe for the fourth and fifth samples after 
consumption of the drink, when there is a small effect of the meal input should 
be taken into account. Such overlap can be corrected by using marker 
recovery with those particular faecal samples. The calculated levels of isotopic
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tracers and Sm (with the standard drink) and Yb (with the standard meal) 
markers in samples collected when there is such a time interval between 
administrations is provided in Figure-19.
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Figure-19: Calculated isotopic tracer and marker distributions in faecal samples when 
the intakes are administered at a 3 day interval
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III.1.2 PRE-IRRADIATION SEPARATION OF IRON AND ZINC
For determination of isotopes in faecal samples by NAA, pre-irradiation 
chemical separation enables reduction of the Compton background (improving 
precision) and reduction of radiation exposure. This approach is also 
advantageous when determining elements which require post-irradiation 
separation (e.g Zn-71m, t1/2=4.1 h) since it reduces the time required to allow 
for decay of major interferences (Na-24, K-42, Mn-56). Nuclear characteristics 
of the tracer isotopes, “ Fe and 70Zn, the selected rare earths markers and of 
potentially interfering isotopes, together with estimated induced activities, 
when 0.1 g of ashed faecal sample is irradiated are provided in Table-45. This 
shows the benefit of pre- and/or post-irradiation separation when the isotopes 
of interest are determined in human faecal samples.
Table-45: Properties of selected tracers, markers and potential interferences 
(Browne et aL, 1978)
Isotope Abundance,%1 
Tracer isotopes 
MFe 0.28 1.1
Radioisotope
Fe-59
t,a 
45 d
7-Energy,
keV
1099
Induced act2. 
kBq
1.48
^Zn 0.6 0.008 Zn-71 4 h 386 0.33
Rare earth markers3 
174Yb 31.8 65 Yb-175 4.2 d 396 259
152Sm 26.7 206 Sm-153 46.7 h 103 1184
Major interferences 
^Na 100 0.1 Na-24 15 h 1369 2220
^Mn 100 13.3 Mn-56 2.6 h 847 2220
37CI 24.2 0.4 CI-38 37.2 m 1642 1480
41k 6.73 1.5 K-42 12.4 h 1525 85.1
“ Cu 69.2 4.4 Cu-64 12.7 h 1346 0.11
^Ca 0.003 0.7 Ca-47 4.6 d 1297 29.6
1.Commission on atomic weights and isotopic abundances (1991)
2.Activity produced when 0.1 g of ashed faecal sample is irradiated in the flux for 6h
3.Activities produced for 10 pgofYband Sm
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Chemical separation of the elements also reduces isobanc interferences in 
their determination by mass spectrometry. In ICP-MS, serious interference 
problems occur due to the formation of polyatomic ions resulting from 
combination of analyte constituents and plasma gases. This effect which is 
particularly serious for isotopes with atomic number between 40-80 (Jarvis et 
al. 1992, pp 129) is also minimized by chemical isolation of the element of 
interest.
The following investigations were carried out to establish a separation 
procedure for iron and zinc:
1. Pre-irradiation separation procedure: This procedure reduces radiation 
exposure and minimizes the time required for decay of major interfering 
radionuclides (Na-24, K-42, Mn-56) in application of NAA. The procedure also 
reduces the matrix effect causing isobaric and polyatomic interferences in 
isotopic quantification by ICP-MS e.g. 58Fe and 58Ni.
2 .Post-irradiation separation procedure: This procedure is applied to reduce 
Compton contribution from CI-38 and Mn-56 in determination of Zn-71m.
Ion exchange separation of iron and zinc is more convenient than pre- and/or 
post-irradiation procedures described previously by Janghorbani etal., (1980) 
and Ting et al. (1982). They have described separation of iron or zinc from 
dissolved ashed faecal samples by precipitation with ammonium 
pyrrolidinedithiocarbamate (APDC) and followed this with post-irradiation 
procedures of co-precipitation and solvent extraction. The use of radioactive 
Zn-65 as yield indicator in trace amounts enables determination of the yield 
in the zinc separation procedure, whilst there is no such practical availability 
for iron since Fe-59 or Fe-55 requires different detection system where “ Fe 
or “ Fe is intended to be used as isotopic tracer. This procedure is 
inconvenient since each extra separation step can cause unknown losses and 
require additional yield measurements. The application of a separate chemical
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separation for each of the elements is also impractical since it requires 
different procedures and reagents e.g. ether extraction for iron, and ion 
exchange column for zinc purification (Tumlund et al., 1982). Considering the 
disadvantages of the approaches given above, an ion exchange separation 
procedure which enabled separation of both elements was investigated.
Investigations of the anion exchange distribution coefficients for all elements 
in HCI show that none of the alkaline and rare earth elements are adsorbed 
by the anion exchange resin (Saito, 1984). The anion exchange separation 
procedure applied in this study has been modified for iron and zinc from the 
procedure used by Kraus and Moore (1953) for the transition elements, Mn 
to Zn.
Pre-irradiation separation of iron and zinc:
The anion exchange procedure was investigated by separation of radioactive 
tracers for Fe and Zn from spiked faecal samples.
Tracers solutions were prepared from Fe which had been irradiated for 20 h 
in 2.7x1012 n cm"2s"1 flux (in the thermal column) and from Zn which had been 
irradiated for 3 h in 4.2x1012 n cm"2s"1 flux (in the CVS), to contain 60 kBq mL'1 
of Fe-59 and 20 kBq mL"1 of Zn-69m, and 1kBq mL'1 of Zn-65.
Duplicates of 0.2 g of ashed faecal samples obtained from the rare earth 
recovery investigation, and containing rare earth markers were spiked with 
200 pL of each of the tracer solutions. The samples were then dissolved in 10 
mL aqua regia with dropwise addition of 5 mL of H20 2 to promote the 
oxidation of remaining organic matter, and evaporated to dryness.
1) 100-200 mesh AG 1X-8 anion exchange resin (Bio-Rad Laboratories) was 
soaked in distilled water overnight. 10 mL of the resin was packed in two 
columns of 1 cm radius and equilibrated with 20 mL of 9 M HCI,
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2) The acid digested samples were loaded on to the columns with 3x2 mL of 
9 M HCI,
3) The columns were washed with 20 mL of 4 M HCI to remove alkali metals 
and Ni, Mn and Co,
4) The iron contents of the columns were eluted with sequential volumes of
0.5 M HCI,
5) The zinc contents of the columns were eluted with sequential volumes of
0.005 M HCI.
6 ) The resin contents of the columns were transferred to counting bottles to 
investigate if any tracers remained in the resin.
The flow rate for all eluent were in 1-1.5 mL min"1. All fractions of eluent were 
collected in polythene counting bottles and made up to 20 mL. All eluent and 
the tracer standard (200 pL fractions of the standard solutions diluted to 20 
mL) were counted on a 130 cc HPGe detector at contact geometry and the 
contents of the eluent were determined by comparing the activities of eluent 
with those of standard.
Results and conclusion
Besides the major activity of Fe-59 in the iron standard, Co-60 (t1/2=5.2 y) and 
Mn-54 (t1/2=291 d) were also found. These two radionuclides were used to 
examine the effectiveness of the separation procedure. The only activities 
identified in the Zn standard were Zn-69m, t1/2=14 h and Zn-65, t1/2=245 d.
The distribution of iron and zinc Recoveries in fractions of eluent are provided 
in Table-46.
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Table-46: Recoveries of iron and zinc in fractions of eluent, determined with Fe-59 
and Zn-69m
Fe recovery, %±SD Zn recovery, %±SD
Eluent Column I Column II Eluent Column I Column II
6  mL 9 M HCI
ND ND ND ND
20 mL 4 M HCI
1.80±0.1 1.3010.1 ND ND
0.5 M HCI 0.005 M HCI
I. 10 mL 63.8±0.5 68.110.5 1. 5mL ND 1.9010.3
II. 10 mL 29.9±0.3 27.110.2 II. 5 mL 34.210.7 22.810.7
III. 5 mL 2.59±0.1 2 .1 0 1 0 .1 III. 10 mL 59.311.1 72.911.4
IV. 5 mL 0.6310.03 0.4910.03 IV. 10 mL 3.1010.2 1.2310.1
V. 10 mL 0.2910.03 0.2510.03 V. 10 mL 0.6510.2 1.8310.5
VI. 10 mL 0 .1 0 1 0 .0 2 0 .1 0 1 0 .0 2 VI. 20 mL 1.8010.5 0.8010.2
Total rec, % 97.310.6 98.110.5 Total rec, % 99.011.4 101.511.7
Resin ND ND 1 .8 8 1 0 .2 ND
In counting of the eluent, it was found that;
1) The impurities in the iron tracer standard (Mn, Co) were totally removed 
with 9M and 4 M HCI eluent,
2) Recoveries of iron with 50 mL of 0.5 M HCI were 97.3±0.6% and 
98.1±0.5% (SD indicates error of the counts),
3) Whilst recoveries of zinc with 60 mL of 0.005 M HCI were 99.0±1.4% and 
101.5±1.7%, an increased elution volume was considered since traces of zinc 
were detected on one of the columns,
4) The amount of iron eluted with 20 mL of 4M eluent (to remove impurities) 
could be reduced by using a smaller volume at this molarity.
The separation was repeated with 4 columns, with a smaller volume of 4 M 
HCI eluent to further optimise volumes (10 mL) and minimise losses, and with 
a larger volume of eluent for zinc (70 mL).
The recoveries of iron and zinc showed that the impurities were effectively 
removed with the loading solution and with 10 mL of 4M HCI. Recoveries
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were quantitative with the volumes of eluent used (Table-47). The 
effectiveness of the procedure also can also be seen from the spectra 
provided in Figure-20, showing removal of the impurities and separation of Fe 
and Zn.
Table-47: Iron and zinc recovery results for 4 columns
Eluent. HCI Col. I Col. II Col.Ill Col. IV
Fe recovery, %±1SD
50 mL 0.5 M 100.9±0.4 101.8±0.4 102.8±0.9 102.1±0.9
70 mL 0.005 M 1 .2 ±0 .1 1 .1±0 .1 0.9±0.06 1 .0 ±0 .1
Zn recovery, %±1SD
50 mL 0.5 M ND ND ND ND
70 mL 0.005 M 100.6±1.9 99.4±1.8 100.7±2.9 102.8±2.9
Losses with the eluent used to remove impurities and any residue on the resin 
were insignificant. The contribution of iron to the zinc eluent was found to be 
approximately 1%. This contribution can be measured where required by 
comparing the analysis of iron and zinc eluent of the samples.
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Figure-21: 7 -spectra of the tracer solution used for ion exchange separation, and of 
the Fe and Zn fraction of eluent
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III.1.3 POST-IRRADIATION SEPARATION OF ZINC
The anion exchange procedure removes many potential interfering elements, 
including the alkali metals, but activated eluents were found to contain traces 
of Mn-56 (t1/2=2.6 h comparable to Zn-7111/2=4 h) and CI-38 (t1/2=37.2 m) from 
the acid eluent. A post-irradiation clean-up was applied to reduce these 
activities.
Janghorbani et al. (1980) and Ting et al. (1982) have described a post­
irradiation separation for determination of 70Zn in faecal samples which 
followed a pre-irradiation separation involving precipitation by APDC. This was 
based on precipitation of Mn02 and solvent extraction of Zn.
The efficiency of post-irradiation precipitation of Mn02 for purification of ion- 
exchange eluent of Zn was investigated.
Procedure
One fraction of 0.2 g ashed faecal sample (obtained from the previous rare 
earth recovery investigation) was spiked with 36.569 pg of 70Zn and a similar 
fraction was processed without addition of the spike. The samples were 
dissolved, and their zinc contents separated by anion exchange as described 
above.
The eluents (70 mL) were evaporated until 5 mL of solution remained with 
addition of 16M HN03 to expel chlorine. The samples were then transferred 
to 10 mL graduated flasks and the volumes made up. Duplicates of 2 mL of 
the samples were pipetted to irradiation vials (the vials were washed with 0.5 
l\^  HN03 and demineralised water, and dried), and evaporated under an IR 
lamp. The samples were then irradiated in the pneumatic system at a flux of 
2.4 n cm'2 s'1 for 1 h. After decay of 30 min, the contents of vials were 
transferred to 50 mL beakers with a few mL of 16M HN03 and the samples
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containing enriched 70Zn were each counted for 2000 s to determine Zn-71m 
at 386 keV and Zn-69m at 438 keV. The samples of natural zinc composition 
were counted for only a short period since the energy band for Zn-71 was 
covered with the compton continuum from Mn-56 at 846 keV.
Separation procedure
The samples were then subjected to Mn separation procedure as follows;
1.After addition of 10 mg of Mn2+ carrier, the samples were heated to boiling 
on a hot plate,
2.0.2 g of NaBr03 was added to oxidize manganese, and the heating 
continued until completion of precipitation of Mn02,
3.The precipitates were filtered through double GF/A filter disks,
4.The filtrates and precipitates were transferred to counting bottles and 
counted for 2 0 0 0  s.
Results and conclusion
The Mn activities found in the samples are included in Table-48, where a 
major reduction is evident. Zn was not detected on the filter papers indicating 
insignificant losses with the MnOz precipitate. The ratio of the decay-corrected 
activities of Zn-71 m at 386 keV and Zn-69m at 439 keV for samples 
containing natural level of 70Zn (natural sample) were compared to evaluate 
the effect of separation procedure. The enrichment factor for the samples 
spiked with enriched 70Zn (enriched sample) was also calculated from the ratio 
of activities by the equation of
. 2)7-71/77. . 2)7-71/77.
12)7-69/77Jfiv~l Zn-GQmlf**Enr=------------ ——--------------
. 2)7-71 m .
Z&-69/7? ^
where [Zn-71 m/Zn-69m] is the ratio of the activities for the enriched (enr) and
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natural (nat) samples. The results are provided in Table-48.
Table-48: Determination of enrichment in ash faecal sample with and without post 
irradiation separation of zinc for comparison
Procedure Manganese activities, cps
Before Mn separation 380 478
After Mn separation 0 .1
Counting ratio,
9.7
(Zn-71 m/Zn-69m)±SD
Enrichment
factorlSD
Natural-! Natural-ll MeaniSDM
Before Mn separation NA NA NA
After Mn separation 0.0099±0.0005 0.0104±0.0005 0.0101±0.0003
Enriched-I Enriched-I I
Before Mn separation 0.0928±0.009 0.094510.009 0.093610.007 8.26710.7
After Mn separation 0.096510.0002 0.097310.0002 0.096910.003 8.59410.4
The accuracy of the results showed that the overall zinc separation procedure 
is quantitative. Losses of zinc due to adsorption on the manganese precipitate 
was below limits of determination. From a comparison of the precision of the 
results, it is obvious that the manganese precipitation procedure is satisfactory 
(98-100% elimination of Mn-56 counts at 847 keV). However the counting 
ratio, Zn-71 m/Zn-69m, for natural sample was not obtainable before, whilst the 
ratio obtained after the separation provided 5% precision. Effective 
manganese elimination can also be seen from Figure-21 for a sample spiked 
with enriched 70Zn.
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Figure-21: 7 -ray spectra of irradiated Zn eluent containing 70Zn enriched spike, 
counted before and after manganese precipitation [The ratio of the counts at 847 keV 
(Mn-56) is a factor of 100-see text]
Enrichment was measured with reference to the counts ratio for the sample 
of natural composition (with ~5% precision). It can be seen that this was found 
to be 8.267±0.7 before and 8.594±0.4 after chemical separation, compared 
with 8.646 obtained for the enriched standard solution. Both results provided 
reasonable accuracy, but better precision was obtained after chemical 
separation. The measurement precision for the ratio for enriched samples 
from which Mn had been removed was found to be 5 times better (~2%) than 
that obtained from which Mn had not been removed.
The 7-ray spectrum of Zn eluent (equivalent to 40 mg of ashed faecal sample) 
containing natural level of 70Zn, counted after Mn separation is provided in 
Figure-22 from which Zn-71 m is clearly visible in the presence of Na-24 and 
CI-38.
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Figure-22: 7 -ray spectrum of irradiated Zn eluent (40 mg ash) containing Zn in 
natural composition, counted after Mn precipitation
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III.2 THE USE OF ENRICHED STABLE ISOTOPIC TRACERS AND RARE 
EARTH MARKERS FOR MEASUREMENT OF LUMINAL DISAPPEARANCE
111.2.1 ETHICAL APPROVAL AND CONSENT OF VOLUNTEERS
The investigation was approved by The Research Ethics Committee of 
Glasgow Royal Infirmary, Greater Glasgow Health Board. Seven subjects (6 
male, 1 female), all in good health and pursuing normal sedentary activities 
participated in the investigation. In all subjects, haemoglobin and ferritin 
concentrations and red cell counts were within the normal range (Table-49). 
They were informed of the theoretical background of the investigation and 
provided written consent. A schematic diagram of the overall procedure is 
provided in Flgure-23.
Table-49: Physical and haematological characteristics of the participants in the 
investigation
PHYSICAL CHARACTERISTICS HAEMATOLOGICAL DATA
Subject
Sex Age
y
Height
m
Weight
kg
Hb 
g dL' 1
RBC
x1 0 12 L' 1
Ferritin
ugL-1
C1 M 56 1.74 79 15.0 4.74 1 0 0
C2 M 37 1 .6 8 65 16.8 5.18 131
C3 M 54 1.85 95 14.4 4.46 82
C4 M 42 1.83 78 15.9 5.34 1 1 0
C5 M 28 1.75 78 15.4 5.34 47
C6 M 32 1.70 70 13.7 4.72 152
C7 F 28 1.57 55 13.5 4.47 49
Normal range1 13-16 4.2-5.9 402
1. Entwistle, 1992
2. Recommended value for subjects who are borderline iron deficient based on measurement 
of iron absorption from the standard solution (Bezwoda et al., 1979, Magnusson et al., 
1981 and Cook et al., 1991)
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Figure-23: Outline of procedure for measurement of intestinal uptake of 2 sequential 
inputs of trace elements
111.2.2 PREPARATION OF DOSES, ADMINISTRATION, SAMPLE 
COLLECTION, SAMPLE PREPARATION
111.2.2.1 PREPARATION OF DOSES
I.Rare earth marker solutions:
Sm solution for standard drink: 58.60 mg of specpure Sm20 3 was dissolved 
in 10 mL of 0.1 M H2S04 and the volume made up to 50 mL to provide 
1.0107 mg mL*1 of Sm.
Yb solution for standard meal: 59.20 mg of specpure Yb20 3 was dissolved in 
10 mL of 0.1 M and the volume made up to 50 mL to provide 1.0398 mg mL*1
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of Yb.
2. Isotope enriched solutions:
Isotope enriched Iron and zinc were obtained in the metallic form (Europa 
Scientific Ltd/UK). The isotopic composition of the elements in enriched and 
natural forms are provided in Table-50.
Table-50: Isotopic composition of iron and zinc in natural and in enriched form
is o t o p ic  c o m p o s it io n , %  o f  w e ig h t
IRON NATURAL1 ENRICHED2 ZINC NATURAL1 ENRICHED2
57Fe “ Fe 70Zn
'Fe. 5.8 - <0 .0 1 “ Zn 48.6 7.05
!Fe 91.72 3.0 0.03 “ Zn 27.9 7.65
Fe 2 . 2 95.15 8.07 67Zn 4.1 2.55
’Fe 0.28 1.85 91.90 “ Zn 18.8 8.65
70Zn 0 .6 74.1±1.4
1.Commission on atomic weights and isotopic abundances, 1991
2.Composition provided by the manufacturer, based on ICP-MS measurements
67Fe enriched solution for standard drink
15 mg of S7Fe enriched metallic Fe was dissolved in 5 mL of 0.5 M H2S04. 
After addition of 1 mL of 8.01 mg mL’1 natural iron solution (in 0.5 M H2S04) 
the volume was made up to 50 mL to provide 0.460 mg mL'1 Fe containing 
0.289 mg mL*157Fe (0.286 mg from enriched and 0.003 mg from natural Fe 
sources), providing 28.6-fold 57Fe enrichment.
Seven 7 mL fractions of the solution were transferred to tubes to provide 3.22 
mg of total Fe containing 2.023 mg 57Fe (2.002 mg from enriched source) for 
each of the subjects, and the residue (approximately 1 mg) retained for use 
as standard.
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58Fe enriched solutions for standard meal
8.2 mg of MFe enriched metallic Fe was dissolved in 5 mL of 11M HCI and 
the solution was then evaporated to dryness. The residue dissolved in 5 mL 
0.01 M HCI. The solution was transferred to a universal tube with several 
rinses of water using a 1mL pipette to provide a total volume of 14 mL. The 
volume was then made up to 15 mL by addition of 1 mL of 15.003 mg mL'1 
natural Fe solution (in 0.01 M HCI) to provide 1.547 mg mL'1 Fe containing
0.505 mg mL'1 of MFe (0.502 mg from enriched and 0.003 mg from natural 
sources), providing 116.6-fold enrichment.
70Zn enriched solutions for standard meal
10.1 mg of 70Zn enriched metallic Zn was dissolved in 3 mL of 0.5 M HCI. The 
solution was then evaporated to dryness. The residue dissolved in 5 mL 0.01 
M HCI. The solution was transferred to a universal tube with several rinses of 
water using a 1mL pipette to provide a total volume of 14 mL. The volume 
was then made up to 15 mL by addition of 1 mL of 12.989 mg mL'1 natural Zn 
solution (in 0.01 M HCI), to provide 1.539 mg mL'1 Zn containing 0.504 mg 
mL'1 70Zn (0.499 mg from enriched and 0.005 mg from natural sources), 
providing 54.6 fold enrichment.
Standard meal (Farina): Wheat flour based Farina meal containing following 
ingredients was prepared as described by Forbes et al. (1989).
Ingredients (one portion)
Farina flour 40 g uncooked (approximately 250 g cooked)
Milk (whole) 120 mL (4% fat)
Butter 14 g
Sugar (white granulated) 24 g 
Ferric chloride 3 mg Fe
Salt 0.5 g
Water 250 mL
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Preparation
Heat water to boiling and add salt. Reduce heat to low, stir farina flour in 
gradually, and cook 1 minute, stirring constantly. Spoon into serving bowls to 
equal (approximately 250 g) portions. Mixture will be slightly thin; thickens 
during sitting.
Hl.2.2.2 ADMINISTRATION AND SAMPLE COLLECTION
The procedure followed for administration of enriched tracers and markers, 
and collection of faeces and urine is described below:
Day -1: Subjects collected one faecal sample and a 24 h urine output for 
measurement of background levels of iron, zinc, and rare earths.
Day 0: Having fasted overnight subjects consumed a standard solution, finally 
diluted to 50 mL with demineralised water, containing 3.22 mg of total iron 
including 2.023 mg of 57Fe, 1.017 mg of Sm, 20 mg freshly prepared ascorbic 
acid. After complete consumption of the solution, two rinses of water were 
also taken to ensure total consumption. The subjects did not take any food or 
drink for 3 h following the administration.
Urine samples were collected for 24 h following the administration and all 
faecal output with associated was collected for 10 days.
Day 3: The subjects having fasted overnight consumed a standard meal 
containing approximately 3 mg of iron as ferric chloride
Immediately after the preparation of the meal 2 mL of Fe solution containing 
a total of 3.094 mg of Fe including 1.010 mg of “ Fe, 2 mL of Zn solution 
containing a total of 3.078 mg of Zn including 1.008 mg of 70Zn, and 1 mL of 
Yb marker solution (1.0398 mg mL'1) were added to each portion. Portions of 
the meal were then mixed well, sugar and butter added on while they were
147
hot, and served with milk. After complete consumption of meals, serving bowls 
were rinsed with milk, and this was also consumed to ensure total 
consumption. The subjects did not take any food or drink for 3 h following the 
administration.
Urine samples were collected for 24 h following administration of the meal. 
Faecal samples were collected for 7 days after the Farina consumption. After 
completion of the period of sample collection, subjects were taken to hospital 
for blood sampling (sample is taken by an authorized person).
| The participants were provided with an information form explaining the
required procedures (Appendix-4) and the following sample collection
'!
| systems.
i 1. A card to record time of bowel movement.
I
| 2. A polypropylene commode stool collection system (SAGE Products Inc,
USA) consisting of a bowl with lid and a frame (Figure-24), "biohazard" 
polythene bags, and pieces of twist wires. After the use of the collection unit, 
the lid is snapped tightly and the frame removed from the unit. The bowl is 
then contained a numbered polythene bag and the opening bound with a twist 
wire.
3. Urine collection container: This was a plastic container of 2 L volume 
containing 25 mL of 2 M HCI as preservative.
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Figure-24: Faecal sample collection system used in absorption investigation 
111.2.2.3 PREPARATION OF SAMPLES
1.Faecal samples :The collected samples were stored in a deep freeze at -20 
°C. Since the plastic sample collection system was not resistant to autoclave 
temperature (120 °C), they were then sterilized by irradiation, receiving a total 
dose of 75 000 Sv from a Co-60 7-source. The samples were oven-dried at 
50 °C and ashed at 450 °C for 16-24 h. They were then ground to provide 
homogeneity and stored in plastic containers for further use.
2.Urine samples: For determination of rare earths in urine samples by ICP- 
MS, 100 mL fractions of the collected urine were digested with gradual 
addition of 20 mL of 16M HN03 and 10 mL of 30% H20 2 until clear colourless 
solutions were obtained. The solutions were then transferred to 100 mL 
graduated flask and the volumes were made up. 5 mL of the acid digested
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Isamples were diluted to 20 mL with 2% v/v HN03 and transferred to polythene 
bottles for further use. A blank solution was also run throughout the procedure 
to take account of rare earth levels in the chemicals.
3.Bk>od samples: 5 mL of blood sample was taken from each of the subjects 
(Glasgow Royal Infirmary, Department of Nutrition) and transferred to tubes 
containing potassium-EDTA as an anticoagulant. Haematologic characteristics 
were determined by Department of Haematology, Glasgow University. Serum 
ferritin concentrations were determined by a radioimmunoassay.
111.2.3 ANALYTICAL PROCEDURE
Markers (Sm and Yb) and tracer isotopes (administered with the Farina meal, 
58Fe and 70Zn) contents of faecal samples were determined by CNAA. Total 
elemental Fe and Zn contents of faecal samples were determined by AAS. 
For determination of rare earths in faecal and urine samples, and S7Fe in 
faecal samples, ICP-MS was employed. An outline of procedure applied to 
faecal samples is provided in Figure-25.
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■11.2.3.1 DETERMINATION OF RARE EARTH CONCENTRATIONS IN FAECAL SAMPLES
BY NEUTRON ACTIVATION ANALYSIS
Procedure:
For cation exchange separation of Sm and Yb, approximately 0.200 g fractions of 
ashed faecal samples were taken in 50 mL beakers and spiked with 200 pg of Pr as 
a yield tracer. The samples were dissolved and their Sm and Yb contents separated 
by cation exchange as previously described. The eluents were evaporated until the 
volume reduced to 5 mL. The solutions were transferred to 10 mL graduated flasks 
and the volumes made up.
Duplicate 1 mL fractions of eluent samples, 100 pL of dosing solutions diluted to 
contain 1.01 pg of Sm and 1.04 pg of Yb, standard solutions containing 1.00 pg of 
Sm and Yb, and a solution containing 100 pg Pr were pipetted in to polypropylene 
irradiation vials. A solution containing 250 pg of Fe was added to each of the 
samples and standards as an internal flux monitor. The solutions were then dried 
under an IR-lamp. One ashed sample for each of the subjects was also prepared for 
non-destructive analysis for further confirmation of results. The vials were wrapped 
in aluminium foils and irradiated in the CVS for 6  h (samples which were obtained 
from the same subject were irradiated in the same batch). They were then allowed 
to decay for 1 d (4 d for ashed samples) to reduce exposure from radionuclides with 
a short half life. The samples were unwrapped and monitored. The dose rate for most 
of the samples were 5-10 pSv h' 1 at 20 cm. Samples and standards were counted 
on a 130 cc HPGe detector at 2.4 cm geometry for 2000-3000 s as convenient.
Results and comments:
Weight of faecal samples and mean concentrations of Sm and Yb found in the ashed 
samples are provided in Appendix-5. The yields for the pre-irradiation separation of 
Sm and Yb were in a range of 80-100%, as was found in rare earth recovery 
investigation. Good agreement between duplicate fractions of the column separated 
and non-destructively analyzed samples showed that the precision of the 
measurements were satisfactory. There was an insignificant difference between two 
measurements (p>0.05). This agreement can be seen from Table-51 for Yb for 
samples which were analyzed by both methods.
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Table-51: Yb concentrations found for duplicate fractions of column separated and 
non-destructively analyzed faecal samples
Yb concentration, pg g 1 ashed faeces
Eluent I Eluent II MeanlSDM INAA
39.7±0.7 40.5H.1 40.110.6 41.810.5
32.1±0.1 32.310.1 32.210.07 31.710.3
89.6±1.6 90.911.1 90.310.9 90.210.5
183±1.8 18511.9 18411.3 18511.7
99.4±1.2 1 0 1 1 1 . 2 1 0 0 1 0 . 8 96.311.1
89.110.7 89.610.7 89.410.4 91.810.8
20.810.5 21.210.5 21.010.3 2 0 .6 1 0 . 2
Sm and Yb concentrations of dosing solutions obtained with reference to the 
standards provided evidence for the accuracy of the results (Table-52). Insignificant 
differences were found between the found and expected concentrations (p>0.05).
Table-52: Sm and Yb contents of dosing solutions with reference to specpure 
standards
Batch no Sm (pg mL'1) Yb (pg mL'1)
1 980.4 967.0
2 940.0 977.4
3 1061 946.2
4 1 0 2 1 998.2
5 950.1 1071
6 970.3 1009
7 929.8 987.8
8 1031 1123
9 998.2 1 0 0 1
MeanlSDM 987.1144.6 1009155
Expected 1010.7 1039.8
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111.2.3.2 DETERMINATION OF IRON AND ZINC BY ATOMIC ABSORPTION
SPECTROPHOTOMETRY
Determination of luminal disappearance using stable isotopic tracers requires 
account to be taken of the isotopic constituents of endogenous secretion 
which contribute to the measured amount of excreted tracer. This can be 
calculated when the amount of the element of interest in the sample is 
determined by AAS (section 1.4.2 ).
Procedure:
Approximately 0.1 g of ashed faeces were dissolved by gradual addition of 10 
mL of aqua-regia and 2-3 mL of 30% H20 2 with heating, and the solutions 
evaporated to dryness. The residues were redissolved in 5 mL of 11M HCI 
and transferred to 20 mL graduated flasks, and the volumes made up by 
addition of demineralised water, to provide stock solutions. A blank solution 
containing the chemicals used was also prepared to determine the 
contribution from reagents.
A solution containing bovine liver (SRM 1577a, standard reference material 
1577a, National Bureau of Standards, U.S.A) was also prepared to monitor 
quality control of the measurements. Approximately 1 g of bovine liver was 
ashed in a furnace at 420 °C for 24 h, dissolved, and contained in a 100 mL 
of solution as described above.
The iron and zinc contents of the samples were determined with a Philips 
flame atomic absorption spectrophotometer, FAAS (Model PU9100) at the 
Department of Chemistry, University of Stratchlyde .The spectrophotometer 
was adjusted for optimum measurement efficiency for each of the elements, 
and calibrated with a range of iron and zinc concentrations to provide 
measurement sensitivity and determination limit (Table-53).
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Table-53: Instrument parameters for the determination of iron and zinc by flame 
atomic absorption spectrophotometer
Philips PU9100 Flame Atomic Absorption Spectrophotometer 
Burner: Air-acetylene flame
Integration time: 4s
Nebulizer uptake rate: 6  mL min' 1
Detection wave length Slit width Lamp current Sensitivity Determination limit
(nm) (nm) (mA) [pg (unit abs.)'1] (pg mL'1)
248.3 (Fe) 0.2 10 0.1 0.004
213.9 (Zn) 0.7 8  0.5 0.02
After appropriate dilution of the solutions to provide concentrations 
comparable to those used for calibration, samples were introduced from a 
nebulizer and the average of 3 absorption readings taken for each sample, an 
online computer integrating the absorbance signal for a period of 4 s. A 
sample with an internal standard, a blank, and a sample of bovine liver were 
analyzed with each set of samples. The procedure was repeated twice for 
each sample and the absorbance data converted to concentrations using a 
linear regression programme. The mean of 2 concentrations with its standard 
deviation was then used to determine the total zinc and iron contents of the 
samples.
Results and comments:
The mean of concentrations of Fe and Zn found in faecal samples are 
provided in Appendix-5 and 6 . The concentrations of iron and zinc in blank 
solutions were below the detection limit, indicating that the contribution from 
Fe and Zn in reagents was insignificant. Results for one sample from each of 
subjects to which an internal standard was added are provided in Table-54 as 
evidence of precision and accuracy.
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Table-54: Precision and accuracy of determination of Fe and Zn by AAS
Fe concentration, pg mL‘1±SD
Sample Samp.+lnt. std Int. std.
7.22±0.04 9.31±0.09 2.09
7.04±0.Q1 9.08±0.02 2.05
3.41 ±0.01 5.50±0.01 2.09
5.01 ±0.02 7.07±0.04 2.06
4.23±0.03 6.32±0.03 2.08
5.75±0.03 7.81 ±0.04 2.06
5.39±0.04 7.33±0.04 1.93
Mean 2.05±0.05
Expected 2.00
Zn concentration, pg mL'1±SD
Sample Samp.+lnt. std Int. std.
2.55±0.01 3.61 ±0.01 1.06
2.60±0.01 3.71±0.09 1.11
1.47±0.01 2.50±0.02 1.02
3.18±0.01 4.25±0.01 1.07
3.42±0.05 4.41 ±0.03 0.99
2.76±0.03 3.78±0.02 1.02
3.21 ±0.03 4.28±0.05 1.07
1.05±0.04
1.00
Good reproducibility was obtained for all samples, with a standard deviation 
of approximately ±1%. Results for the internal standard confirmed the 
reproducibility of measurements (p>0.01, one-tailed t-test). Concentrations of 
Fe and Zn in Bovine Liver were found to be 189±7 for Fe and 122±8 for Zn 
(mean of 8 measurements), which were not significantly different from the 
certified concentrations of 194±20 and 123±8. This was further evidence for 
the accuracy of measurements.
III.2.3.3 DETERMINATION OF “ Fe, 70Zn BY NEUTRON ACTIVATION ANALYSIS
I. Determination of 68Fe and 70Zn in dosing solutions
The “ Fe and 70Zn contents of the dosing solutions were confirmed by NAA.
Procedure
1. “ Fe in dosing solution
Replicates of 200 pL of diluted dosing solution containing 1.10 pg of “ Fe and 
1 mL of Fe standards of natural composition containing 2.8 pg of “ Fe were 
pipetted into irradiation vials. After addition of a solution containing 1 pg of Yb
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to each of the samples as a flux monitor, they were dried under an IR-lamp. 
The samples were wrapped in aluminium foils and irradiated for 6 h in the 
CVS (4.2x1012 n cm*2 s'1 ).
The samples were allowed to decay for 1-2 days and were then counted on 
a 130 cc HPGe detector at contact geometry for 2-5 h. The concentration of 
58Fe in the dosing solution was calculated with reference to the Fe standards, 
with account of flux corrections.
2. 70Zn in dosing solution
Replicates of 200 pL of the diluted dosing solution containing 1.01 pg of 70Zn 
and 300 pL of Zn standards of natural composition containing 1.8 pg of 70Zn 
were pipetted into irradiation vials. After addition of 100 pL of 16 M HN03 to 
expel chlorine, they were dried under an IR-lamp. The samples in batches 
consisting of 1 dosing solution and 1 standard were irradiated for 1 h in the 
pneumatic system (2.7x1012 n cm'2 s‘1).
After decay of half an hour, the samples were counted on a 130 cc HPGe 
detector for 2000 s on contact geometry. The concentration of dosing solution 
was then calculated with reference to the Zn standard.
Results and comments
The enriched isotope contents of dosing solutions, determined by NAA with 
reference to standards of natural abundance are provided in Table-55. As can 
be seen from the table, there is no significant difference between the 
concentrations found and those expected (p>0.05, one-tailed t-test). The 
precision of 58Fe measurements were in a range of 2-5% because of counting 
time. This can be reduced by longer periods of counting, or using increased 
amounts of the dose fractions.
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Table-55: Concentrations of 58Fe and 70Zn in enriched dosing solutions
Sample No 58Fe enriched dose 70Zn enriched dose
pg mL' 1 pg mL*1
1 492±8 520135
2 494±8 557136
3 513±13 520136
4 480±8 494130
5 494±24 517128
6 467±10 504139
7 518±16 567138
8 507±21
9 544±11
1 0 531 ±21
MeantSDM 504123 526127
Expected 505 504
The precision of 70Zn results showed that the contribution to precision from the 
reference standard with no enrichment were ~5% whilst those from the isotope 
enriched dose solution were 2-3%. This suggests that the used amount of 
dose fraction in determination of the enrichment in samples will be 
satisfactory.
II. Determination of “ Fe and 70Zn in faecal samples
Approximately 0.200 g of ashed samples were dissolved and the Fe and Zn 
contents were separated by anion exchange as previously described. The 
eluents obtained were evaporated, with dropwise addition of 5 mL of 16 M 
HN03 to expel chlorine, until the volumes were reduced to 5 mL. Solutions 
were made up 10 mL in graduated flasks and stored for analysis.
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Procedure
1.Determination of 58Fe concentrations in faecal samples
The following samples and standards were prepared for determination of 58Fe
concentrations in faeces;
a) Duplicates of 2 mL fractions of column eluents containing Fe58 from 
approximately 40-80 mg of ashed faeces,
b) 200 pL of dosing solution diluted to contain 1.01 pg of 58Fe,
c) 200 pL of iron solution of natural composition containing 0.84 pg of 58Fe,
d) 100 pL of zinc solution of natural composition containing 63.2 pg of ^Zn.
For each subject, representative ashed samples (1) and column-separated 
samples (2) were analyzed to monitor the separation yield. Accuracy was 
also confirmed by results obtained for duplicates samples of ashed bovine 
liver (SRM 1577a).
The sample and standard solutions were pipetted into irradiation vials. After 
addition a solution containing 1 pg Yb as flux monitor, they were dried under 
an IR-lamp. The samples obtained from the same subjects and standards 
were then wrapped in aluminium foils and irradiated for 6 h in a flux of 
4.2x1012 n cm'2 s'1 (in the CVS).
The gross induced activities in samples and standards were allowed to decay 
for 1-2 d after irradiation to reduce radiation exposure from radionuclides with 
short half lives. The samples were then unwrapped and counted on a 130 cc 
HPGe on contact geometry for 2-5 h for samples and for 10 h for standards. 
The 58Fe contents of samples were calculated with reference to the Fe58 
content of dosing solution. Zinc contents of Fe eluents was also examined, 
with reference to Zn-65, t1/2=244.1 d, to confirm complete separation. In most 
cases Zn was not detected.
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2. Determination of 70Zn concentrations in faecal samples 
Duplicates of 2 mL of column separated zinc solution and 200 pL of 70Zn 
enriched dose solution containing 1.01 pg of 70Zn were pipetted into counting 
vials and dried under an IR-lamp. Two samples from different duplicates and 
a standard were irradiated as a batch in the pneumatic system for 1 h 
(2.7x1012 n cm'2 s'1).
After decay of half an hour, the standard was transferred to a counting bottle 
with 2 mL 16M HN03 and counted on the detector for 2000 s on contact 
geometry. While the standard was being counted, the samples were subjected 
to the Mn separation procedure previously described. The samples were then 
counted for 2000-3000 s and their 70Zn contents determined with reference 
to the 70Zn content of the dosing solution.
Results and comments
1 .Determination of S8Fe
The specific activities at the end of an irradiation of 6 h, for isotope enriched 
dose solution and iron solution of natural isotopic composition were found to 
be 1.68±0.39 and 1.65±0.38 cps pg'1±SDM. The difference between the 
activities is insignificant (p>0.05, paired t-test) and indicates that systematic 
errors (pipetting and evaporation of standards) were insignificant.
The Fe58 concentrations found in faecal samples are provided in Appendix-6 . 
An example set of Fe58 concentrations (one sample for each subject) 
determined by CNAA and INAA are provided in Table-56 for quality control of 
the measurements.
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Table-56:58Fe content of faecal samples determined by CNAA and INAA
SamDle
58Fe concentration in ashed faeces, pg g1±SD 
CNAA INAA
RatialSD
l/CNAA
C1
Dupl. I 
44.6±0.5
Dupl. II 
44.1±0.5
MeanlSDM
44.310.4 42.611.1 0.9610.03
C2 134.8±1.5 136.711.4 135.811.4 137.912.2 1 .0 1 1 0 . 0 2
C3 75.1±1.3 76.411.2 75.810.9 80.111.7 1.0510.02
C4 34.3±1.6 35.711.2 34.911.0 36.110.6 1.0310.03
C5 15.8±0.3 16.110.3 15.910.2 16.710.4 1.0510.03
C6 20.8±0.3 20.410.5 20.610.3 21.310.5 1.0310.03
C7 7.8±0.3 8.010.3 7.910.2 7.810.2 0.9910.04
The Fe58 concentrations found in duplicate samples of faeces agree providing 
1-3% precision for duplicate samples where the standard deviations of 
measurements were also 1-3%. This was obtained with the use of an internal 
flux monitor. There was insignificant difference (p>0.05) between results 
obtained by chemical NAA (CNAA) and non-destructive NAA (INAA) indicating 
that the overall chemical procedure was effectively quantitative. Iron 
concentration in bovine liver (187±4 pg g‘1±SDM, mean of 2 measurements) 
determined by INAA agrees with the certified content of this standard (194±20 
pg g'1). This was a further evident for accuracy of the results.
The losses of Zn with Fe eluents and the Fe contribution to Zn eluents were 
below the limit of determination or occasionally <1%. 64Zn with the activation 
product of Zn-65 (t1/2=244.1 d) also enabled comparison of the Zn contents of 
ashed and column separated faecal samples, examination of the reliability of 
Zn concentrations determined by AAS. MZn concentrations of samples 
determined by INAA and CNAA (one sample for each subject) and those 
derived from elemental concentrations obtained by AAS are provided in Table- 
57 for comparison.
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Table-57:64Zn contents of faecal samples determined by CNAA, INAA and AAS (SD 
for all measurements were 1 % or less)
MZn concentration, pg g' 1 in ash Ratio
SamDle CNAA INAA AAS l/CNAA IN A/
C1 1168 1030 1039 0 .8 8 1 .0 1
C2 949 894 926 0.94 1.03
C3 516 525 512 1 .0 2 0.98
C4 765 761 811 0.99 0.94
C5 1451 1423 1318 0.98 0.93
C6 1543 1559 1535 1 .0 1 0.98
C7 1073 1 0 0 2 1014 0.93 1 .0 1
It was found that there were no significant differences between results 
obtained from any of the measurements techniques (p>0.05). This indicates 
that the chemical yield of the pre- and post-irradiation separation were 
quantitative. Zinc concentration in Bovine Liver was found to be 124±3 pg g’1 
(mean of 2 measurements by INAA) which agrees with the certified content 
of this standard (123±8 pg g’1). This confirms the accuracy of the results.
2.Determination of 70Zn
The specific activities at the end of irradiation for each of the standards for
each irradiation batch were found to be constant through the analysis period,
at 0.70±0.03 cps pg’1 with ±SDM and all were within the 95% confidence limit.
The reproducibility of results indicates that random errors were insignificant.
70Zn concentrations for duplicate samples with no enrichment of isotopic tracer 
determined by CNAA and those derived from elemental concentrations 
determined by AAS results are provided in Table-58, for one sample for each 
subject.
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Table-58:70Zn concentrations in faeces at background level obtained by CNAA and 
AAS
70Zn concentration, ua a1±SD in ash
CNAA AAS Ratio
Sample Dupl. I Dupl. II Mean±SDM AAS/CNAA
C1 11.9±2.8 15.2±4.0 13.6±2.3 13.4 0.98±0.17
C2 17.3±1.0 18.4±1.5 17.8±0.8 18.0 1.01 ±0.04
C3 6.9±1.3 8.4±1.6 7.7±1.0 7.2 0.94±0.12
C4 9.6±1.4 1 0 .6 ±0 .8 10.1±0.7 10.3 1.02±0.07
C5 12.8±0.9 14.0±2.1 13.4±0.8 13.9 1.04±0.06
C6 14.4±1.8 15.8±1.2 15.2±1.0 15.8 1.04±0.07
C7 1 1 .1±2 .1 13.2±2.2 12.1±1.5 10.9 0.90±0.11
The insignificant difference between results obtained by two different
measurement techniques (p>0.05) was further evidence for quantitative yield 
of the overall procedure and confirm accuracy of the results.
The precision of the results can be seen vary between ±10-30% providing 5- 
20% precision for the mean. This can be attributed to the lower amounts 
determined, e.g. 0.3 pg in a 40 mg fraction of ashed faecal sample. The 70Zn 
concentrations found in faecal samples are provided in Appendix-6 .
IH.2.3.4 MEASUREMENTS BY ICP-MS
ICP-MS was employed for determination of the enrichment of 57Fe 
administered with standard solution. The natural levels of rare earths in faecal 
and urine samples were also determined by this method. The specifications 
and operating conditions of the spectrometer are provided in Table-59.
163
Table-59: Specifications and operating conditions of the ICP-MS used for 
determination of 57Fe and rare earths
Instrument PlasmaQuad 11 STE (Fisons Instruments Elemental Analysis)
RF power :1349 W
Reflected power :<5 W
Nebuliser : DeGalan V-groove
Spray chamber : Scott-type double bypass (cooled to 12 °C)
Sampling cone : Nickel, 1.0 mm orifice
Skimmer cone : Nickel, 0.75 mm orifice
Auxiliary gas flow : 0.75 L min' 1
Coolant gas flow : 14.0 L min' 1
Nebuliser flow rate : 0.899 L min' 1
Sampling depth : 10 mm
Sample uptake rate : 0.8 mL min' 1
Optimization : The lenses were adjusted to maximize the 115ln signal
Acquisition parameters
Mass range : 51 to 116.5 amu for Fe, 99-185 amu for RE analysis
Channels per amu : 20
Dwell time : 320 ps
Collector : Dual mode
Acquire time : 30 s
Acquires per sample : 3 s
1.Measurement of 57Fe in faecal samples 
Procedure
The following samples and standards were prepared and diluted with 2% v/v 
HN03 to determine 57Fe concentrations,
1) Standards containing 22, 44 and 88 pg L'1 of 57Fe were prepared from a 
specpure Fe solution,
2) 1 mL fractions of column separated samples were diluted to 50-100 mL as 
appropriate for the expected concentrations,
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3) 0.1 mL of the dose solution diluted to provide 28.9 pg L'1 of S7Fe,
4) Approximately 1 g of bovine liver (dry weight) was ashed, acid digested, 
and subjected to the column separation procedure as described previously. 
The iron eluent was finally diluted to 100 mL to provide approximately 40 pg 
L’1 of 57Fe,
4) A blank solution which had been run through the separation procedure was 
prepared to determine the contribution from reagents.
All samples and standards were spiked with 115ln as an internal standard to 
monitor signal fluctuations and drift.
The system was calibrated with the standards and the regression coefficient 
of linearity for the ion counts at these concentrations was found to be 
r=0.9998.
The S7Fe content of the column separated samples, bovine liver, and the blank 
were determined by 3 measurements for each solution. A wash solution of 2% 
v/v aristar HN03 and one of the calibration standards were run between every 
3 sample to minimize inter-sample overlap, and to confirm the stability of the 
system through the measurement period.
Results and comments
Concentrations of 57Fe found in faecal samples are provided in Appendix-5. 
Examples of measured concentrations for the solutions prepared from column 
eluents and the dose solution together with concentration determined in the 
blank and the mean of 4 (3 runs for each) measurements for bovine liver are 
provided in Table-60.
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Table-60: ICP-MS measurements of 57Fe in column eluents after a dilution by factor 
of 1 0 0 0
S7Fe concentrations, pg L' 1
Sample Run I Run II Run III Mean ±SDM
C1 32.1 31.1 30.4 31.2±0.9
C2 14.0 13.5 13.4 13.7±0.3
C3 42.2 44.0 43.9 43.4±1.0
C4 2 2 . 0 2 1 . 2 21.3 21.5±0.4
C5 29.7 28.4 29.8 29.6±0.8
C6 2 0 . 6 19.8 19.4 2 0 .0 ±0 .6
C7 24.3 23.7 23.5 23.8±0.4
Blank 3.26 3.20 3.30 3.27±0.03
Derived concentrations
S7Fe in dosing solution, pg mL*1 
305 295 290
Fe in bovine liver, pg g*1 in dry 
(Mean of 4 measurements) Certified
190±1.5 194±10.3
297±7.6
Expected
289
Repeatability of 3 measurements of concentrations for the solutions was found 
to be 2-3%. The constant concentration for the blank solution showed that the 
contribution from the contents of chemicals used was measured with 1-2 % 
precision. The result for dosing solution was found to be very close to the 
expected value with 2.5% precision suggesting the results were accurate. The 
Fe content of bovine liver derived from 57Fe determinations (as the mean of 
4 measurements) also confirmed the accuracy of the results.
2 .Measurement of rare earths in faecal and urine samples bv ICP-MS
Natural background levels of rare earths were determined in faecal and urine 
samples provided before administration of the standard solution. Urine 
samples provided after consumption of the standard solution and meal were
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also analyzed to investigate if any absorption had occurred at levels which 
were below the determination limits of NAA.
Procedure
Approximately 0.1 g of ashed faecal samples were digested in 10 mL of 16M 
aristar HN03 by heating and the solutions evaporated to near dryness. 
Solutions of digested faecal samples were made up to contain 0.1 %, w/v solid 
concentrations in 2% v/v HN03.
The system was calibrated for the measured isotopes using multi-element 
standards containing 0.2, 1 and 10 ng mL'1 of the rare earths with 
consideration of their natural abundances. The regression coefficients for the 
calibrations were found to be 0.9979-1.0000. The following samples and 
standards were analyzed with 3 runs for each,
1. A blank solution provided from the faecal sample preparation,
2. Acid digested faecal samples,
3. A blank solution provided from the urine sample preparation,
4.Previously prepared acid treated urine samples containing 25% v/v urine in 
final solution (Section III.2.2.3.),
4. BHVO-1 geological standard (Watkins and Nolan, 1992) for quality control 
of rare earth analysis
After addition of 115ln as internal standard to monitor signal fluctuations and 
drift, analysis of the samples was carried out starting from the blank (for 
urine), followed by urine samples, to minimize possible contamination. Since 
the urine samples contained a significant amount of solid, after 3 runs for 
each of the samples one wash solution was also processed to clean the 
instrument. The analysis procedure was continued with the blank and 
solutions of acid digested faecal samples. A multi-element calibration standard 
containing 1 ng mL"1 of rare earths was analyzed with 2-3 sample intervals 
to monitor stability of the measurement system.
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Results and quality control
Rare earth concentrations in faecal and urine samples, taking account of 
dilution, are provided in Appendix-7.A and B.
Examples of measured concentrations in solutions derived from faecal and 
urine (provided 24 h after the meal consumption) samples for subject C2, and 
a blank for each are provided in Table-61 for quality control. Rare earth 
concentrations determined for BHVO-1 geological standard are also provided 
in the table to confirm accuracy of the results.
As can be seen from the table, the measured concentrations (blank 
subtracted) of rare earths in the solution of faecal sample were usually 
significantly higher than those found in the blank solution. Reproducibility of 
the concentrations measured in faecal samples (mean of 3 measurements) 
were reasonably good, providing up to 10% standard deviation.
Concentrations of the light rare earths in urine samples were significantly 
higher than those measured in the blank solution. The levels of heavy rare 
earths were very low and close to the concentrations determined in the blank 
solution. The reproducibility of measurements were reasonable at such low 
levels providing 10-50% standard deviation. The insignificant difference 
between rare earth concentrations determined in BVHO-1 standard and those 
provided by Watkins and Nolan (1992) was evidence for the accuracy of the 
results.
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III.3 RESULTS AND DISCUSSION
In this section the recoveries of Sm and Yb are provided for consideration of 
their kinetic behaviour. Attention is also be given to their possible absorbance 
in view of concentrations found in urine and final faecal samples. 
Consideration is given to the determination of luminal disappearance of 
isotopic tracers by analysis of individual samples and composites of a limited 
number of faecal samples. The excretion kinetics of excreted fractions of the 
tracer isotopes are compared with those of the Sm and Yb markers.
III.3.1 RECOVERIES OF THE RARE EARTH MARKERS
Faecal recoveries of Sm and Yb derived from experimental data given in 
Appendix-5 and 6 are provided in Table-62.a-g.
The tables contain the time elapsed after administration of the dose, 
recoveries of the rare earths (% of ingested dose in stool) in individual 
samples and cumulative recoveries obtained by addition of sequential outputs. 
Standard deviations for individual recoveries represent measurement errors, 
whilst the deviations for the total recoveries take account of sum of the errors 
(99% confidence limit).
The recoveries of Sm and Yb with individual samples and composite of 
sequential outputs are depicted as a function of time post-dosing in Figure- 
26.a-g.
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Table-62.a: Faecal recoveries of Sm and Yb markers for subject C1
SUBJECT C1
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 25.0 78.48±0.99 78.5 22.3 11.8710.17 11.9
2 49.0 25.67±0.37 104.2 46.3 50.8910.56 62.8
3 73.0 1.0810.03 105.2 70.3 33.5310.25 96.3
4 97.0 0 .2 6 1 0 . 0 2 105.5 94.8 2.9010.04 99.2
5 1 2 1 .0 0 .1 8 1 0 .0 1 105.6 118.8 0.2910.02 99.5
6 145.0 0 .1 2 1 0 .0 1 105.8 142.8 0.2710.04 99.8
7 169.5 0.0910.002 105.9 168.5 0.4010.03 1 0 0 .1
8 193.5 0.0910.003 106.0
1 0 0 .1 1 1 .8Total recovery, 
%±3SD
106.013.3
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Figure-26.a: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C1
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Table-62.b: Faecal recoveries of Sm and Yb markers for subject C2
SUBJECT C2
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 13.3 9.92±0.04 9.9 25.7 21.8710.06 21.9
2 39.0 25.17±0.18 35.1 62.9 55.5110.27 77.4
3 63.3 35.4010.28 70.5 86.7 2 6 .8 6 1 0 . 0 6 104.2
4 98.4 27.8710.35 98.4 1 1 1 .0 0.3410.01 104.5
5 . 135.6 0.5310.03 98.9 145.4 0.0910.01 104.6
6 159.4 0.4810.01 99.4 167.0 0.0410.01 104.7
7 183.7 0 .0 6 1 0 .0 0 1 99.5 195.8 0 .1 0 1 0 .0 1 104.8
8 218.1 0.0510.001 99.5
104.810.9Total recovery, 
%±3SD
99.511.5
100
100
80
m 60
60
20
40 150 200
TIME P0ST-00SNA. h
100
20
220120 20020 40 60 80 100 140I 180 
TIME POST-DOSING, h
180
Figure-26.b: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C2
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Table-62.c: Faecal recoveries of Sm and Yb markers for subject C3
SUBJECT C3
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 10.3 59.80±0.53 59.8 11.4 6.98±0.05 7.0
2 24.1 34.39±0.52 94.2 23.1 22.80±0.10 29.8
3 48.6 6.50±0.10 100.7 30.0 51.57±0.22 81.4
4 71.6 0.84±0.02 101.5 47.5 13.04±0.11 94.4
5 83.3 0.12±0.03 1 0 1 .6 70.9 3.17±0.05 97.6
6 95.0 0.06±0.01 101.7 80.3 0 .1 0 ±0 .0 2 97.7
7 103.9 0.19±0.01 101.9 96.9 0.13±0.03 97.8
8 121.4 0.17±0.01 1 0 2 .1 124.8 0.14±0.03 97.9
9 144.8 0 .2 0 ±0 .0 2 102.3 142.6 0.21 ±0.04 98.1
1 0 154.2 0 .1 1 ±0 .0 1 102.4 154.6 0.29±0.06 98.4
Total recovery, 
%±3SD
102.4±2.4 98.4±0.9
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Figure-26.c: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C3
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Table-62.d: Faecal recoveries of Sm and Yb markers for subject C4
SUBJECT C4
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 21.9 64.29l0.62 64.3 24.0 90.4110.64 90.4
2 45.9 39.7410.39 104.0 47.9 6.8710.05 97.3
3 69.5 3.3810.09 107.4 70.7 2.6110.04 99.9
4 96.2 0.1410.01 107.5 94.1 0.9210.02 100.8
5 120.1 0.0210.01 107.6 118.0 0.1010.01 100.9
6 142.9 0.0410.001 107.6 142.3 0.0510.001 101.0
7 166.3 0.0410.001 107.6 165.5 0.1510.01 101.1
8 190.2 0.0910.001 107.7
101.111.8Total recovery, 
%±3SD
107.712.1
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Figure-26.d: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C4
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Table-62.e: Faecal recoveries of Sm and Yb markers for subject C5
SUBJECT C5
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 15.3 20.05±0.28 2 0 .1 8 . 2 43.36±0.22 43.4
2 30.6 74.73±1.05 94.8 33.3 44.68±0.29 8 8 .0
3 60.6 5.78±0.10 1 0 0 .6 59.9 11.91±0.18 99.4
4 81.2 0.46±0.04 1 0 1 .0 85.6 0.85±0.05 1 0 0 .8
5 106.4 0.17±0.02 1 0 1 .2 97.2 0.31 ±0.02 1 0 1 .1
6 133.0 0.24±0.02 101.4 124.2 0.04±0.01 1 0 1 .1
7 158.7 0.05±0.01 101.5 149.5 0.09±0.01 1 0 1 .2
8 170.3 0.03±0.001 101.5
1 0 1 .2 ±1 .2Total recovery, 
%±3SD
101.5±3.3
100
100
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Figure-26.e: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C5
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Table-62.f Faecal recoveries of Sm and Yb markers for subject C6
SUBJECT C6
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 3.5 1 0 .8 8 ±0 .2 2 10.9 25.0 48.87±0.17 48.9
2 22.5 77.4610.11 88.3 48.8 42.9810.22 91.9
3 48.3 11.40±0.05 99.7 70.3 3.4610.03 95.3
4 53.5 1 .8 8 ±0 .0 2 1 0 1 .6 80.3 0 .1 2 1 0 .0 1 95.4
5 71.4 1.03±0.02 1 0 2 .6 94.8 0.1510.01 95.6
6 97.7 0 .1 2 ±0 .0 1 1 0 2 .8 118.8 0 .2 1 1 0 .0 1 95.8
7 121.5 0.16±0.01 102.9 142.1 0.2910.02 96.1
8 143.0 0.04±0.002 103.0
9 153.0 0 .1 1  ±0 .0 0 2 103.1
1 0 167.3 0.04±0.001 103.1
Total recovery, 
%±3SD
103.110.9 96.110.9
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Figure-26.f: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C6
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Table-62.g: Faecal recoveries of Sm and Yb markers for subject C7
SUBJECT C7
FAECAL
SAMPLE
NO
TIME 
POST- 
DOSING, h
Sm RECOVERY TIME 
POST- 
DOSING, h
Yb RECOVERY
INDIVIDUAL,
%±SD
CUMULATIVE,
%
INDIVIDUAL,
%±SD
CUMULATIVE,
%
1 8.5 10.2010.23 1 0 .2 23.0 69.1810.38 69.2
2 23.4 74.0210.32 84.2 36.8 18.6210.13 87.8
3 47.8 13.6710.07 97.9 47.8 6.4210.12 94.2
4 73.3 1.4210.08 99.3 72.3 1.7110.06 95.9
5 95.8 0.3610.02 99.7 81.6 0.3110.002 96.2
6 109.6 0 .1 0 1 0 .0 1 99.8 94.3 0 .2 2 1 0 .0 1 96.5
7 1 2 0 .6 0.0710.01 99.8 118.3 0.2310.01 96.7
8 145.1 0 .0 8 1 0 .0 0 1 99.9 142.3 0.2510.03 96.9
9 154.4 0.0310.001 99.9 166.7 0.2410.03 97.2
1 0 167.1 0.0910.001 1 0 0 .0
97.211.2Total recovery, 
%i3SD
1 0 0 .0 1 1 .2
100
100
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§  40
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40 150
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Figure-26.g: Faecal profile of Sm and Yb recoveries for individual samples and
composite of sequential outputs for subject C7
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III.3.2 DISCUSSION OF RECOVERY OF Sm and Yb MARKERS
IM.3.2.1 RECOVERY OF Sm and Yb MARKERS
Recoveries of the rare earth markers were found to be essentially quantitative 
for all participants for both Sm and Yb despite the fact that their modes of 
intake were different. The means of marker recoveries were 102.8±3.0% 
(range of 99.5-107.7) for Sm which was taken with a drink, and 100.1 ±3.1% 
(range of 96.1-104.8) for Yb which was taken with a meal (Table-63). The 
mean recoveries for both Sm and Yb were nearer to 100% than those 
obtained in previous investigations, principally due to inclusion of toilet papers 
in sample collection, and improvements in sample collection and preparation.
Table-63: Summary of all faecal recoveries of rare earths
Initial. INAA
Rare earth recovery, %±SD 
Extended. CNAA S.l. Tracer studv
Subject RE Subject RE Subject Sm Yb
A1 89.5±1.9 B1 96.611.1 C1 106.011.1 1 0 0 .1 1 0 .6
A2 98.1±1.8 B2 1 0 0 .2 1 1 .1 C2 99.510.2 104.810.3
B3 91.111.3 C3 102.410.8 98.410.3
B4 94.210.4 C4 107.710.7 1 0 1 .1 1 0 .6
B5 88.111.3 C5 101.210.4 103.110.2
B6 94.511.3 C6 103.110.3 96.110.3
C7 100.010.4 97.210.4
MEAN1SDM
93.816.1 94.114.2 102.813.0 100.113.1
Quantitative recoveries were obtained after elimination of steps in the sample 
preparation procedure which caused sample losses by using a modem 
commode sample collection system, radiation sterilization instead of polythene 
bags for collection, and autoclave sterilization which resulted in incomplete 
sample transfer for ashing. This suggests that the lower recovery results were
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due to losses during sample collection and processing rather than adsorption 
or absorption in the intestine.
A comparison of levels of the administered rare earths in natural (baseline) 
samples obtained before consumption of Sm and Yb and those in samples 
provided at the end of the collection period are provided in Table-64 where it 
can be seen that the Sm and Yb concentrations in the final samples are 
comparable to natural levels.
Table-64: Comparison of Sm and Yb concentrations in ashed faecai samples 
provided at the end of collection period with natural levels
Time post-dosing, h RE in ash, pg g 1
Subject Sm Yb Sm Yb
C1 194 169 0.14±0.01 1.3710.27
C2 218 196 0.16±0.01 0.2110.06
C3 154 155 0.12±0.03 0.3110.12
C4 190 166 0.15±0.01 0.2510.06
C5 170 150 0.17±0.01 0 .1 8 1 0 .0 6
C6 167 142 0 .2 8 1 0 . 0 2 0.4510.09
C7 168 167 0.1910.01 1.3110.48
MEANtSDM 0.1710.05 0.5810.52
RANGE 0.12-0.28 0.18-1.37
Natural level in pre-dose sample
MEANtSDM
RANGE
0.1710.02
0.15-0.19
0.4310.32
0 .1 2 -1 .0 1
These results are further evidence that absorption of rare earths is negligible, 
or any possible absorption must be at a fraction of the natural levels.
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111.3.2.2 DISCUSSION OF THE NATURAL LEVELS OF RARE EARTHS IN URINE AND 
FAECAL SAMPLES
Sm and Yb concentrations in urine samples
Urine samples were provided by 4 of the 7 participants. Samples were 
collected for 24 h before (for 3 subjects), and after each administration (for 4 
subjects) bearing in mind results obtained by Kramsch et al. (1980) which 
indicated that when monkeys were fed a test meal containing 40 mg kg'1 body 
weight of La, the level of La in circulating blood returned to natural levels after 
12 h (64.5 pg of La was detected in 24 h urine). Sm and Yb concentrations 
found in samples provided before and after administrations are compared to 
evaluate absorbability in Table-65.
Table-65: Concentrations of Sm and Yb in urine samples provided before and after 
consumption of a standard solution containing Sm and a farina meal containing Yb
Sm or Yb concentration in urine (ng L' 1 ±SDM)
a. Sm
Mean Range n Statistical evaluation1
Natural level 153 ±37 123-193 3
After drink 1249 ±436 853-1824 4 p<0 .0 0 1
After meal 162 ±82 73-262 4 p>0 .1 0
b. Yb
Natural level 137 ±70 80-287 7
After meal 93 ±17 72-108 4 p>0 .1 0
1. Null hypothesis is that the concentrations do not differs significantly from natural levels
As can be seen from the table, there is a significant difference between Sm 
concentrations determined in samples provided before administration and after 
consumption of the standard solution (p<0.001). This indicates the occurrence 
of slight absorption. The difference between the natural level of Sm and the 
level in samples provided 3 days after its administration (i.e. after the meal) 
is insignificant (p>0.10) which suggested that the Sm concentration returned
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to the natural level. There was no significant difference between Yb 
concentrations in samples provided before or after the meal (p>0.10). This 
indicates that absorption of Yb from meal was not significant.
The slight absorption of Sm may be explained by the fact that when Sm is 
administered with a solution (with no food) it can not be hydrolysed completely 
since some intestinal secretion is only stimulated when a meal enters the 
intestinal system.
It is worth mentioning that Sm can form an absorbable complex with ascorbic 
acid. Hasegawa et al. (1988) showed that ascorbate, as a uninegative anion 
forms weak complexes with the rare earths. The formation of the Sm complex 
was calculated to be ~1 % of the total Sm dose used in the current investigation 
(1 mg) using association constant of Sm ascorbate provided by Hasegawa 
and Sugawara. With the assumption of a steady state between Sm in blood 
and in urine, and a total blood volume of 5 L, the level found in urine is 
equivalent to absorption of approximately 0.5%. In conclusion, the slight 
absorption of Sm can be explained to the fact that a small fraction of the Sm 
dose remains in an ionic form (non-hydrolysed) and this forms absorbable 
complexes with ascorbate provided with the drink consumed or chelates 
provided by intestinal secretion. From data provided by Robinowitz et al.
(1988), the absorbability of La was calculated to be <1% from concentrations 
determined in various tissues of rats fed with 40 mg d'1 La contained in 
drinking water. This could be considered as a further evidence of low but 
determinable absorbability of rare earths when they are administered to 
subjects who fasted overnight and consumed rare earths with a drink.
Hutcheson et al. (1975) found that no absorption occurred when three 
generations of mice were fed grains containing rare earth oxides and the 
same conclusion was reported by Luckey et al. (1975) for rats fed with pellets 
labelled with rare earth nitrates. The results for the absorbability of Yb 
consumed with a meal suggest that absorption of rare earths is very low when
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they are administered with food as found by Hutcheson et al. (1975).
Rare earth concentrations in urine and faecal samples
The mean of natural levels of rare earths determined in ashed faeces and in 
urine samples are provided in Table-66 . The table also contains rare earth 
concentrationsexpected in faeces calculated from the average intakes with a 
U.K. diet (MAFF Food Surveillance Paper No. 45,1994), and La, Ce, and Sm 
concentrations in ashed faecal samples for a New York population (Linsalata 
and Eisenbud, 1986).
Table-66: Natural levels of rare earths in ashed faecal samples
RE
RE IN 
URINE, ng L 1
RE IN FAECES, |ig 9 ASH
GLASGOW1 MAFF2 NEW YORK3
MeaniSDM RANGE RANGE MEAN RANGE
La 87±52 1 .3510.52 0.82-2.26 1.25-0.75 0.810.5 0.2-1.5
Ce 188±130 1.76±0.68 1.14-3.34 4-1.50 2.311.6 0.4-5.4
Pr 142±25 0.31±0.11 0.19-0.52 0.5-<0.25
Nd 126±43 1.04±0.33 0.69-1.63 1-0.75
Sm 158±62 0.1810.03 0.15-0.23 0.5-<0.25 0.1210.09 0.02-0.28
Eu 81 ±25 0.0910.07 0.04-0.24 0.5-<0.25
Gd 84±33 0.1910.06 0.11-0.28 0.5-<0.25
Tb 66±23 0.0610.05 0.02-0.18 0.5-0.00.
Dy 49±9 0.1610.04 0 .1 1 -0 . 2 2 0.5-<0.25
Ho 2 1  ± 8 0.0310.01 0.02-0.04 0.5-0.00
Er 33±17 0.0810.03 0 .0 1 -0 . 1 2 0.5-0.00
Tm 11±7 0.0210.003 0 .0 1 -0 . 0 2 0.5-0.00
Yb 1 2 ± 6 0.2910.26 0 .1 1 -1 .0 1 0.5-0.00
Lu 4±11 0.0210.004 0 .0 1 -0 . 0 2 0.5-0.00
As can also be seen in Table-66 concentrations of some of the light rare 
earths agree with those derived for the daily UK input per person (on the 
basis 4 g d'1 ash faecal sample), whilst the range for other rare earths are not
1 8 2
assessable since they are below the limits of detection. Comparison of 
theresults for current investigation and for those obtained for a New York 
population indicates that the inputs of rare earths via dietary intakes are 
comparable. Chondrite normalized rare earth concentrations in faecal and 
urine samples for this investigation, and those in faecal samples derived from 
the average intakes with a U.K. diet (MAFF, 1994) and provided by Linsalata 
and Eisenbud (1986) for a New York population are provided in Figure-27.
O RE IN FAECES □  RE UN FAECES (MAFF. 1994)
•  RE IN URINE V  RE IN FAECES (Linaoloto. 19S6)
3  0.1
0.01
0.001
0.00001
Pr Nd Sm Eu Gd Tb Dy He Er Tm Yb LuLa Ce
Figure-27: Chondrite normalized rare earth concentrations in ashed faeces and urine
As an be seen from the figure the results for faecal samples provide a smooth 
trend which is further evidence for the accuracy of the results.
In order to derive evidence of the extend of transfer of rare earths to the body, 
the total output of rare earths with faeces and urine on a daily basis were 
compared. By assuming daily faecal output of 4 g (ashed) and a urine output 
of 1.4 L d’1, and taking account of the indicated levels in outputs, the fraction 
absorbed via intestinal system is found to be in a range of 0.006-0.19%. 
Calculated absorbances ranged from 0.006% for La and 0.09% for Eu,
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representing light rare earths, and 0.04% for Er and 0.19% for Lu, 
representing heavier rare earths. Tjioe et al. (1983) have shown that there is 
reduced retention of the heavier rare earths in the human liver or an increased 
retention of the lighter rare earths. When the results for urine samples are 
considered alone, the observed anomalies suggest the conclusion of Tjioe et 
al. (1983) for the levels determined in the human liver.
III.3.2.3 FAECAL APPEARANCE PROFILE OF Sm AND Yb
The recovery profiles for Sm and Yb showed a similar kinetic pattern for all 
subjects. The first appearance time was in 24 h after administration. The 
patterns have a maximum marker content by 40 h, except for one, and the 
markers were recovered quantitatively with provision of 3-4 samples in 72 h. 
For all subjects the content of the rare earths in the fifth sample was below 
1% of the doses administered.
Recoveries with the first samples were in a range of 10-80% for Sm, and 7- 
90% for Yb. Means of doses recovered with the first 2 samples 82±26% for 
Sm (range of 25.3-98.3, the range was 84.2-98.3% for 6 out of 7 subjects), 
whilst the mean of recoveries for Yb 75±24% were in a range of 30.3-96.2% 
containing major fraction of doses administered. The recoveries of both 
elements are nearly quantitative by collection of the third samples, and after 
collection of the fourth samples the remainder was below 1 %. Recoveries 
obtained by summation of recoveries in 2,3, or 4 samples per subject are 
provided in Table-67 togetherwith the elapsed time between consumption and 
collection of the final sample. The overall means are compared with those 
obtained in the previous investigations. Recoveries with number of collection, 
showing the means of recoveries, are depicted in Figure-28 as a function of 
time post-dosing.
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Table-67: Recoveries of Sm and Yb obtained by addition of sequential faecal outputs
2  samples 3 samples 4 samples
Recovery, 
Subject %
Time post- 
dosing, h
Recovery,
%
Time post- 
dosing, h
Recovery,
%
Time post- 
dosing, h
Results for Sm
C1 98.3 49 99.3 73 99.5 97
C2 25.3 39 70.9 63 98.9 98
C3 92.0 24 98.3 49 99.2 72
C4 96.6 45 99.7 70 99.8 96
C5 93.4 31 99.1 61 99.5 81
C6 85.7 23 96.7 48 98.5 54
C7 84.2 23 99 48 99.3 73
MeantSDM 82±26 33±11 95±11 59±11 99±0.4 82±17
Results for Yb
C1 62.8 46 96.3 70 99.2 95
C2 63.8 63 99.5 87 99.8 1 1 1
C3 30.3 23 82.7 30 95.9 48
C4 96.2 48 98.8 71 99.7 94
C5 90.3 37 96.9 48 98.7 72
C6 8 6 .0 33 97.6 60 98.4 8 6
C7 95.6 49 99.2 70 99.3 80
MeantSDM 75±24 43±13 96±6 62±18 99±1.3 84±20
Results from the initial INAA investigation (2 subjects)
MeantSDM 78±25 38±7 94±10 62±6 98±2.3 85±8
Results from the detailed recovery investigation ( 6  subjects)
MeantSDM 64±26 38±4 89±13 54±8 98±2.1 73±8
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Figure-28: Total recoveries (±SD) of Sm (O), and Yb ( • )  as the mean of recoveries 
obtained by addition of sequential faecal outputs as a function of the mean of time 
post-dosing
As can be seen from the table and the figure, the Sm recovery rate is higher 
than that of Yb. This suggests that the intestinal passage time of Sm 
administered with a solution is shorter than that of Yb consumed with a meal. 
However the mean recovery of Sm with 2 samples was not significantly 
different from that with 4 samples, as was the case with Yb from 3 samples 
(p>0.05, paired t-test).
Results obtained in a kinetic evaluation of the transit time of Sm and Yb, 
using a logarithmic relation between fraction of retention and time post dosing 
(as described in section II.2.6.3) are provided in Table-68 with regression 
coefficients for Log retention% and time post-dosing.
1 8 6
Table-6 8 : Kinetic characteristics of Sm and Yb markers when they are administered 
with different modes of intake
a. Characteristics for Sm consumed with a standard drink
Subiect
First appearance 
h±SD
G.l. half-life 
hlSD
Time for total excretion 
hlSD r2
C1 7.1±2.0 14.714.2 58.3116.6 0.958
C2 24.1 ±8.4 35.8H2.5 99.5132.3 0.844
C3 3.8±0.8 9.812.0 43.818.8 0.953
C4 11.8±1.4 18.512.1 56.216.5 0.988
C5 7.2±1.5 15.413.3 61.5113.1 0.951
C6 3.4±0.3 10.911.1 53.415.3 0.974
C7 3.610.4 11.911.4 59.117.2 0.980
MEAN±SDM 8.7±7.4 16.718.9 61.7117.6
b. Characteristics for Yb consumed with a reference meal
C1 15.7±2.6 26.114.3 84.6114.1 0.961
C2 28.7±8.7 37.9111.5 89.8127.3 0.901
C3 12.3H.2 2 0 .6 1 2 .1 67.816.8 0.968
C4 NA NA NA NA
C5 9.7±0.9 17.511.6 61.015.4 0.994
C6 7.712.0 18.414.8 79.1120.6 0.988
C7 16.511.3 24.311.9 67.815.3 0.995
MEAN±SDM 15.117.5 24.117.5 75.0111.1
Results from the initial INAA investigation (2 subjects)
MEANlSDM 2 1 .2 1 6 .8 29.719.0 77.3121.8
Results from the detailed recovery investigation ( 6  subjects) 
MEANlSDM 12.1±1.7 22.7±3.3 82.3±22.5
As can be seen from the table, it is confirmed that the first appearance time 
for Sm given with the standard drink is earlier than for Yb consumed with a 
meal (p>0.05, two-tailed t-test). Such measurements could be used to 
measure the passage time of diets or pharmaceuticals in the intestine.
The kinetic characteristic of the elements for subjects 1 and 2 who 
participated in the three investigations were compared, for evidence of
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reproducibility, and are provided in Figure-29.a and b.
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Figure-29: Comparison of faecal excretion rates of rare earths for subjects 1 and 2
The profiles obtained could be considered as characteristic of intestinal
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physiology. Luckey et al. (1979) has suggested that the rate of excretion 
varies between individuals. Some have slow, some have fast excretion rates 
which are not related to age, sex, or life style but could be related to intestinal 
physiology. The excretion profile for Subject-1 indicates a more regular rate 
of excretion compared with that for Subject-2 despite the fact that both 
subjects consumed the rare earths with the same meal and/or solution.
189
111.3.3 LUMINAL DISAPPEARANCE OF IRON DETERMINED WITH S7Fe TRACER 
AND Sm MARKER, CONSUMED AS A STANDARD SOLUTION
In this section, recoveries of marker and tracer are discussed with reference to their 
kinetic behaviour. The use of a rare earth marker to determine the luminal 
disappearance of Fe from a drink with single or limited faecal sampling is considered 
by comparing the results with those obtained from total collections of stools.
The recoveries of Sm and 57Fe were determined for 5 consecutive faecal samples 
provided after administration. The number of samples collected were sufficient to 
recover non-absorbable marker quantitatively so that the kinetic behaviour of the 
marker and tracer could be evaluated.
Presentation of results
Recoveries and luminal disappearances have been calculated by applying Equation- 
5.b (Section 1.5) to experimental data provided in Appendix-5. The recoveries of Sm 
marker and 57Fe tracer, and luminal disappearance derived from recoveries are 
provided in Table-69.a-g.
Faecal recovery (%±SD) indicates the recovery of Sm marker and 57Fe tracer with 
individual samples with ±SD derived from errors of measurement. Tracer recoveries 
take account of the endogenous contribution,
Luminal disappearance (%±SD) indicates the luminal disappearance with ±SD 
derived from the recoveries obtained for marker and tracer for individual samples 
(where applicable, otherwise indicated with n.a.) and for cumulative collections which 
are composites of the samples accumulated consecutively. Luminal disappearance 
derived from recovery of tracer, assuming no losses occurred during collection, are 
provided at the end of each table.
It can be seen that the luminal disappearances obtained for single samples are only 
provided for initial outputs, where the recoveries of the marker and tracer are 
significant, since those from later collections are low and include possibly re-excretion 
of tracer initially taken up. Profiles of faecal outputs for marker and tracer for 
individual samples and for total pools which are composites of summation of 
sequantial outputs are also provided in accompanying figures (Figure-30.a-g).
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Table-69.a: Faecal recoveries of Sm marker, 57Fe tracer, and luminal disappearance
of iron, when consumed with a reference drink
SUBJECT 1
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %iSD
Sm ^Fe Individual Cumulative
1 25.0 78.48±0.99 35.4011.51 54.912.5 54.912.45
2 49.0 25.67±0.37 17.1210.54 33.311.2 49.611.60
3 73.0 1.08±0.03 2.1710.05 n.a. 48.011.49
4 97.0 0.26±0.02 1.7810.03 n.a. 46.511.40
5 1 2 1 .0 0 .1 8 1 0 .0 1 1.0710.03 n.a. 45.511.46
Total, % 105.711.1 57.511.6
100 - Total ^Fe recovery 42.5±1.6%
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Figure-30.a: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output (Cumulative) for Subject-1
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Table-69.b: Faecal recoveries of Sm marker, 57Fe tracer, and luminal disappearance
of iron, when consumed with a reference drink
SUBJECT 2
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %±SD
Sm ^Fe Individual Cumulative
1 13.3 9.92±0.04 7.57±0.22 23.7±2.5 23.7±2.5
2 39.0 25.17±0.18 18.98±0.51 24.6±1.2 24.3±1.6
3 63.3 35.40±0.28 23.87±0.54 n.a. 28.5±1.5
4 98.4 27.87±0.35 25.02±0.75 n.a. 23.3±1.4
5 135.6 0.530.03 5.30±0.18 n.a. 18.4±1.5
Total, % 98.9±0.5 80.7±1.1
100 - Total ^Fe recovery 19.3±1.1 %
0  2 0  4 0  GO BO 100 120 140
TIME P O S T-D O SIN G , h
I 120
TIME POST-DOSING, h
Figure-30.b: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output (Cumulative) for Subject-2
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Table-69.c: Faecal recoveries of Sm marker, 57Fe tracer, and luminal disappearance
of iron, when consumed with a reference drink
SUBJECT 3
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %iSD
Sm ^Fe Individual Cumulative
1 10.3 59.80±0.53 39.6610.81 33.710.4 33.710.7
2 24.1 34.39±0.52 20.6510.55 40.011.2 36.010.6
3 48.6 6.50±0.10 8 .2 1 1 0 . 2 2 n.a. 31.910.5
4 71.6 0.8410.02 11.1610.23 n.a. 21.510.3
5 83.3 0 .1 2 1 0 .0 2 2.2410.05 n.a. 19.410.3
Total, % 101.610.7 81.911.0
100 - Total ^Fe recovery 18.1±1.0%
TIME POST-DOSING, h
80
TIME POST-DOSING, h
Figure-30.c: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output for (Cumulative) Subject-3
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Table-69.d: Faecal recoveries of Sm marker, 57Fe tracer, and luminal disappearance
of iron, when consumed with a reference drink
SUBJECT 4
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %1 SD
Sm ^Fe Individual Cumulative
1 21.9 64.29±0.62 55.1811.42 14.210.3 14.210.4
2 45.9 39.7410.39 29.5211.26 25.710.4 18.610.4
3 69.5 3.3810.09 5.8510.15 n.a. 15.710.3
4 96.2 0.1410.01 6.6110.14 n.a. 9.610.2
5 1 2 0 .1 0.0310.01 1.6610.04 n.a. 8 .1 1 0 .2
Total, % 107.610.7 98.811.0
1 0 0  - Total ^Fe recovery 1 .2 ±1 .0 %
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Figure-30.d: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output for (Cumulative) Subject-4
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Table-69.e: Faecal recoveries of Sm marker, 57Fe tracer, and luminal disappearance
of iron, when consumed with a reference drink
SUBJECT 5
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %iSD
Sm CTFe Individual Cumulative
1 15.3 20.05±0.28 16.6910.57 16.710.6 16.710.6
2 30.6 74.74±1.05 33.5310.57 55.111.2 47.010.9
3 60.6 . 5.78±0.10 10.2510.27 n.a. 39.910.7
4 81.2 0.46±0.04 0.9510.05 n.a. 39.210.7
5 106.4 0.17±0.02 0.8710.02 n.a. 38.410.7
Total, % 1 0 1 .2 1 1 .1 62.310.9 37.710.5
100 - Total 57Fe recovery 37.7±0.9%
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Figure-30.e: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output (Cumulative) for Subject-5
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Table-69.f Faecal recoveries of Sm marker, S7Fe tracer, and luminal
disappearance of iron, when consumed with a reference drink
SUBJECT 6
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %iSD
Sm 57Fe Individual Cumulative
1 3.50 1 0 .8 8 1 0 .2 2 7.9210.26 27.311.05 27.3H.0
2 22.5 77.4610.11 72.1811.58 6.810.15 9.310.2
3 48.3 11.4010.04 10.1310.29 11.210.32 9.510.2
4 53.5 1 .8 8 1 0 .0 2 3.3810.06 n.a. 7.910.1
5 71.4 1.0310.01 2.3010.04 n.a. 6 .6 1 0 .1
6 97.7 0 .1 2 1 0 .0 2 1.8310.04 n.a. 4.910.1
Total, % 102.810.3 97.711.6
100 - Total ^Fe recovery 2.3±1.6%
TIME POST-DOSING, h
TIME POST-DOSING, h
Figure-30.f: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output for (Cumulative) Subject-6
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Table-69.g: Faecal recoveries of Sm marker, 57Fe tracer, and luminal disappearance
of iron, when consumed with a reference drink
SUBJECT 7
Faecal 
sample No
Time post- 
dosing, h Faecal recovery, %±SD
^Fe Luminal 
disappearance, %1 SD
Sm ^Fe Individual Cumulative
1 8.5 10.20±0.23 9.5810.31 6.110.24 6 .1 1 0 .2
2 23.4 74.02±0.32 39.5511.69 46.612.00 41.711.5
3 47.8 13.67±0.07 10.0110.41 2 6 .8 1 1 .1 0 39.611.2
4 73.3 1.42±0.08 2.7110.09 n.a. 37.711.1
5 95.8 0.36±0.02 0 .0 2 1 0 .0 0 1 n.a. 37.911.1
Total, % 99.710.4 61.911.1
100 - Total ^Fe recovery 38.111.1%
TIME POST-DOSING. h
Figure-30.g: Faecal profile of Sm marker and 57Fe tracer for individual samples and
composites of sequential output (Cumulative) for Subject-7
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III.3.4 DISCUSSION
111.3.4.1 RECOVERY KINETICS OF ^Fe AND Sm
As can be seen from Table-69.a-g luminal disappearances derived from 
composites of the first 2-3 stools are different from those derived from the 
complete collection (composites of 5 samples). This can be explained by the 
intestinal passage time of marker and tracer being different or the tracer 
initially retained (mucosal uptake+mucosal surface adsorption) being released 
later and appearing in stools after the marker, i.e. the tracer and the marker 
have become dissociated.
For comparison of kinetic behaviour of marker and isotopic excreted tracer, 
the ratio of tracer to marker recoveries for individual samples and those 
derived from composites of sequential outputs for all subjectsare provided in
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Figure-31: Ratios of faecal recoveries of 57Fe tracer and Sm marker for individual
samples, • ,  and for composites of sequential outputs, O, for all subjects
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For the first faecal samples, the ratio of recoveries of the marker and tracer differs 
significantly from that derived from composites of the first two samples. Deviations 
of the first samples, as obtained for 3 subjects, are associated with marker recoveries 
less than 20%, and may be indicative of streaming. This suggests that the first faecal 
sample collected from an individual after consumption may not contain marker and 
tracer from which initial luminal disappearance can be determined so that at least the 
first two samples should be collected to evaluate the fraction initially retained.
The ratio of recoveries after the second samples show a trend to increase. This 
increase which is more obvious for individual samples suggests a slower loss of the 
tracer and could be indicative of release of 57Fe which has been retarded in the gut 
perhaps by surface adsorption or mucosal uptake and release in desquamated ceils. 
However Hayes et al. (1964) (by using radioactive La-140 marker and Fe-59 tracer) 
and Boender & Verioop (1969) (by using radioactive Ba-131 marker and Fe-59 
tracer) found similar results where the participants consumed a standard solution. 
Ratios of recoveries derived from the results of Hayes et al. and Boender & Verioop 
are provided in Figure-32.
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Figure-32: Ratio of faecal recoveries of tracer and marker derived from the results 
of Hayes et al. (1964) (data available for recovery ratio only) and Boender and 
Verioop (1969)
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That the ratios of recoveries obtained in this investigation and those from 
Boender and Verioop (1969) agree indicates that retarded excretion of tracer 
becomes significant after the first 2-3 outputs.
The magnitude of the contribution of 're-excreted' tracer to the outputs 
obtained in composites of the third to fifth sequential faecal samples can be 
illustrated by the difference between fractions of the total recoveries of tracer 
and marker in individual faecal samples. The differences should be negative 
for samples in which tracer is initially retained or positive for samples in which 
're-excretion' of tracer occurs, with an equal integrated area for both sides. 
The differences for individual samples obtained by this approach as a function 
of the sequence in which faecal samples were collected after consumption of 
marker and tracer are depicted in Figure-33.
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Figure-33: Differences between relative recoveries (percent of total output) of Sm 
marker and 57Fe tracer for all subjects
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For all subjects the net differences between relative recoveries of tracer and marker 
are negative for composites of the first 2  samples composite but is positive for the 
following samples which contains a fraction of tracer initially retained.
Evaluation of the kinetic behaviour of Sm marker and 57Fe tracer with the above 
approaches suggests that net luminal disappearance obtained from the fractions of 
marker and tracer recovered with composites of the initial two or three faecal 
samples minimizes the contribution of 're-excreted' tracer. Linear relation between 
outputs of marker and non-retained tracer, derived from recoveries for all subjects, 
should provide the number of faecal samples required to obtain the net luminal 
disappearance in which contribution of 're-excreted' tracer is minimal.
The linear relation between the recoveries of marker and tracer with composites of 
the first two samples (since the recovery rates of marker and tracer with the first 
samples are not reliable) and with the following individual outputs, as percent of their 
total recoveries for composites of the first three to five faecal samples, for all subjects 
are provided in Table-70. The linearity for the composites of the first two samples is 
derived from the relative recoveries of marker and tracer obtained for composites of 
the first three samples. The linear relation is also derived for the collection of five 
stools for which the first and second outputs are considered as individual samples, 
to show the effect of the relative recoveries of marker and tracer obtained for the first 
samples, and provided in the table. The table contains linearity between the 
recoveries and its correlation coefficient.
Table-70: Linearity between the relative recoveries of Sm marker and 57Fe tracer 
[y=(A±a)x+(B±b), where y and x are recovery of tracer and marker, and A and B are the slope 
and intercept]
Composites Ala Bib R2
3 samples (2 samples composites & 3. samples) 0.9010.02 4.7511.46 0.991
(2 samples composites) 0.8910.07 6.5415.87 0.971
4 samples (2 samples composites and 3. and 4. samples) 0.8510.02 4.9011.22 0.985
5 samples (2 samples composites and 3., 4., 5. samples) 0.8210.02 4.2510.98 0.980
5 samples (From the first to frfith individual samples) 0.7710.03 4.5111.00 0.945
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As can be seen from Table-70 that slopes of the linear relations which are the 
closest to the unity are obtained for the samples which the relative recoveries 
obtained from composites of the first three samples or composites of the first two 
stools of the three samples composites. This indicates that recoveries obtained for 
composites of the 2 or 3 samples are the most appropriate for calculation of luminal 
disappearance with minimum effect of 're-excretion' of isotope initially retained.
111.3.4.2 LUMINAL DISAPPEARANCE AND SIGNIFICANCE OF RETARDED EXCRETION
Having evaluated the excretion kinetics of marker and tracer, the difference between 
luminal disappearances derived from various composites of sequential faecal 
samples were considered to see the extent to which they were possibly effected by 
're-excretion' of initially retained tracer. The mean of luminal disappearance obtained 
for individual samples for which it could be calculated, for composites of 1,2,3 and 
4 samples, and for total collections together with marker recoveries for the 
corresponding groups of samples are provided in Table-71.
The mean of luminal disappearances obtained for the first two or three single 
samples provided high coefficients of variations for 6  of the 7 subjects due to 
different kinetic behaviour of marker and tracer in the first samples. The difference 
between the mean of luminal disappearances obtained for composites of sequential 
two and three samples, in which major fraction of marker was recovered were found 
to be insignificant (p>0 .1 0 ), whilst the differences between those obtained for the 
composites of 1-4 samples, and the total collection (5 samples) were significant, 
p<0.05. This indicates the effect of 're-excretion' of tracer initially retained, as 
discussed above.
The differences in luminal disappearances obtained for sequential composites, SC, 
(2SC and 3SC, 3SC and 4SC, and 4SC and 5SC) are provided in Figure-34 for each 
subject. The differences between those obtained for composites of sequential outputs 
and total collection (2SC and 5SC, 3SC and 5SC, and 4SC and 5SC) are provided 
in Figure-35 for each subject.
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Figure-34: Differences between luminal disappearances obtained for composites of 
sequential 2-5 samples with means and 95% confidence limits
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Figure-35: Differences between luminal disappearances obtained for composites of 
sequential 2-4 samples and total collection with means and 95% confidence limits
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The differences between luminal disappearances obtained for composites of 
sequential the first two and three, three and four, and four and five samples were 
1.9±3.5, 4.0±3.5, and 1.9±1.7% of the dose administered respectively. The 
differences were not significantly different from each other (p>0.05). Differences 
between luminal disappearances of composites of sequential the first two to four 
samples and of total collection (five samples composite) were 7.8±3.5, 5.9±3.5, and 
1.9±1.7% of the dose for the first two and five, three and five, and four and five.
Initial luminal disappearance that can not be measured by faecal monitoring, in which 
the contribution of tracer initially retained is the least can be derived from the 
differences described above. The differences as a function of the mean of time post- 
dosing for provision of the first two, three, and four samples (34, 59, and 81 h 
respectively) are provided in Figure-36.A and B.
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Figure-36: The mean of differences between luminal disappearances of composites 
of sequential pairs in 2-5 samples (A), [Y=(8.2x1CT4±0.05)X+(2.6±3.1), R^ O.OOOS], and 
between those of composites of sequential 2-4 samples and total collection (B), [Y— 
(0.1±0.03)X+(12.5±1.8), R2=0.946] (O indicates the differences at t=0 by extrapolation)
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From the relations between the differences and time post dosing, the 
difference between luminal disappearances of the initial and of composites of 
the first two sequential samples can be calculated to be 2.6±3.1%, and that 
between luminal disappearances of the initial and of total collection is 
12.5±1.8%. By addition of these differences to the luminal disappearances 
obtained for composite of the first two sequential samples (30.7±16.4%) and 
of total collection (22.9±17.2%), the initial luminal disappearances are found 
to be 33.3±16.5% and 35.4±17.3%. The initial luminal disappearance found 
with both approaches are not significantly different from that determined for 
composites of the first two sequential samples, p>0.05.
Marx (1979) suggested that the net luminal disappearance can be measured 
accurately only shortly after ingestion of a test dose. In normal subjects when 
the tracer retained is measured 72 h after ingestion the values are lower than 
the initial measurement due to excretion of iron initially retained. The results 
of this investigation confirm this conclusion. A similar effect has been 
observed in earlier studies where La, Cr, and Ba were used as radioactive 
markers by Hayes et al (1964) (La-140), Powell et al (1970) (Cr-51), and 
Boender and Verloop (1969) and Jasani et al (1971) (Ba-131) respectively 
where the marker and Fe-59 tracer were consumed in a drink.
By considering the retarded excretion of tracer as a fraction of the dose 
consumed (3 mg of iron), approximately 30% of 1 mg initially retained iron is 
excreted within 5 days (mean luminal disappearance was ~20%) of 
administration, at 0.06 mg per day. When the losses from initial retention are 
considered with reference to the biological half-life of iron (483 d, Hunt et al., 
1994), the results obtained, when a tracer is consumed with a drink, indicate 
that the amount initially retained in the intestinal mucosa is not absorbed or 
transferred into the body through the mucosa.
The mean and range of luminal disappearances obtained in this study and 
those obtained for the same mode of intake but using radioactive marker and
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tracer (Table-72) are similar and so suggest the applicability of rare earths as 
marker in investigations of Fe absorption from a standard Fe solution by 
faecal monitoring. With radioactive tracers net luminal disappearance (with the 
collection of initial 2-3 samples) has been determined in patients with iron 
deficiency anaemia, idiopathic haemosiderosis (genetic haemochromatosis) 
where the mucosal transfer index is close to 1, i.e. the fraction of Fe-59 tracer 
initially taken up by the intestinal mucosa is the same with that retained in the 
body when measured 2 weeks after the administration (Marx, 1979). The 
kinetic evaluation of results of this current investigation also suggest that initial 
luminal disappearance can be obtained from composites of the two or three 
samples so that similar applications with stable rare earth markers should be 
possible.
Table-72: Summary of measurements of luminal disappearance of iron when 
consumed as a drink (FM, faecal monitoring and WBC: whole body counting)
Subject 
no (sex)
Iron uptake 
%±SD & range
Dose, mg in 
intake mode
Tracer, marker 
and method
Reference
6 (M) 29.3±11.1 1 mg in drink Fe-59, Ba-131 Boender &
(17-47) (FM) Verloop, 1969
15 (M) 37.6±16.8
(3.6-60.7)
1 mg in drink Fe-59, Cr-51 
(FM and WBC)
Marx, 1979
10(F) 42.8±16.2
(13.1-68.3)
11 (M) 22.8±9.4 8.8 mg in drink “ Fe, Carmine Fairweather-
(3-38) (FM and NAA) Tait et al, 1983
10 (4M, 6F) 29±5.1 10 mg in drink “ Fe, Carmine 
(FM and NAA)
Fairweather- 
Tait and Minski 
1986
7 (6M, 1F) 22.9±17.2
(1.2-45.5)
3 mg in drink 57Fe, Sm 
(FM, NAA, 
ICP-MS)
This study
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m.3.4.3 LUMINAL DISAPPEARANCE OF ^Fe IN RELATION TO IRON STATUS
Marx (1979) described iron absorption as occurring in two phases: firstly, 
mucosal uptake from the intestinal lumen and secondly transfer of iron 
through the mucosal cells towards the blood. A transferrin-like protein 
identified as isoferritin is responsible for the rapid transfer of iron from brush 
border to the blood. The amount of this protein in mucosal cells binds various 
amounts of iron, and eventually releases this iron to the blood at a rather slow 
rate. In normal subjects a considerable amount of iron is apparently not 
released from the ferritin but desquamated with these cells into the lumen of 
the gut, resulting in relatively low values for the mucosal transfer fraction of 
iron.
A proportion of the iron entering the mucosal cells is transferred to the portal 
circulation within minutes. Transfer continues at a much slower rate for 12-24 
h, but some of the iron is sequestered as ferritin and is eventually lost when 
the mucosal cell exfoliates. The relative proportions following these alternative 
pathways depend on the requirement for iron, transfer being enhanced when 
iron deficiency is present and ferritin formation being maximal when the body 
is replete with iron (Chariton and Bothwell, 1983).
A linear relationship between serum ferritin concentration and body iron stores 
has previously been demonstrated by Cook et al. (1974) and Lynch et al.
(1989). A regulatory function for both serum and mucosal ferritin in iron 
absorption had been proposed by Halliday et al. (1978). Subsequently with 
immunologic studies, it is consistent that ferritin being a storage protein which 
incorporates iron to prevent oxidative damage to the cell rather than it being 
a regulator of iron absorption (Conrad and Umbreit, 1993). However Conrad 
et al. (1993) postulated that mucosal uptake of iron from the gut lumen was 
mediated via integrin-mobilferrin pathway; 'Dietary nonheme iron is solubilized 
at acidic pH of the stomach. At acid pH, it combines with mucins that maintain 
the iron soluble and available in the more alkaline small intestine. Integrins
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that traverse the luminal surface of the absorptive cell may facilitate the 
uptake of iron into the mucosal cell in association with mobilferrin. Mobitferrin 
is a cytosol protein that is probably important in the regulation of iron 
absorption.'
A significant correlation between serum ferritin (as an index of iron status) and 
luminal disappearances obtained for both composite of the first 2 samples 
(r=-0.807, p<0.05), and completion of collection (r=-0.725, p<0.10) was found 
(Figure-37). These correlations might suggest that luminal disappearance of 
ferrous iron is related with ferritin, as postulated by Walters et al. (1975). 
Agreement between the correlations obtained for the luminal disappearances 
of the first 2 samples composite and total collection (5 samples) could also be 
considered as evidence that a fraction of iron initially retained in the intestine 
is excreted with exfoliated mucosal cells in which ferritin is associated with the 
tracer retained in the mucosa (Marx, 1979).
60
O TWO SAMPLE COMPOSITE 
•  COMPLETION OF COLLECTION
50
40
r=—0.725
(p<0.10)
20
60 140
SERUM FERRITIN, ng mL
16060 12040 100 -I
Figure-37: Correlation between serum ferritin and luminal disappearances obtained 
for composite of the first two stools (solid line), and total collection (dashed line)
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IIII.3.5 LUMINAL DISAPPEARANCE OF IRON CONSUMED WITH A FARINA MEAL, 
DETERMINED WITH “ Fe TRACER AND Yb MARKER
Faecal recoveries of Yb marker and non-retained 58Fe tracer and luminal 
disappearance of tracer derived from the recoveries are provided in this 
section. Luminal disappearances determined for individual and composites of 
sequential samples, and for total collection following consumption of a 
standard farina meal are provided and considered with reference to the 
intestinal kinetic profiles of marker and tracer.
Recoveries and luminal disappearances have been calculated by applying 
Equatk>n-5.b (Section 1.5) to experimental data provided in Appendix-6 . 
Recoveries of Yb marker and S8Fe tracer and luminal disappearance derived 
from recoveries are provided in Tables-73.a-g. The nature of the contents of 
the tables are explained in the previous section. Recoveries of marker and 
tracer with single and composites of sequential collections are depicted as a 
function of time and provided in the accompanying Figures-38.a-g.
2 1 0
Table-73.a: Faecal recoveries of Yb marker, 58Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 1
Faecal 
sample No
Time post- 
dosing, h
Recovery, %±SD “ Fe Luminal 
disappearance, %±SD
Yb “ Fe Individual Cumulative
1 22.3 11.87±0.17 10.30±0.11 13.3±0.2 13.3±0.2
2 46.3 50.89±0.56 43.86±0.29 13.8±0.2 13.710.2
3 70.3 33.53±0.25 27.81 ±0.20 17.110.2 14.910.1
4 94.8 2.90±0.04 3.30±0.09 n.a. 14.010.1
5 118.8 0.29±0.02 0.84±0.08 n.a. 13.410.1
6 142.8 0.27±0.04 0.60±0.17 n.a. 13.H0.1
7 168.5 0.40±0.03 0.52±0.09 n.a. 12.910.1
Total, % 100.1 ±0.6 87.210.7
100 - Total “ Fe recovery 12.8±0.70%
0 20 40 80 80 100 120 140 160 180
TIME POST-DOSING, h
I 140 180
TIME POST-DOSING, h
Figure-38.a: Faecal profile of Yb marker and 58Fe tracer for individual samples and
composites of sequential output (Cumulative) for subject-1
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Table-73.b: Faecal recoveries of Yb marker, 58Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 2
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
“ Fe Luminal 
disappearance, %iSD
Yb “ Fe Individual Cumulative
1 25.7 21.87±0.05 16.7510.21 23.410.3 23.410.3
2 62.9 55.5110.27 40.3010.32 27.410.3 26.310.2
3 86.7 26.8610.06 20.6510.22 23.110.3 25.510.2
4 111.0 0.3410.01 0.6310.03 n.a. 25.110.2
5 145.4 0.0910.01 0.4310.03 n.a. 24.710.2
6 167.0 0.0410.005 0.3610.05 n.a. 24.410.2
7 195.8 0.1010.01 0.4110.06 n.a. 24.110.2
Total, % 104.810.3 79.510.5
100 - Total “ Fe recovery 20.5±0.5%
w 
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_  80
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100
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200
Figure-38.b: Faecal profile of Yb marker and 58Fe tracer for individual samples and
composites of sequential output (Cumulative) for subject-2
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Table-73.c: Faecal recoveries of Yb marker, 58Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 3
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
“ Fe Luminal 
disappearance, %iSD
Yb “ Fe Individual Cumulative
1 11.4 6.98±0.05 5.8010.10 16.910.3 16.910.3
2 23.1 22.80±0.10 18.2910.22 19.810.3 18.310.2
3 30.0 51.57±0.22 42.9610.56 16.710.2 17.610.2
4 47.5 13.04±0.11 9.1910.15 n.a. 19.210.2
5 70.9 3.17±0.05 5.0010.17 n.a. 16.710.1 .
6 80.3 0.10±0.02 0.9510.06 n.a. 15.810.1
7 96.9 0.13±0.03 0.2610.04 n.a. 15.710.1
8 124.8 0.14±0.03 0.4810.04 n.a. 15.310.1
9 142.8 0.2110.04 0.1610.09 n.a. 15.310.1
10 154.6 0.2910.05 0.6110.10 n.a. 15.010.1
Total, % 98.410.3 83.710.7
100 - Total “ Fe recovery 16.3±0.7%
100
_  80 oM
> ae ui > o
8 oo
I I Yb O Yb100 -O— 0-0M
80
8  80u
40
23O
0 20 40 60 80 100 120 140 160
TIME POST-DOSING, h
c S —  _  __ _
20 100 120 140
TIME POST-DOSING, h
160
Figure-38.c: Faecal profile of Yb marker and 5SFe tracer for individual samples and
composites of sequential output (Cumulative) for subject-3
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Table-73.d: Faecal recoveries of Yb marker, 58Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 4
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
“ Fe Luminal 
disappearance, %±SD
Yb “ Fe Individual Cumulative
1 24.0 90.41 ±0.64 66.43±0.90 26.510.4 26.510.4
2 47.9 6.87±0.05 5.85±0.21 n.a. 25.710.4
3 70.7 2.61 ±0.04 2.85±0.06 n.a. 24.810.3
4 94.1 0.92±0.02 2.5110.07 n.a. 23.010.3
5 118.0 0.10±0.01 0.89±0.12 n.a. 22.210.3
6 142.3 0.05±0.002 0.8410.12 n.a. 21.410.3
7 165.5 0.15±0.01 0.1310.02 n.a. 21.410.3
Total, % 101.1 ±0.6 79.510.9
100 - Total “ Fe recovery 20.5±0.9%
0  2 0  40  60  8 0  100 120 140 160
TIME POST-DOSING, h
I 120
TIME POST-DOSING, h
Figure-38.d: Faecal profile of Yb marker and 58Fe tracer for individual samples and
composites of sequential output (Cumulative) for subject-4
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Table-73.e: Faecal recoveries of Yb marker, 58Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 5
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
“ Fe Luminal 
disappearance, %±SD
Yb “ Fe Individual Cumulative
1 8.2 43.36±0.22 34.3110.35 20.910.2 20.910.2
2 33.3 44.68±0.29 35.3110.47 21.010.3 20.910.2
3 59.9 11.91±0.18 11.4310.22 n.a. 18.910.2
4 85.6 0.85±0.05 1.1110.03 n.a. 18.510.2
5 97.2 0.31 ±0.02 1.2810.09 n.a. 17.510.2
6 124.2 0.04±0.01 0.3510.02 n.a. 17.210.2
7 149.5 0.09±0.01 1.0110.06 n.a. 16.210.1
Total, % 101.210.4 84.810.6
100 - Total “ Fe recovery 15.2±0.6%
100
a 
_  80 
oM
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20
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Figure-38.e: Faecal profile of Yb marker and 58Fe tracer for individual samples and
composites of sequential output (Cumulative) for subject-5
0 20 40 60 80 100 120 140 160
TIME POST-DOSING, h
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Table-73.f: Faecal recoveries of Yb marker, “ Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 6
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
“ Fe Luminal 
disappearance, %iSD
Yb “ Fe Individual Cumulative
1 25.0 48.87±0.17 32.4510.31 33.610.3 33.610.3
2 48.8 42.9810.22 29.8210.37 30.610.4 32.U0.3
3 70.3 3.4610.03 2.2810.05 34.110.8 32.210.3
4 80.3 0.1210.01 0.3110.02 n.a. 32.010.3
5 94.8 0.1510.01 0.0410.01 n.a. 32.010.3
6 118.8 0.2110.01 1.0010.08 n.a. 31.210.3
7 142.1 0.2910.02 0.7210.06 n.a. 30.610.3
Total, % 96.110.3 66.610.5
100 - Total “ Fe recovery 33.4±0.5%
0  2 0  4 0  BO BO 100 120  140
TIME POST-DOSING, h
I 120
TIME POST-DOSING, h
Figure-38.f: Faecal profile of Yb marker and 58Fe tracer for individual samples and
composites of sequential output (Cumulative) for subject-6
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Table-73.g: Faecal recoveries of Yb marker, 58Fe tracer, and luminal disappearance
of iron, when consumed with a farina meal
SUBJECT 7
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
“ Fe Luminal 
disappearance, %iSD
Yb “ Fe Individual Cumulative
1 23.0 69.18±0.38 48.7010.93 29.610.6 29.610.6
2 36.8 18.6210.13 14.2510.29 23.510.5 28.310.5
3 47.8 6.4210.12 4.9110.14 23.510.8 28.010.4
4 72.3 1.7110.06 2.5210.04 n.a. 26.610.4
5 81.6 0.3110.002 0.6610.01 n.a. 26.210.4
6 94.3 0.2210.01 0.9110.04 n.a. 25.410.4
7 118.3 0.2310.01 0.6210.02 n.a. 24.910.4
8 142.3 0.2510.03 0.6710.07 n.a. 24.510.3
9 166.7 0.2410.03 0.3010.02 n.a. 24.310.3
Total, % 97.210.4 73.511.0
100 - Total “ Fe recovery 26.5±1.0%
180
Figure-38.g: Faecal profile of Yb marker and 58Fe tracer for individual samples and
composites of sequential output (Cumulative) for subject-7
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III.3.6 DISCUSSION
m.3.6.1 RECOVERY KINETICS OF “ Fe AND Yb
As can be seen from Table-73.a-g luminal disappearances (intestinal uptakes) 
derived from composites of the initial sequential samples are different from 
those derived from completion of collection (composites of 7 samples). This 
can be explained by the tracer initially retained being released at a slower rate 
after recovery of marker is completed.
For comparison of kinetic behaviour of marker and isotopic tracer excreted, 
the ratio of tracer to marker recoveries for individual samples and those 
derived from composites of sequential outputs for all subjects are provided in 
Figure-39 .
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Figure-39: Ratios of recoveries of 58Fe tracer and Yb marker for individual samples,
• ,  and for composites of sequential outputs, O, for all subjects
218
As can be seen from the above figures, for most of the subjects the ratio of 
recoveries after the second or third samples show an increasing trend which 
is more obvious for individual samples. This increase illustrates the 're- 
excretion' of the tracer. Deviations from the expected increasing trend for 
individual samples could indicate irregularities in 're-excretion' of tracer but 
they were only for samples in which recoveries of marker or tracer was less 
than 0.5%.
The magnitude of the contribution of 're-excreted' tracer to outputs obtained 
in composites of 3-7 samples can be illustrated by the difference between the 
fractions of total recoveries of tracer and marker in individual samples as 
described previously (Section III.3.4.1). The differences for individual samples 
as a function of the sequence in which faecal samples were collected are 
provided in Figure-40.
S u b je o t-lK
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Figure-40: Difference between relative recoveries (percent of their total outputs) of 
Yb marker and 58Fe tracer for all subjects
For all subjects the net differences between relative recoveries of tracer and marker
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are negative for composites of the first two samples but is usually positive for the 
following samples which contains a fraction of tracer initially retained.
Evaluation of the kinetic behaviour of Yb marker and 58Fe tracer with the above 
approaches, which are illustrated in Figure-39 and 40, suggest that the initial luminal 
disappearance, obtained from the fractions of marker and tracer recovered with 
composites of the initial two or three faecal samples, minimizes the contribution of 
retarded excretion of tracer.
The linear relation between the relative recoveries of marker and tracer with 
composites of the first two samples (since the recovery rates of marker marker and 
tracer with the first samples may not be reliable) and with the following individual 
outputs, as percent of their total recoveries for composites of the first three to five 
faecal samples and for total collection (7samples), for all subjects are provided in 
Table-74. The linearity for the composites of the first two samples is derived from the 
relative recoveries of marker and tracer obtained for composites of the first three 
samples. The linearity is also derived for the collection of five stools for which the first 
and second samples are considered as individual samples, to show the effect of the 
relative recoveries of marker and tracer obtained for the first samples, and provided 
in the table.The table contains the linearity between the recoveries and its correlation 
coefficient.
Table-74: Linearity between recoveries of Yb marker and 58Fe tracer for all subjects 
[y=(A±a)x+(B±b), where y and x are recoveries of tracer and marker, and A and B are the 
slope and intercept]
Composites Ala Bib R2
3 samples (2 samples composites & 3. samples) 0.9810.01 0.8510.42 0.999
(2 samples composites) 0.9910.02 0.1411.38 0.998
4 samples (2 samples composites & 3. and 4. samples) 0.9710.01 0.9310.35 0.989
5 samples (2 samples composites & 3., 4., 5. samples) 0.9610.01 0.8410.26 0.999
[5 samples (The first to flfith individual samples) 0.9510.01 0.9910.23 0.998]
Total collection (2 samples composites & 3.,...,7. samples) 0.9510.05 0.8210.17 0.999
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As can be seen from Table-74 that slopes of the linear relations which are 
the closest to the unity are obtained for the samples, which the relative 
recoveries obtained from composites of the first three samples or composites 
of the first two stools of the three samples composites. This indicates that 
recoveries obtained for composites of the two or three samples are the most 
appropriate for calculation of luminal disappearance with minimum effect of 
're-excretion' of isotope initially retained.
lil.3.6.2 LUMINAL DISAPPEARANCE AND SIGNIFICANCE OF RETARDED EXCRETION
The means of luminal disappearance obtained for individual (single) samples 
for which it could be calculated, for composites of the first one to six samples, 
and for total collections, togetherwith marker recoveries for the corresponding 
groups of samples are provided in Table-75.
The mean of luminal disappearances obtained for the first two or three single 
samples provided coefficients of variation of 6-15% for 6 of the 7 subjects. 
This can be explained by slight difference between kinetic behaviour of marker 
and tracer in the first samples or contribution of re-excreted tracer to the third 
samples. The difference between the mean of luminal disappearances 
obtained for composites of two and three or four samples were found to be 
insignificant (p>0 .10), whilst the differences between those obtained for the 
composites of 2-6 samples and total collection (7 samples) were significant, 
p<0.05. This indicates the effect of retarded excretion of tracer initially 
retained, as discussed above.
The differences in luminal disappearances obtained for composites of 
sequential samples, SC, (2SC and 3SC, 3SC and 4SC,.., and 6SC and 7SC) 
are provided in Figure-41, and the differences between those obtained for 
composites of sequential samples and total collection (2SC and 7SC, 3SC 
and 7SC,.., and 6SC and 7SC) are provided in Figure-42 for each subject.
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Figure-41: Differences between luminal disappearances obtained for composites of 
two to seven sequential samples with means and 95% confidence limits
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Figure-42: Differences between luminal disappearances obtained for composites of 
sequential two to seven samples and total collection with means and 95% confidence 
limits
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The mean differences between luminal disappearances obtained for the first 
2 and 3, 3 and 4,....and 6 and 7 samples were found to be 0.5±1.0, 0.5±1.1, 
0.8±0.8, 0.6±0.3, and 0.4±0.3% of the dose administered respectively. The 
differences were not significantly different from each other (p>0.05). 
Differences between luminal disappearances of composites of sequential two 
to six samples and of total collection (7 samples composite) were 2.8±1.4, 
2.3±0.8, 1.8±0.8, 1.0±0.3, and 0.4±0.3% of the dose.
The initial disappearance, in which the contribution of tracer initially retained 
is the least can be derived from the differences described above. The 
differences as a function of time of the mean of time post dosing for provision 
of the first 2,3,.., and 6 samples (42, 61, 84,105, and 125 h respectively) are 
provided in Figure-43.A and B.
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Figure-43: The mean of differences between luminal disappearances of composites 
of sequential pairs in 2-7 samples (A), [Y=-(5.9x10r*±2.9x10"3)X+(0.6±0.3), ^ 0 .0 1 3 ], and 
between those of composites of sequential 2-6 samples and total collection (B), 
[Y=(0.03±0.002)X+(4.1±0.2)] (O  indicates the differences at t=0 by extrapolation)
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From the relations between the mean differences and time post dosing, the 
difference between luminal disappearances of the initial and of composites of 
2 sequential samples can be calculated to be 0.6±0.3%, and that between 
initial and of total collection is 4.1 ±0.2% by extrapolating the linear regressions 
to t=0. By addition of these differences to the luminal disappearances 
obtained for composite of the first 2 sequential samples (23.6±6.3%) and of 
total collection (20 .8±6 .2%), the initial luminal disappearances are found to be 
24.2±6.3% and 24.9±6.2%. The initial luminal disappearances found with both 
approaches are not significantly different from that determined for composites 
of 2 sequential samples.
By considering the re-excreted fraction of the dose consumed (3 mg of iron), 
approximately 10% of 0.7 mg initially retained iron is excreted within 6 days 
of administration, at 0.01 mg per day. Dubach et al. (1955) found the average 
daily excretion over a period of 100 days was 0.01% of the dose when 5-14 
mg of iron labelled with Fe-59 was injected into 4 healthy individuals. When 
the average of daily losses from initial retention obtained for this investigation 
(-0.5%) is compared with that found by Dubach etal. (0.01 %), the losses found 
should not be the fraction of iron transferred to the blood and back to the 
lumen. This should be the fraction taken up by the intestinal mucosa and 
eventually desquamated with shedded mucosal cells. If the difference between 
luminal disappearances of composites of the first two and seven samples 
(23.6±6.3% and 20.8±6.2% of the dose) was the fraction retained temporarily, 
-90% of iron initially retained (equivalent to 0.6 mg of iron) should be absorbed.
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111.3.6.3 LUMINAL DISAPPEARANCE OF “ Fe IN RELATION TO ITS MODE OF
ADMINISTRATION AND IRON STATUS
Jasani et al. (1971) demonstrated that there was no temporary retention of 
radioactive iron (Fe-59 in ferric chloride, or citrate form) when it was given to 
healthy subjects with a meal, the absorption being measured by monitoring 
the subjects for 14 days using whole body counting. Permanent retention of 
iron was proved with reference to initial retention of iron measured with the aid 
of non-absorbable BaS04 marker labelled with radioactive Ba-131. It was 
speculated that the percentage of Fe-59 temporarily retained when retention 
of Ba-131 of less than 1 % was below the detection limit for 9 out of 10 healthy 
subjects (the exception was an individual who retained 5.7%). Jasani and 
Fletcher (1972) confirmed that iron absorption from a meal (which was 
labelled with radioactive Fe-59 as ferric chloride or citrate, and Ba-131 as 
marker) measured by whole body counting in 14 subjects, 10 days after 
administration was insignificantly different from that determined by monitoring 
faecal samples composites of samples collected for 3 days.
The results of this investigation show that temporary retention of iron is ~3% 
of the dose when the mean of luminal disappearances obtained for 
composites of the initial two samples and that obtained for composites of 
samples collected for a week is compared. Insignificant differences were 
found between luminal disappearances obtained for composites of the first 
two, three, and four samples in which marker recovery is major or nearly 
quantitative. This suggest that the initial luminal disappearance can be 
obtained from the first two, three, and four samples (2-3 days collection) with 
minimal effect of the fraction of iron temporarily retained and agrees with 
conclusion drawn by Jasani and Fletcher (1972).
Bjom-Rasmussen et al. (1972) showed that absorption from an uncooked 
wheat based meal (dough) containing 1.5 mg of iron labelled intrinsically with 
Fe-55 and extrinsically with Fe-59 as ferric chloride were not significantly
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different. The study was performed on 5 healthy subjects and they consumed 
the meal with tap water. The mean of absorption measured from blood 
samples withdrawn 2 weeks after administration and by whole body counting 
was 29.3±12.4% (range 12.9-36.9%). In this current investigation, luminal 
disappearance from a wheat based farina meal (cooked) labelled with 3 mg 
of Fe containing 58Fe tracer was determined for 7 healthy subjects. Luminal 
disappearances were 23.6±6.3 (range 13.7-32.2%) for 2 faecal sample 
composites and 20.8±6.2 (range 12.9-30.6%) for 7 sample composites. The 
absorption results for both investigations agree with similar mean and range 
for comparable nature of input.
Luminal disappearances found for composites of sequential 2-7 samples and 
serum ferritin levels of participants were also subjected to statistical evaluation 
to see if there is any significant correlation between them. Unlike the situation 
for ferrous iron consumed with a standard solution, no significant correlation 
was found (p>0.05).
III.3.6.4 LUMINAL DISAPPEARANCE OF FERROUS VERSUS FERRIC IRON
There was a significant inverse correlation between luminal disappearance of 
ferrous-iron derived from the first two and five samples composites and serum 
ferritin concentrations of the subjects. This can be explained by the amount 
of ferrous-iron temporarily retained in the intestinal lumen, or the absorbed 
fraction being related to serum ferritin concentrations. Unlike ferrous-iron, 
there was no significant correlation when intestinal uptakes for ferric-iron 
consumed with a meal were subjected to the same evaluation, as reported by 
Mason et al. (1990). In contrast a negative relation was found by Tumlund et 
al. (1990) but it was not significant, intestinal uptakes being obtained by the 
use of isotopically labelled ferric-iron with faecal monitoring. These 
contradictory correlations between serum ferritin concentration and the 
intestinal uptake for ferrous- and ferric-iron may indicate that the regulatory 
mechanism for uptake of iron depends on the oxidation state of iron or the
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composition of input (solution or meal).
Forbes et al. (1989) demonstrated that ferric-phosphate was less bioavailable 
than ferrous-sulphate (both labelled with radioactive tracer) when they were 
consumed with a farina meal, and that their absorption was enhanced by 
addition of ascorbic acid. The absorption determined for blood samples was 
inversely related with iron status (serum ferritin level). Siegenberg et al. (1991) 
reported that the inhibitory effects of polyphenols and phytates on non-haem 
iron absorption could be prevented by ascorbic acid. In contrast, results based 
on a 10 week investigation of women with low iron stores carried out by Hunt 
etal. (1994) revealed that ascorbic acid supplementation had a more modest 
effect on iron absorption from a diet with poorly bioavailable iron or a typical 
western diet than was indicated by studies with single meals. The results also 
suggested that serum ferritin was not a good indicator of short-term 
improvements in iron stores. However, Nuriez etal. (1994) speculated that a 
human intestinal epithelium cell line mediated the reduction of ferric-iron in the 
apical medium. Conrad et al. (1993) and Conrad and Umbreit (1993) 
concluded that ferritin is a storage protein which incorporates iron to prevent 
oxidative damage to the cell rather than a regulator of iron absorption.
In the light of the above considerations, the intestinal uptake of ferrous-iron, 
inversely correlated with serum ferritin level and possibly encouraged by 
added ascorbic acid, should have been more consistent at the amount initially 
taken up if the fraction taken up was transferred to circulating blood with an 
irreversible regulatory absorption mechanism based on reduction-oxidation 
chemistry. This could be explained by iron in the ferrous state being readily 
bioavailable. It is taken up by epithelial cells in the intestine and transferred 
into circulating blood [serum enrichment reaching a maximum approximately 
2 h after oral administration (Barrett et al., 1994)] whilst a considerable 
fraction initially retained with epithelial cells is exfoliated with shedded cells. 
Marx (1979) explained this mechanism by regulation of iron absorption taking 
place at least at 2 sites; at the brush border a transferrin like protein is
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responsible for rapid transport of iron from brush border to the blood (this 
pathway was defined as mucin-mobilferrin-integrin by Conrad and Umbreit, 
1993), whilst a considerable amount of iron is bound by ferritin within mucosal 
cells and is not released but desquamated with these cells in to the lumen of 
the gut. The results obtained from this investigation which indicate significant 
temporary retention support the interpretation of Marx.
The intestinal uptake of ferric-iron (chloride) was not correlated with serum 
ferritin but the amount initially retained was more consistent. The difference 
is related to its oxidation state or the composition of the mode of intake. 
Jasani et al. (1971) and Jasani and Fletcher (1972) demonstrated that 
temporary iron uptake from a solution containing ferric-chloride or -citrate 
(labelled with radioactive Fe-59 as tracer and Ba-131 as marker) and ascorbic 
acid was not significant when the solution was consumed with a standard 
meal (chicken, tomato, lettuce, and banana), but it was high when tracer was 
given with haemoglobin. Absorption of iron determined by faecal monitoring 
with marker method and by whole body counting suggested that the 
absorption of haemoglobin iron was not well regulated and occurred more 
slowly so that absorbed iron appears in the plasma later when compared with 
of inorganic iron, providing good agreement between results of the two 
measurements (for whole body counting, even 10 days after consumption). 
Jasani et al. (1971) found that temporary retention and the amount of finally 
absorbed ferric iron was the same as the amount initially retained by the 
intestinal mucosa. The intestinal uptake results for the present investigation, 
in which a farina meal labelled with stable isotopic tracer in ferric form was 
used, demonstrate that the major fraction (-90%) of iron initially taken up 
should be transferred into circulating blood. In the context of administration of 
iron with a meal, the conclusion of this investigation agrees with that drawn 
by Jasani et al. (1971).
In comparison of intestinal uptake results obtained for ferrous and ferric iron, 
ferrous iron was found to be readily absorbed in an amount depending upon
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iron status, but absorption was not as well regulated as ferric iron. The 
absorption of ferric-iron phosphate and of ferrous-iron sulphate from a farina 
meal, as indicated by Forbes et al. (1989) showed that ferrous iron is four 
times more absorbable (3.30% of 3 mg iron) than ferric phosphate (0.83% of 
3 mg iron) due to the lower solubility of iron (III) phosphate, whilst absorption 
of dissolved iron phosphate from a cocoa drink was 25% of 10 mg iron 
(Fairweather-Tait et al., 1983). The intestinal uptake of iron from a farina meal 
was found to be approximately 0.6 mg (20% of a 3 mg dose). This is less 
than the uptake of 2.5 mg (25% from 10 mg of ferric phosphate) from a cocoa 
drink described by Fairweather-Tait et al. (1983), although the fractional 
uptakes are comparable. This suggests that highly soluble iron (III) chloride 
should be more absorbable than iron phosphate in amounts comparable with 
iron sulphate. However, recent investigations have focused the use of 
NaFe(lll)EDTA as iron additive (Davidsson et al., 1994) instead of 
Na2Fe(ll)EDTA (MacPhail etal., 1994).
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III.3.7 LUMINAL DISAPPEARANCE OF ZINC CONSUMED WITH A FARINA MEAL, 
DETERMINED WITH 70Zn TRACER AND Yb MARKER
Recoveries of Yb marker and non-retained 70Zn tracer and luminal 
disappearance of tracer derived from the recoveries are provided in this 
section. Luminal disappearances determined for individual and composites 
of sequential samples, and for total collection following consumption of a 
standard meal (farina) are provided and considered with reference to the 
intestinal kinetic profiles of marker and tracer.
Recoveries and luminal disappearances have been calculated by applying 
Equatk>n-5.b (Section 1.5) to experimental data provided in Appendfx-6 . 
Recoveries of Yb marker and 70Zn tracer and luminal disappearance derived 
from recoveries are provided in Tables-76.a-g. The nature of the contents of 
the tables is explained in the previous section. Recoveries of marker and 
tracer with single and composites of sequential collections are depicted as a 
function of time and provided in the accompanying Flgures-44.a-g.
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Table-76.a: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 1
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %±SD
Yb 70Zn Individual Cumulative
1 22.3 11.87±0.17 7.20±0.36 39.3±2.0 39.3±2.0
2 46.3 50.89±0.56 33.49±0.89 34.2±1.0 35.2±0.9
3 70.3 33.53±0.25 22.18±0.63 33.8±1.0 34.7±0.7
4 94.8 2.90±0.04 n.d. n.a. 36.6±0.7
5 118.8 0.29±0.02 n.d. n.a. 36.8±0.7
Total, % 99.5±0.6 62.9±1.1
100 - Total 70Zn recovery 37.1±1.1%
20 40 60 80 100 120
TIME POST-DOSING, h
100
TIME POST-DOSING, h
Figure-44.a: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-1
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Table-76.b: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 2
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %±SD
Yb 70Zn Individual Cumulative
1 25.7 21.87±0.05 13.7910.50 36.9H.3 36.911.3
2 62.9 55.51 ±0.27 36.9710.96 33.410.9 34.410.7
3 86.7 26.8610.06 17.1810.53 36.011.1 34.810.6
4 111.0 0.34±0.01 0.8510.07 n.a. 34.210.6
5 145.4 0.0910.01 n.d. n.a. 34.310.6
Total, % 104.710.3 68.811.2
100 - Total 70Zn recovery 31.2±1.2%
0 20 40 SO 80 100 120 140
TIME POST-DOSING, h
I 120
TIME POST-DOSING, h
Figure-44.b: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-2
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Table-76.c: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 3
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %1SD
Yb c
N£
Individual Cumulative
1 11.4 6.98±0.05 4.2910.55 38.615.0 38.615.0
2 23.1 22.80±0.10 15.98±0.52 29.911.0 31.911.2
3 30 51.57±0.22 35.1111.33 31.9H.2 31.910.9
4 47.5 13.04±0.11 8.3810.33 35.711.5 32.510.8
5 70.9 3.17±0.05 n.d. n.a. 34.710.9
6 80.3 0.10±0.02 n.d. n.a. 34.710.9
Total, % 97.710.3 63.811.6
100 - Total 70Zn recovery 36.211.6%
TIME POST-DOSING, h
80
TIME POST-DOSING, h
Figure-44.c: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-3
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Table-76.d: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 4
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %±SD
Yb 70Zn Individual Cumulative
1 24 90.41 ±0.64 51.60±1.11 42.911.0 42.911.0
2 47.9 6.87±0.05 3.92±0.11 42.911.3 42.910.9
3 70.7 2.61 ±0.04 0.9310.05 n.a. 43.510.9
4 94.1 0.92±0.01 0.6410.03 n.a. 43.410.9
5 118 0.10±0.01 n.d. n.a. 43.410.9
Total, % 100.9±0.6 57.1±1.1
100 - Total TOZn recovery 42.9±1.1 %
0 20 40 60 BO 100 120
TIME POST-DOSING, h
100
TIME POST-DOSING, h
Figure-44.d: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-4
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Tab!e-76.e: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 5
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %±SD
Yb 70Zn Individual Cumulative
1 8.2 43.36±0.22 21.86±0.48 49.6±1.1 49.6±1.1
2 33.3 44.68±0.29 19.45±0.34 56.5±1.1 53.1 ±0.8
3 59.9 11.91±0.18 5.79±0.23 51.4±2.2 52.9±0.7
4 85.6 0.85±0.05 0.42±0.03 50.6±5.0 52.9±0.7
5 97.2 0.31 ±0.02 n.d. n.a. 53.0±0.7
Total, % 101.1±0.4 47.5±0.6
100 - Total 70Zn recovery 52.5±0.6%
TIME POST-DOSING, h
TIME POST-DOSING, h
Figure-44.e: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-5
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Table-76.f: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 6
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %1SD
Yb 70Zn Individual Cumulative
1 25 48.87±0.17 27.5910.76 43.511.2 43.511.2
2 48.8 42.98±0.22 25.52l0.70 40.611.1 42.110.8
3 70.3 3.4610.03 1.4810.1 n.a. 42.710.8
4 80.3 0.1210.01 n.d. n.a. 42.710.8
5 94.8 0.1510.01 n.d. n.a. 42.810.8
Total, % 95.610.3 54.611.0
100 - Total 70Zn recovery 45.4±1.0%
TIME POST—DOSING, h
Figure-44.f: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-6
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Table-76.g: Faecal recoveries of Yb marker and 70Zn tracer, and luminal
disappearance of zinc, when consumed with a farina meal
SUBJECT 7
Faecal 
sample No
Time post- 
dosing, h Recovery, %±SD
70Zn Luminal 
disappearance, %±SD
Yb 70Zn Individual Cumulative
1 23 69.18±0.38 47.58±1.41 31.2±0.9 31.2±0.9
2 36.8 18.62±0.13 12.50±0.44 32.9±1.2 31.6±0.8
3 47.8 6.42±0.12 4.32±0.27 32.6±2.1 31.6±0.7
4 73.3 1.71 ±0.06 1.75±0.14 n.a. 31.0±0.7
5 81.6 0.31 ±0.002 0 .1 1 ±0 .0 1 n.a. 31.1±0.7
Total, % 96.2±0.4 66.3±1.5
100 - Total 70Zn recovery 33.7±1.5%
TIME POST—DOSING, h
TIME POST-DOSING, h
Figure-44.g: Faecal recovery profile of Yb marker and 70Zn tracer for individual
samples and composites of sequential output (Cumulative) for Subject-7
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III.3.8 DISCUSSION
111.3.8.1 RECOVERY KINETICS OF 70Zn AND Yb
As can be seen from Table-76.a-g luminal disappearances (intestinal uptakes) 
obtained for the second, third, and even fourth individual samples are not 
significantly different from those of composites of 2-5 sequential samples. The 
deviations obtained for the first samples, particularly for the samples in which 
recovery of marker is less than 40%, suggest that at least two the first two 
samples should be collected to evaluate the fraction initially retained.
For comparison of kinetic behaviour of marker and isotopic tracer excreted, 
the ratio of tracer to marker recoveries for individual samples and those for 
composites of sequential outputs for all subjects are provided in Figure-45.
S
20
Subject—1 S u b je c t-2 S ub ject-3 Subject—4 Subject—6 S ub ject-a S u b je c t-7
e£ 15
I  » 
i
I s
1.0 0 - 1-
0.75
Of iOOe a o o© ® o o
o o o9 0 0 0
0.00
1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  1 2 3 4 5
FAECAL SAMPLE SAMPLE NO (o r COMPOSITES OF *n* SAMPLES)
Figure-45: Ratios of recoveries of 70Zn tracer and Yb marker for individual samples,
6 , and for composites of sequential outputs, O, for all subjects
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The ratio of recoveries are constant for composites of the first two to five sequential 
samples. Irregular deviations for individual samples (usually after the third samples) 
can be explained by the enrichment of isotopic tracer over natural level of the isotope 
being below the limit of detection or that determined less than 1 % of the dose, with 
recovery of marker being only a few percent of the dose. The magnitude of the 
differences between marker and tracer as a function of the sequence in which faecal 
samples were collected after consumption of marker and tracer are provided in 
Figure-46, as described previously.
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Figure-46: Differences between recoveries (as percent of their total outputs) of 70Zn 
tracer and Yb marker for all subjects
As can be seen from the figures differences are much less than was obtained for iron 
and do not show a regular trend which could be indicative of re-excretion of tracer 
initially retained. The magnitude of differences also indicate the differences in kinetic 
behaviour of marker and tracer are small and insignificant.
The linear relation between the relative recoveries of Yb marker and 70Zn tracer with 
composites of the first two samples (since the recovery rates of marker and tracer
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with the first samples may not be reliable) and with the following individual outputs, 
as percent of their total recoveries for composites of the first three to five faecal 
samples for all subjects are provided in Table-77. The linearity for the composites of 
the first two samples is derived from the relative recoveries of marker and tracer 
obtained for composites of the first three samples. The linearity is also derived for the 
collection of five stools for which the first and second samples are considered as 
individual samples, to show the effect of the relative recoveries of marker and tracer 
obtained for the first samples, and provided in the table. The table contains the 
linearity between the recoveries and its correlation coefficient.
Table-77: Linearity between recoveries of Yb marker and 70Zn tracer for all subjects 
[y=(A±a)x+(B±b), where y and x are recoveries of tracer and marker, and A and B are the 
slope and intercept]
Composites Ala Bib R2
3 samples (2 samples composites & 3. samples) 1.0110.01 -0.6210.18 1.000
(2 samples composites) 1.0110.01 -0.70i0.58 1.000
4 samples (2 samples composites & 3. and 4. samples) 1.0110.01 -0.3110.28 0.999
5 samples (2 samples composites & 3., 4., 5. samples) 1.0110.01 0.3010.25 0.999
[5 samples (The first to ftfith individual samples) 1.0210.01 -0.38l0.29 0.997]
As can be seen from Table-77 that slopes of the linear relations which are the closest 
to the unity are obtained for all composites. This suggests that luminal 
disappearances derived from the recoveries obtained for composites of the two or 
three samples should not be significantly different from those obtained for the 
following composites.
111.3.8.2 DISCUSSION OF LUMINAL DISAPPEARANCE OF ZINC
The results for intestinal uptakes (luminal disappearances) of 70Zn tracer determined
with Yb yield correction are provided in Table-78. The table contains the results for
individual samples where available and for composites of the first to fifth sequential
samples. The recoveries of marker with the corresponding composites are also
provided.
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As can be seen from the table the mean of luminal disappearances for the first two 
samples composites is 38.7±7.8. This is not significantly different from the means for 
composites of the first one, three, four, and five samples and individual stools, 
p>0.10. The initial two sample composites were chosen as the reference for 
comparison since the mean of uptakes for the first samples showed a slight positive 
bias when compared with that for the composites of initial two sample, which may be 
explained by temporary mucosal trapping of the uptake of tracer from the lumen.
For 2 samples composites, intestinal uptake of 38.7% is equivalent to uptake of 1.1 
mg of Zn for an input of 3 mg. For consumption of 3 meals per day containing 
comparable levels of Zn (or a total of 9 mg), the daily uptake of zinc would be 3.3 
mg. The amount taken up is comparable to the amount endogenously secreted and 
so obviously replaces the losses, as found by Tumlund et al. (1984).
The range of absorption from different dietary intakes using different methods of 
measurement, as provided by different authors are provided in Table-79. The 
agreement between the absorption results provided by Couzy et al. (1993) and this 
investigation (39.2±9.8% range 27.5-54.2% and 38.7±7.8% range 31.6-53.1%) are 
worthy of note. The dietary intake had similar constituents with comparable levels of 
zinc.
In conclusion, intestinal uptake of zinc from a farina meal labelled with 70Zn tracer 
and Yb marker was determined from composites of sequential two to five faecal 
samples. Difference between intestinal uptakes obtained for the composites were 
insignificant, which agreed with the findings provided by Flanagan et al. (1985) where 
radioactive tracer (Zn-65) and marker (Cr-51) were used. The best approach for 
determination of intestinal uptake is the determination in the first 2  consecutively 
accumulated stool samples (recovery of marker as the mean of Yb recoveries for 7 
subjects was 76±23% provided in 42±14 h post-dosing), which minimise the possible 
effects of temporary retention and re-excretion.
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Table-79: Summary of measurements of absorption of zinc (WBC: whole body
counting, FM and UM: faecal and urine monitoring)
Subject no 
(sex)
Absorptk>n,%±SD
(Range)
Dose, mg 
Intake mode Method of analysis Reference
5 (M) 29.6±4.9
(21.7-39.5)
Zn-65
(Breakfast)
Zn-65 in blood Spencer, 1965
8(F) 46.0114.5' Basic formula 
11 mg/d labelled 
with mg 70Zn
FM by NAA King, 1978
5 (M) 61*
(41-79)
2 mg of ZnS04 
labelled with 69mZn 
in solution
^Zn in blood Molokhia, 1980
5' 58126' 3 mg Zn labelled 
with Zn-65
WBC and FM Payton, 1982
10 (M) 57.1118.5
(16-89)
7-11 mg/d Zn with 
chicken etc. 
labelled with 70Zn 
and 88Zn
FM by NAA Janghorbani et 
al, 1982
8 (M) 82.1110.6
(61-93)
1.5-15 mg dose 
dependent input 
labelled with 70Zn
FM by NAA Istfan et al, 1983
1 (M) 38.7113.4
(20.7-57.8)
5 mg Zn labelled 
with 67Zn , 
intravenous
FM by TIMS Jackson et al, 
1984
4 (M) 34.0112.5
(21.9-51.3)
15 mg/d labelled 
with 87Zn, egg 
albumin protein 
diet
FM by TIMS Tumlund et al, 
1984
15(F) 27.418.7
(14.3-43.2)
5.711.0 mg/d Zn 
labelled with 87Zn 
and 70Zn, milk and 
formula diet
FM by ICPMS Egan, 1991
4 (2M, 2F) 61.013.0
(57-65)
2 mg 70Zn in 
solution
FM by NAA Wastney et al, 
1991
4 (3M, 1F) 49.8122.9
(24-70)
9i4 mg/d Zn 
labelled with 3mg 
of 70Zn or 4mg of 
88Zn, oral and iv 
simultaneously
UM by FAB-SIMS Friel et a l, 1992
11 (M) 31.1111.8
(10-57)*
3 mg Zn labelled 
with 2 mg 87Zn in 
chicken sandwich 
and 1.5 mg 70Zn 
intravenous
FM by TIMS Fairweather-Tait 
etal, 1992
9 (M) 38.919.8
(27.5-54.2)
1.84 mg Zn 
labelled with 0.8 
mg 70Zn in milk, 
butter and jam with 
rolls
FM by TIMS Couzy et al, 1993
7 (6 M, 1F)
------- FTTZ---- C-----=
38.717.8
(31.6-53.1)
3 mg Zn labelled 
with 1 mg of°Zn, in 
Farina meal
FM by NAA This study
* No absorption results available for each subject
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Payton et al. (1982) determined the 'absorption' of zinc, administered as 
solution, from the first three consecutive faecal samples, re-entry of initially 
absorbed dose being assumed to be 1 % d'1 and insignificant. The authors 
used radioactive Zn-65 as tracer and Cr-51 as non-absorbable marker. 
Flanagan et al. (1985) used the same tracer and marker to investigate zinc 
uptake from a solution and a test meal by taking account of the marker and 
tracer contents of the first stool samples which contained >10% of marker. 
Results of both studies showed that intestinal uptake of zinc could reliably be 
determined by faecal monitoring and results were confirmed by whole body 
counting. However the associated exposure to radiation was a continuing 
limitation (Flanagan et al., 1985 estimated the radiation dose to be 500 pSv 
assuming 50% of Zn-65 was absorbed).
The absorbed amount of the extrinsic addition should be the same as the 
natural zinc content of the food. Janghorbani et al. (1982) compared 
absorption of extrinsically added zinc with that of chicken meat tagged 
intrinsically. It was concluded that the extrinsic tag approach was valid for 
measurement of bioavailibility of dietary zinc in human subjects where the 
difference between intrinsic and extrinsic labels was relatively small (6-11 %) 
and could be attributable to a systematic bias inherent in NAA. Fairweather- 
Tait et al. (1991) showed that despite the food itself having a more profound 
effect on apparent zinc absorption, extrinsically and intrinsically labelled foods 
may provide different answers. In contrast, the results based on determination 
of zinc absorption from milk based diets in adult human subjects indicated that 
the technique of extrinsic labelling could be valid (Egan et al., 1991). Egan et 
al. found no significant difference between intrinsic and extrinsic labels, even 
though inter-subject variation was relatively high. It is also worth mentioning 
that Couzy et al. (1993) showed that the different amounts of zinc in two test 
meals (2.74 vs 1.84 mg Zn) had no significant influence on results unless the 
extrinsically added zinc exceeded 4.5 mg. The study was based on the 
comparison of zinc absorption (in elderly and young men) from a high 
bioavailibility test meal with a low bioavailibility test meal.
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Additional questions related with the physiological process of intestinal uptake 
of zinc when determined with isotopic tracers (radioactive or stable) are: 1) the 
amount of the endogenous contribution to total faecal output during the 
sample collection period and 2 ) the degree of uptake of the dietary mineral 
from the lumen which is temporarily trapped in the mucosal cells and 
subsequently excreted in faeces.
The endogenous contribution to total faecal output is considerable, ranging 
from 2.2 mg to 5.4 mg, which is approximately equivalent to daily zinc 
absorption (Tumlund et al., 1982, 1984, and 1986). The average faecal 
excretion of intravenously administered radioactive Zn-65 has been found to 
be 12.8% over 12 days, whereas the average excretion in urine was 1.6% 
(Spencer et al., 1965). The mean excretion of intravenously administered 70Zn 
was found to be 7.5% in collection of faeces for 5d and 0.9% d‘1 seven day 
post-injection whereas it had fallen to 0.3% at 20-21 d in healthy adult men 
(Fairweather-Tait et al., 1992). By the use of faecal tracer excretion results 
from the former study, the authors and Swanson et al. (1983) indicated the 
difference between apparent and true absorption was minimal and insignificant 
when endogenous losses are small. In order to avoid overestimation of the net 
absorption of tracer, which required complete collection of faecal samples 
containing all unabsorbed isotope, Solomons et al. (1982) suggested that 
collection of five consecutive stools after oral administration would be 
sufficient to collect all unabsorbed stable isotopic tracer. Changes in the 
amount of isotopic tracer in faecal samples due to re-entry to the faecal pool 
of absorbed tracer in this period would not be detectable.
Solomons et al., 1982 have suggested that the fraction of zinc trapped in 
mucosa may be involved in normal intestinal regulation of zinc absorption. In 
an investigation considering the relation of zinc absorption with the vitamin B-6 
content of diet, Tumlund et al. (1991) found that the serum zinc increased 
linearly with vitamin B-6 . It was concluded that zinc was sequestered within 
the gastro intestinal tract or elsewhere, and not transferred to the blood when
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vitamin B-6 was depleted. This suggests that a fraction of zinc taken up might 
be trapped in the intestinal mucosa, depending on regulatory factors of zinc 
absorption.
The results of above considerations for physiological influences in 
determination of 'zinc absorption' assume 'apparent absorption' to be nearly 
equivalent to 'true absorption'. However almost all authors agree that the 
endogenous losses (secretion) play an important role in the homeostasis 
(Tumlund et al., 1982, Sian et al., 1993, and Lee et al., 1993). Considering 
this, it seems that determination of zinc uptake from a diet labelled with stable 
isotopic tracer based on determination of faecal disappearance in composite 
of the first 2 samples, the effects of both the endogenous contribution and 
temporary mucosal retention would be minimized.
Results for the intestinal uptake of zinc were consistent and the results 
obtained from the first 2 sample composites were not significantly different 
from those obtained from 3,4, or 5 sample composites. Unlike ferrous-iron, 
there was no correlation between ferritin and the intestinal uptake results, 
although a recent investigation carried out by Yokoi et al. (1994) implies a 
possible relation.
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IV. CONCLUSION
To confirm that orally administered rare earths are not absorbed, faecal 
recoveries and recovery profiles of five selected rare earths (La, Sm, Eu, Tb, 
and Yb) have been investigated.
The suitability of rare earths for use as recovery indicators in determination 
of luminal disappearance of trace elements with enriched stable isotopic 
tracers has been considered, with particular attention to the possibility of 
determination of uptake from reduced faecal collection. The luminal 
disappearance of iron from a standard solution and from a wheat flour based 
farina meal, and of zinc from the meal were investigated with different rare 
earth markers (Sm and Yb) for each mode of intake.
Rare earth recoveries
Mean faecal recoveries of the 5 selected rare earths were found to be 
93.8±6.1 % for initial investigation on 2 subjects and 94.1 ±4.2% for 6 subjects. 
The insignificant difference between recoveries obtained for each of rare 
earths; coefficients of variation were 1% for the initial and 0.5% for the second 
investigation. Recoveries of Sm, Eu, Tb, and Yb were not significantly different 
each other (p>0.05), but those of La were different from the other rare earths 
(p<0.05) until account was taken of baseline levels. Concentrations of La 
determined in faecal samples provided at the end of the collection period were 
not significantly different from those determined in baseline samples. These 
imply that incomplete recovery is due to losses during sample collection or 
sample processing and that the losses due to absorption are less probable.
Quantitative recoveries of rare earths were obtained for Sm and Yb in the 
isotopic application, with total subject cooperation, the use of an improved 
faecal collection system, and improved analytical procedures. Mean recoveries 
were 102.8±3.0% for Sm and 100.1 ±3.1% for Yb. By comparing the level of 
the rare earths in urine samples before and after consumption, it was evident
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that absorption of Sm consumed with a solution was low (<1%) whilst no 
absorption was found for Yb consumed with the meal.
Mean recoveries of rare earths are provided in Table-80. The results for 
recoveries of rare earths obtained by Luckey et al. (1977) and of Dy, which 
was used by Schuette etal. (1993) for determination of absorption of Zn, Cu, 
and Mg whilst the present investigation was in progress are also provided for 
comparison.
Table>80: Summary of faecal recoveries of rare earths
Number of Recovery of RE, % of dose
Rare earth subjects (Sex) Mean±SDM Range Median Reference
Mean of 5 RE 4 (M) 93.7±10.7 84.6-109 87.4 Luckey et al, 1977
m 3(M) 88.4±6.2 82.7-95.0 87.4 w
i i 2(M) 93.816.0 89.5-98 - This study
n 6 (5M, 1F) 94.214.4 88.1-101 94.5 H
Dy 6 (4M, 2F) 10312 92-108 104 Schuette et al, 1993
i f i f 10515 96-128 103 N
Sm 7 (6M, 1F) 10313 99.5-108 102 This study
Yb •1 10013 96.1-105 100 I f
Recoveries of 5 selected rare earths obtained in this investigation are higher 
than those obtained by Luckey et. al (1977). The coefficient of inter element 
variation was less than 1% (for all subjects) whilst Luckey et. al (1977) 
obtained coefficient of variation of 5%. Recoveries of Sm and Yb used in the 
isotopic applications were nearly quantitative for all subjects for the present 
investigation, those of Dy reported by Schuette et. al (1993) were also 
reported to be quantitative but some of the results, which were >100%, were 
explained as being due to inherent errors in administration and quantification.
From recovery profiles of rare earths for all subjects, it can be seen that the 
rare earths appear in the first 24 hours after consumption, and reach a 
maximum in 48 hours. Recovery of the major fraction is obtained with the first
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two samples provided after administration; the recoveries ranged 45-82% for 
the initial investigation, 43-97% (median: 84%) for the extended investigation, 
25-98% (median: 92%) for Sm and 30-96% (median: 86%) for Yb for the 
isotopic application. Rare earth recoveries with the first 3 samples collected 
following consumption were not significantly different from recoveries with 4-5 
samples in all investigations. However, in the case of Sm which was 
consumed with a drink, mean of recoveries were almost quantitative by the 
first two samples. This suggests that the intestinal passage rate is faster after 
consumption of a solution than after consumption of a meal. The time of the 
first appearance for Sm consumed with a solution ranged 3.4-24.1 h (median: 
7.2 h) compared with 7.7-28.7 h (median: 12.3 h) for Yb received with a meal.
Measurement of intestinal uptake of trace elements by the use of isotopic 
tracers and rare earth markers
The luminal disappearance of tracer isotopes obtained from the results of 
analysis of single samples, for composites of sequential output, and for total 
collections were evaluated for evidence of comparable behaviour of tracers 
and markers and to ascertain the minimum faecal output required to reliably 
determine uptake.
For iron consumed in solution or with a meal, ratios of tracer to marker 
obtained for composites of the first two and three samples were constant. For 
the following composites, the ratios increased due to retarded excretion of 
tracer initially taken up. This increase was more significant for iron consumed 
with a standard solution compared with that for iron consumed with the meal. 
For zinc, there was no significant difference between tracer to marker ratios 
obtained for composites of the first two to five samples indicating insignificant 
retarded excretion of the tracer.
The significance of differences in the kinetic behaviours of each tracer and 
marker were calculated as differences between their relative recoveries 
(fractions of total output) for all subjects, for each of one to five individual
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faecal samples and are provided in Figure-47.
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Figure-47: Means and deviations of differences between relative faecal recoveries 
of 57Fe and Sm (with a standard solution) and “ Fe, 70Zn and Yb (with a meal) for 7 
subjects
The mean of luminal disappearances obtained for iron and zinc for all 
subjects, obtained for composites of the first one to five sequential samples 
are provided in Table-81.
Table-81: Luminal disappearance and recoveries of markers for composites of 1-5 
samples (mean±SDM for 7 subjects)
Tracer 1 sample
^Fe, with solution 24.0±16.8  
“ Fe, with meal 23.5±7.1
70Zn, with meal
Sm, with solution 
Yb, with meal
Luminal disappearance for composites of 1-5 samples, %±SD
2 samples 3 samples 4 samples 5 samples
30.7±16.4 28.8±15.1 24.8±16.3 22.9±17.2
23.6±6.3 23.1±6.2 22.6±5.9 21.8±6.4
40.3±5.8 38.7±7.8 38.9±7.8 39.0±7.7 39.4±7.5
Marker recovery, %
36±30 86±24 98±12 102±3 102±3
42±31 76±23 96±7 99±4 100±3
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Luminal disappearances obtained from the first samples after consumption of 
the solution were not reliable. This was more obvious for the first samples in 
which recovery of marker was 20% or lower. For iron and zinc consumed with 
a meal, mean of luminal disappearances obtained for the first samples was 
not significantly different from those of the first two sample composites. The 
difference was significant for some subjects when recovery of marker with the 
first sample is less than 40%.
The initial intestinal uptake of iron in which contribution of retarded excretion 
of tracer is minimal was obtained from composites of the first two samples. 
The uptakes obtained for composites of the first three (or the first three or four 
for iron with a meal) samples were also not significantly different from that of 
initial uptake, p>0.05. Uptakes for zinc found for the first one to five samples 
composites were constant, p>0.10. This agrees with the conclusion drawn by 
Schuette et. al (1993), who also investigated applicability of dysprosium for 
determination absorption of Mg and Cu using enriched stable isotopic tracers. 
The results showed that the approach for Mg was as applicable as for Zn, but 
significant difference between absorption of Cu obtained from composites of 
initial samples and total collection was associated with re-excretion of tracer.
Conclusion
1. Investigations performed to confirm the non-absorbability of rare earths 
demonstrate that rare earths can be recovered quantitatively with total subject 
cooperation and attention to sample processing. Agreement between 
recoveries of the 5 selected rare earths indicates that differences of 
absorbability between the rare earths are negligible, confirming reproducibility 
of the results when any of member of this element group is used.
With attention to sample collection, recoveries were quantitative when two rare 
earths (Sm and Yb) were applied to measurement of intestinal uptake of iron 
and zinc. The quantitative recoveries obtained suggest that rare earths could 
be used as markers in preference to PEG, which is commonly used and for
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which losses due to hydrolysis, fermentation, and absorption (Egan et al., 
1991) prevent reliable recovery measurement.
2. From analysis of individual faecal samples, recoveries of the rare earths for 
composites of the first three samples were nearly quantitative. The times of 
first appearance were significantly different for rare earths consumed with a 
solution and with a meal. This difference suggest that the rare earths could 
be used to determine intestinal transit times of various types of intake. 
Comparative studies could be earned out to investigate the effect of intestinal 
kinetics on absorption, such as investigation of the relation between the time 
available for digestion and microbic utilization and intestinal passage time by 
addition of a different rare earth to each substance consumed. Recovery 
profile and intestinal kinetic of rare earths could also provide information on 
time dependent biological variations in studies of intestinal physiology.
3. Results obtained from determination of the luminal disappearance of 
ferrous-iron consumed with a drink demonstrate that initial luminal 
disappearance can be determined from composites of the first two faecal 
sample. Composites containing samples collected beyond the second include 
a significant amount of retarded excretion of tracer. The coefficient of variation 
for the mean of results for composites of the first two to five samples, each 
composite being mean of 7 subject, was 13.4%.
The luminal disappearance of ferric-iron consumed with a meal was found to 
be more consistent when the results were obtained from the first one to seven 
consecutively accumulated samples. The coefficient of variation for the mean 
of results for composites of the first two to five samples, each composite being 
mean of 7 subject, was 3.3%.
The use of markers should enable investigation of the effect of oxidation state 
(e.g. Fe, Se) and/or the mode of intake of a trace element on intestinal 
uptake. Such investigation could be carried out for portions of a diet
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administered at an interval of a few days to avoid possible isotopic exchange, by 
labelling with different stable isotopic tracers in different oxidation states with a rare 
earth marker for each.
4. The main concern of this investigation has been determination of intestinal uptake 
by faecal monitoring so that information for the fate of tracer taken up from the 
intestinal has not been provided. Significant correlation was found between serum 
ferritin and luminal uptake of ferrous iron (invetigated by using a tracer consumed in 
a solution containing ascorbic acid) but not for ferric iron (investigated by using a 
tracer in farina meal). This may be explained by there being two different absorption 
mechanism for each of the oxidation states. Determination of the amount of tracer 
taken up from the intestinal lumen and the fraction appearing in the blood, and their 
relation with ferritin levels could provide more information on the absorption 
mechanism.
5. For zinc, luminal disappearances derived from composites of the first one to five 
consecutively accumulated samples were found to be very reproducible. The 
coefficient of variation for the mean of results for composites of the first two to five 
samples, each composite being mean of 7 subject, was 0.8%.
Application of the use of multiple stable isotopic tracers for determination of intestinal 
uptake of zinc is limited since the amount of endogenously excreted tracer could 
be considerable when an enriched tracer of high natural abundance is used. 
Available isotopes are 70Zn and 67Zn with abundances of 0.6% and 4.1%, with the 
next lowest abundant isotope being 68Zn with an abundance of 18.6%. Assuming 
50% of a dose is absorbed and 75% of the unabsorbed fraction is recovered with 
collection of faeces for 2  days (or 2  samples), to produce a 1 0 % enrichment over 
a 30 mg natural zinc content, the required doses will be 1.6 mg for 68Zn, 2.2 mg for 
66Zn with 28% abundance, and 3.9 mg for 64Zn with 47.8% abundance. Without 
limited collection the doses for high abundant isotopes will exceed the physiological 
dose, or long-term cumulative endogenous secretion could compromise
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subsequent measurements and precision. This advantage obtained with 
reduced faecal sample collection by the use of rare earths markers could be 
extended to other essential trace elements where multi isotopic applications 
are required.
6 . As used in this investigation, the required doses of saFe (0.28% abundant) 
and 70Zn (0.6%) were 1 mg for extrinsic labelling of a diet. By the use of rare 
earth markers, which enable reduced faecal collection, the required doses of 
tracers could be reduced to 0.1 mg, which would enable their determination 
with satisfactory precision in two day sample pools. For such application, 
0.05-0.1 mg of rare earth marker would be sufficient for precise determination 
in the two day pool, where >60% of the dose is expected to be recovered. 
This reduction from the above used dose would provide two major 
advantages; 1) The cost of stable isotopic tracers for applications in mineral 
absorption investigations would be reduced proportionally, so that 
investigations could be extended to field investigations involving greater 
number of subjects, 2) Possible dose related effects of added stable isotopic 
tracers on absorption from the natural content would be reduced.
In this context, the following essential elements for which 'absorption' has 
been determined using stable isotopic tracers with faecal monitoring offers 
potential for future investigations; Copper (Johnson et al., 1988, Tumlund, 
1990), Calcium (Janghorbani et al., 1981, Yergey et al., 1990), Magnesium 
(Schwartz, 1982), Selenium (Patterson et al., 1989), and Molybdenum 
(Tumlund etal., 1995).
By addition of rare earths markers to different inputs, containing different 
elements, investigation of inter element effects (with reduced collection) 
should also be possible.
7. For investigations which require radioactive tracers (usually involving whole 
body counting) or methods based on measurement of tracer incorporated in
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tissue associated with faecal monitoring (dual radio-isotopic tracers, one tracer 
and the other inert marker), the use of inactive rare earth would avoid the 
contribution of markers to radiation exposure.
In conclusion, the use of rare earths as non-absorbable markers in studies of 
absorption of essential elements by faecal monitoring enables determination 
of intestinal uptake with reduced faecal collection. In this investigation, all 
single faecal outputs were analyzed to establish output profiles and 
tracer/marker comparability. In future practical applications, analysis would be 
simplified by processing of pooled outputs. Errors which can arise from 
incomplete sample collection are accounted for by measurement of marker 
recovery, and the ability to determine intestinal uptake from a limited faecal 
output is more acceptable by subjects. This advantage makes investigations 
based on the use of stable isotopic tracers more economic so that field 
research should be possible. Applicability of the rare earths for determination 
of intestinal uptake of iron and zinc has been undertaken in this investigation 
to demonstrate their use in multi-element and -isotope applications. For wider 
applications to the other trace elements, further investigations of the intestinal 
kinetic behaviour of such element in relation to that of rare earth markers 
would be required. For iron and zinc further investigations of absorption in 
children and in unconfined situations could be performed.
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APPENDICES
appendix-1: Information and consent form for subjects who participated in
investigation of determination of faecal recovery of rare earths
INFORMATION FOR VOLUNTEER
1 .ln the established method for determination of trace element absorption using 
stable isotopic tracers, with absorption determined by the difference between input 
and faecal output, measurement of complete output requires accumulation of ail 
faecal output over a period of days. By addition of an inert marker to the tracer dose, 
determination of marker in faeces facilitates measurement of recovery and 
determination of absorption from limited faecal collection, which enables application 
of the method to unconfined situations.
2 .The rare earths are suitable potential markers for such application, having been 
demonstrated to be non-toxic and not absorbed from the gastro-intestinal tract. The 
initial intention is to extend previous studies of the rate of throughput of such 
markers, with pre-irradiation separation where appropriate, to reduce radiation 
exposure whilst processing samples and reduce the limit of detection. On 
identification of the acceptable limited collection, the method will be applied to studies 
of the absorption of essential trace elements. The initial investigation has been 
approved by the Joint Ethical Committee of Grampian Health Board, since it is being 
carried out in association with the Department of Child Health and Nutrition, 
University of Aberdeen.
3. Volunteers are required to consume a marker solution with their Monday lunch,and 
to bring faecal collections to the laboratory for analysis over a period of a week. For 
this part of the investigation, it is important that no output be overlooked. The marker 
solution will have an acid taste, but will not be unpleasant, and sample odours should 
be adequately contained in the collection procedure.
4. When the marker solution is consumed, it should be followed by drinking two water 
rinses of the container, to ensure total consumption. Volunteers will be provided with
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a ring which fits beiow a toilet seat, numbered biohazard bags which can be attached 
to the toilet-ring with an O-ring, bag sealing wires, a sealable polythene bowl, and a 
record card.
A bag should be securely attached to the toilet ring (check by giving slight pull) to be 
available when required. The ring should be located on the toilet so that the bag 
collects faeces but not urine. If there are significant solids on paper, these should be 
added to the bag. On completion, the bag should be separated from the ring, closed 
with the twist-wire, and further contained in the polythene bowl. The date and time 
of movement, and bag marker should be entered on the record card, and the sample 
provided to me, I will return the container for further use.
Thank you for your cooperation.
CONSENT BY VOLUNTEER
I understand that this investigation, which has been fully explained to me, is part of 
a research project which has been approved by the Joint Ethical Committee of 
Grampian Health Board, and may be no benefit to me personally.
I consent to participate in the study, and understand that I am free to withdraw if I so 
desire.
Signature of volunteer: Date: 10.10.1992
I confirm that I have explained to the volunteer named above, the nature and purpose 
of the investigation.
Signature of investigator.
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appendix-4: Information and consent form for subjects who participated in 
investigation of determination of intestinal uptake of trace elements using stable 
isotopic tracers and rare earth markers
INFORMATION FOR VOLUNTEERS
In the established method for determination of the absorption of trace element using 
stable isotopic tracers, with absorption determined by the difference between input 
and output, measurement of complete output requires accumulation of all faeces over 
a period of days. By addition of an inert marker to the tracer dose, determination of 
marker in faeces facilitates measurement of recovery and determination of absorption 
from limited faecal collection. The rare earths are suitable potential markers for such 
application, having been demonstrated to be non-toxic and not absorbed from the 
gastro intestinal tract.
The principal of determination of absorption with limited sample collection will be 
validated by application to measurement of the absorption of Fe and Zn by healthy 
volunteers.
Requirements are for consumption of a standard solution and a standard meal on 
subsequent mornings, and the provision of faecal output over a period of 10 days, 
and urine sample collection for 24 h, following each of the inputs for analysis. A 
blood sample is also required for determination of haematologic characteristics. The 
required procedure is based on the objectives of the study mentioned above. It is 
requested that the following principles of the procedure should be taken into account;
1. Because of the effects of sample losses during the collection period on results, it 
is important that no output be overlooked, and toilet papers used should also be 
collected.
2. The determination of isotopic enrichment above baseline level of a particular 
isotope is the principal of measurement of absorption. Excessive consumption of Fe 
and Zn effects the measurement of enrichment resulting in less precision. For this 
reason participants are requested to avoid excessive consumption of meat and meat
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products (particularly heart, kidney, and liver), and some of cereals e.g. All-Bran and 
Special K.
Procedure
1. On day 1, after an overnight fast, 50 mL of standard drink containing 3 mg of Fe, 
20 mg of ascorbic acid (Vitamin-C), and 1 mg of Sm as marker will be provided. This 
should be consumed with two rinses of water to ensure total consumption. No food 
or drink should be taken for 3 h after the standard drink.
2. On day 4, after overnight fast a wheat flour based standard meal (served with milk) 
containing 3 mg of iron, 3 mg of Zn, and 1 mg of Yb as marker will be provided. This 
should be eaten slowly and to ensure complete consumption with two rinses of milk. 
No food or drink should be taken for 3 h after the consumption.
3.The following samples will be required;
a) Stools should be collected from the day before the input and for 10 days 
thereafter,
b) Urine samples should be collected for 24 h before the first input and for 24 
h following each of the inputs.
c)A 5 mL of blood samples will be taken to establish haematological 
characteristics at the end of study period, at Royal Infirmary, Glasgow by an 
authorized person.
4. Volunteers will be provided with commode specimen collection systems, and 
plastic containers containing 20 mL of 2 M HCI for urine collection.
5. For stool sample collection, the ring should be located on the toilet and the 
specimen collection system should be securely attached to the toilet ring so that the 
bowl collects faeces nut not urine. On completion, the lid should be snapped on 
tightly and the frame of system should be removed (see the instruction given on lids). 
The bowl should then be contained one of the numbered bags and closed with a 
twist wire. Sample need to be stored in a cool place until it can be brought to a 
freezer at the SURRC. The date and time of movement and bag number should be 
entered on the record sheet enclosed.
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ICONSENT BY VOLUNTEER
I understand that this investigation, which has been fully explained to me, is part of 
a research project which has been approved by The Research Ethics Committee of 
Greater Glasgow Health Board, Royal Infirmary Unit, and may be no benefit to me 
personally.
I consent to participate in the study, and understand that I am free to withdraw if I so 
desire.
Signature of volunteer Date: 15.10.1993
I confirm that I have explained to the volunteer named above, the nature and purpose 
of the investigation.
Signature of investigator
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appendix-5: Concentrations of Sm marker, 57Fe tracer, and Fe (determined by CNAA, ICP-MS,
and AAS) in ashed faecal samples
Faecal weight, g Concentrations in ash, pg g'1±SD
Faecal 
sample No i
Time post- 
dosing, h i Wet j Dry Ash
I Sm j 
(CNAA) j
57Fe j 
(ICP-MS) j
Fe
(AAS)
SUBJECT C1
1 I 25 | 193.5 | 56.8 | 5.03 I 157.59±2.84 j 201.61 ±8.06 S 2912.7±43.7
2 ! 49 I 161.7 I 36.7 j 3.96 | 65.46±1.18 j 142.92±4.00 I 2656.9±39.9
3 I 73 | 114.5 | 24.6 | 2.11 j 5.19±0.17 | 88.33±1.86 I 3101.5±46.5
4 97 j 110.0 j 31.5 j 2.99 I 0.87±0.04 j 92.50±0.56 | 3538.6±53.1
5 j 121 j 190.3 | 45.8 I 5.44 j 0.34±0.02 | 71.29±2.07 | 3091.8±46.4
6 ! 145 I 225.6 j 52.0 | 6.26 | 0.20±0.02 | j
7 | 169.5 j 221.6 | 51.2 ! 5.89 I 0.15±0.01 | I
8 I 193.5 | 249.6 ! 54.5 | 6.26 j 0.14±0.01 | j
SUBJECT C2
1 i 13.3 j 134.2 | 42.9 | 5.45 I 15.60±0.28 | 110.71 ±2.77 | 3798.3±57.0
2 I 39 ! 64.2 | 20.6 j 2.54 I 73.54±1.32 | 189.78±4.18 j 3097.3±46.5
3 I 63.3 | 56.7 | 23.1 j 3.05 j 128.99±2.45 j 261.63±4.45 j 3546.3±53.2
4 i 98.4 S 171.7 | 56.0 j 7.24 ! 29.22±0.56 j 137.81±3.58 j 3101.8±46.5
5 j 135.6 ! 73.8 | 26.3 j 3.18 j 1.67±0.04 j 115.75±3.59 | 3237.7±48.6
" 6 | 159.4 i 317.0 i 80.3 j 8.42 I 0.58±0.01 j
7 I 183.7 | 69.1 I 19.8 j 2.2 | 0.27±0.01 |
8 ! 218.1 ! 90.5 | 29.9 j 3.38 ! 0.16±0.00 | j
SUBJECT C3
1 ! 10.3 j 280.3 ! 54.4 7.25 I 83.31±1.83 | 149.17±2.09 | 1920.9±28.8
2 ! 24.1 ! 234.0 I 49.6 5.72 | 60.73±1.52 | 112.88±2.48 | 1924.5±28.9
3 I 48.6 ! 277.4 ! 66.8 7.73 | 8.49±0.20 ! 57.11±1.31 j 1652.4±24.8
4 I 71.6 I 279.4 | 78.0 j 8.98 | 0.94±0.07 j 54.07±0.76 j 1354.1±20.3
5 I 83.3 | 100.2 | 31.2 | 4.67 j 0.25±0.06 ! 43.70±0.79 I 1510.3±22.7
6 ! 95 ! 56.6 ! 17.5 j 2.55 j 0.25±0.03 |
j
7 ; 103.9 j 165.9 j 48.3 | 9.01 | 0.21 ±0.02 j |
8 121.4 j 194.6 I 40.7 j 7.27 | 0.23±0.02 j
9 144.8 j 387.4 j 107.0 j 14.66 j 0.14±0.01 j
10 | 154.2 ! 203.9 j 50.2 9.25 I 0.12±0.01 } j
Administered dose, pg ! 1017 ! 2023
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appendix-5: Concentrations of Sm marker, 57Fe tracer, and Fe (determined by CNAA, ICP-MS,
and AAS) in ashed faecal samples
Faecal weight g Concentrations fan ash, pg g'1±SD
Faecal 
sample No i
Time post- I 
dosing, h Wet Dry Ash |
Sm
(CNAA) i
57Fe
(ICP-MS)
Fe
(AAS)
SUBJECT C4
1 | 21.9 235.8 55.9 j 5.69 114.11±2.05 | 244.50±5.13 | 2499.1±37.5
2 I 45.9 197.0 51.1 | 4.98
j 80.59±1.45 166.83±6.67 I 2317.8±34.8
3 j 69.5 | 137.4 i 39.4 | 4.18 j 13.25±0.28 72.92±1.53 j 2071.7±31.1
4 I 96.2 j 180.8 47.6 | 4.95 j 0.29±0.02 85.50±1.37 I 2160.2±32.4
5 i 120.1 | 106.7 | 20.0 j 2.16 0.11±0.01 78.64±1.73 | 2769.0±41.5
6 ! 142.9 113.7 34.6 3.4 i 0.11±0.01 j !
7 | 166.3 j 250.4 75.0 | 7.05 i 0.13±0.01 |
8 j 190.2 I 194.9 i 38.1 | 4.39 0.15±0.00 I i
SUBJECT C5
1 \ 15.3 170.6 55.4 ! 5.19 39.01 ±0.90 j 164.60±5.10 | 4625.0±69.4
2 I 30.6 198.3 49.0 | 5.24 144.05±3.46 224.47±1.80 j 4518.6±67.8
3 I 60.6 303.1 65.1 6.14 9.51±0.24 i 109.00±2.40 ! 3471.8±52.1
1
4 81.2 j 125.9 i 55.5 ! 4.9 i 0.94±0.06 i 108.04±6.05 j 4457.4±66.9
5 ! 106.4 138.2 34.7 ! 3.96 0.44±0.05 i 85.96±1.03 I 3352.9±50.3
6 | 133 267.0 I 71.2 | 8.04 i 0.30±0.03
7 i 158.7 54.8 i 13.9 1.48 : 0.31 ±0.05
8 ! 170.3 470.0 I 83.3 1.54 0.17±0.00 I
SUBJECT C6
1 i 3.5 46.7 : 5.7 | 0.76 144.60±0.43 i 237.29±6.88 j 1534.7±23.0
2 I 22.5 127.1 37.0 | 4.73 I 165.40±0.33 337.38±5.40 j 1781.3±26.7
3 I 48.3 170.5 21.8 j 2.64 43.63±0.17 ; 127.14±3.18 | 2372.0±35.6
4 ! 53.5 138.4 24.6 3.37 j 9.01 ±0.07 j 68.57±0.75 I 2226.8±33.4
5 ! 71.4 247.9 29.9 4.35 2.39±0.04
j 55.83±0.67 | 2068.0±31.0
6 ! 97.7 144.0 32.4 2.73 0.45±0.03 76.45±1.22 ! 2386.2±35.8
7 | 121.5 303.2 60.5 | 7.53 0.21 ±0.02
8 ! 143 49.4 14.7 | 1.69 0.22±0.01 |
9 I 153 176.9 34.7 | 4.3 0.26±0.01
10 167.3 48.1 12.7 j 1.61 I 0.28±0.01 j ;
Administered dose pg 1017 2023
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appendix-5: Concentrations of Sm marker, 57Fe tracer, and Fe (determined by CNAA, ICP-MS,
and AAS) in ashed faecal samples
Faecal 
sample No
Time post- 
dosing, h
Faecal weight, g
Wet Dry Ash
Concentrations in ash, |ig g'1±SD
Sm | 57Fe Fe 
(CNAA) [ (ICP-MS) | (AAS)
SUBJECT C7
1 8.5 36.2 9.9 1.03 ! 89.76±1.89 | 270.66±7.85 \ 4042.0±60.6
3 | 3 !1
0
I ] i ....
...
...
.i
23.4 240.4 j 39.5 j 4.69 | 141.67±2.27 | 231.52±9.26 j 3339.3±50.1
3 47.8 160.2 j 23.9 2.92 I 52.20±0.94 ! 109.33±4.15 | 1924.8±28.9
4 73.3 70.9 j 16.3 j 1.58 I 9.10±0.25 ] 81.18±2.27 j 2164.1 ±32.5
5 95.8 145.9 | 30.7 j 3.62 ! 1.10±0.03 I 123.15±3.45 | 2697.9±40.5
6 109.6 98.1 19.8 1.88 I 0.53±0.04
7 120.6 82.1 ! 23.0 2.3 ! 0.31±0.04
8 145.1 143.3 ! 27.7 | 3.31 j 0.24±0.01
9 154.4 40.3 j 10.2 0.95 j 0.29±0.01
10 167.1 233.1 | 43.4 4.6 0.19±0.00
Administered dose, pg I 1017 | 2023 I
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appendix-3: List of suppliers
Materials
Hydrochloric acid (Aristar grade) 
Nitric acid (Aristar grade) 
Hydrogen peroxide (Aristar grade)
Supplier
BDH or Merck/ UK
AAS standards (specpure) 
Rare earth oxides (specpure)
Johnson Matthey, Material 
Technology/UK
Isotope enriched iron and zinc (metallic form) Europa Scientific Ltd/UK
Farina, wheat based flour Cook, J.D., Deparment of 
Medicine, Kansas 
University Medical 
Centre/USA
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